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Evidence synthesis is considered a corner stone of modern health care and clinical practice. 
Systematic reviews of randomised trials, when undertaken with meta-analysis provide 
summary estimates on the effectiveness of interventions. However, the findings of meta-
analysis are often limited by the selective reporting of primary studies, and the variations in 
population, intervention and outcomes. Furthermore, difficulties in disentangling the study 
and individual level associations in meta-analysis make them susceptible to ecological fallacy, 
and may lead to incorrect conclusions. 
 
Meta-analysis using Individual Participant Data (IPD) has the potential to overcome many of 
the above limitations, by using raw trial data. Access to IPD minimises problems from 
incomplete or incorrect reporting of trial outcomes, by verifying reported results, and by 
standardising the definition of outcomes where possible. Importantly, this allows detecting 
any variation in the effects of interventions according to characteristics of the participants. 
Amalgamated individual datasets assembled to address the effectiveness question, can be 
further used to explore secondary objectives such as the relationship between surrogate and 
clinical outcomes. This maximises the use of available clinical data, and addresses the 
problem of research waste. 
 
In this thesis, I evaluated the effects of diet and physical activity based interventions in 
pregnancy on maternal and offspring outcomes using both study-level and IPD meta-analyses, 
and assessed the differential effects of interventions on outcomes according to mother’s BMI 
pre or in early pregnancy. I reviewed the variation in outcomes reported in this field, and 
developed composite outcomes for IPD meta-analysis. I also evaluated the relationship 
between weight gain in pregnancy and clinical outcomes in pregnancy using the IPD meta-
analysis methodology.  





The aim of this thesis was to evaluate the effects of diet and physical activity based 
interventions in pregnancy on clinical outcomes using standard and advance methods of 
evidence synthesis; assess the variation in outcomes and their clinical importance in a trial 
with those interventions and examine the relationship between gestational weight gain and 
important clinical outcomes. 
   
Methods 
Delphi methodology, systematic reviews of literature, and meta-analyses using study-level 




Developed composite outcomes comprise of four maternal (gestational diabetes, hypertensive 
disorders in pregnancy, preterm birth, caesarean section) and four offspring outcomes 
(stillbirth, small for gestational age, large for gestational age, and admission to neonatal 
intensive care unit). The components to assess maternal composite outcome were available in 
two-thirds (66.7%, 24/36) and for offspring composite in half (50%, 18/36) of the studies in 
the IPD meta-analysis. The effect of interventions was not statistically significant neither on 
the maternal nor on the offspring composite – Odds Ratio (OR) 0.90 (95% CI 0.79, 1.03) and 
OR 0.94 (95% CI 0.83, 1.08), respectively. The direction of the pooled effect was consistent 
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Effects of diet and physical activity based interventions 
The IPD meta-analysis of 36 RCTs (>12 500 women) showed a significant effect of diet and 
physical activity based interventions in pregnancy in reducing gestational weight gain (Mean 
Difference -0.70 kg, 95% CI -0.92, -0.48) and chance of caesarean section delivery (OR 0.91, 
95% CI 0.83, 0.99) in comparison to routine antenatal care. There was no effect of the 
interventions on any of the offspring complications. Incorporation of outcome data 
unavailable on study-level returned more modest magnitude of the summary estimates in 
comparison to effects obtained using study-level data of trials that shared IPD. The addition of 
study-level data from non-IPD trials changed the magnitude and the statistical significance of 
the summary effects on GDM – from OR 0.89 with only IPD (95% CI 0.72, 1.10; 27 studies, 
9 427 women) to OR 0.76 (95% CI 0.65, 0.89; 59 studies, 16 885 women). It has also changed 
the funnel plot structure in the meta-analysis for gestational weight gain (Egger’s test p = 0.04 
with only IPD to p= 0.61).  
 
The IPD meta-analysis shows that the effects of diet and physical activity based interventions 
on the maternal and the offspring outcomes did not differ by women’s BMI status. While the 
study-level meta-regression indicated that the interventions might reduce gestational weight 
gain stronger for the obese women – coefficient -0.22 (95% CI -0.33, -0.11) for each 10% 
change in the proportion of women in the obese class. 
 
Outcomes in trials with diet and physical activity based interventions 
66 primary publications from trials with diet and physical activity based interventions in 
pregnancy reported 142 outcomes. Half of those outcomes appeared in the publications once 
(72/142). ‘Critically important’ outcomes are reported less often in comparison to ‘non-
critical’ ones (15.5%, 22/142 vs 68.3%, 97/142). The overall quality of outcome reporting 
varied between trials with the least frequently provided information on the methods to 
improve the quality of outcome measures (33.3%, 22/66 publications). 
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Gestational weight gain and pregnancy outcomes 
IPD from 4 429 pregnant women randomised to the control arms of RCTs with diet and 
physical activity based interventions were available for the analysis. Women who most often 
exceeded the IOM recommendation belonged to the overweight (51.5%, 641/ 1 245 women) 
and the obese groups (44.5%, 695/ 1 562 women) while women with normal BMI most often 
gained below the recommended amounts (40%, 649/1 622 women). Each kilogram of 
gestational weight gain within the IOM ranges was not link with a change in the chances of 
preterm birth, caesarean section, or birth of LGA and SGA infant. Not achieving of the 
recommended weight was associated with the decreasing chance of giving birth to LGA infant 
with each kilogram below the lower limit among the obese women (OR 0.80, 95% CI 0.65, 
0.99). Each kilogram of weight gain above the upper limit was associated with an increase in 
the chance of caesarean section (adjusted 1.04, 95% CI 1.01, 1.08) and delivering LGA infant 
(adjusted 1.08, 95% CI 1.05, 1.12) regardless on women’s BMI status. 
 
Conclusions  
Diet and physical activity based interventions in pregnancy moderately reduced gestational 
weight gain and decrease the odds of caesarean delivery. Overall, IPD meta-analysis 
improved the robustness of the evidence synthesis of RCTs with diet and physical activity 
based interventions. However, more attention is needed for the data-related issues in IPD 
meta-analysis as the purported benefits of the method are not always practically realised. The 
use of the composite outcomes was hampered by the variable availability of important clinical 
outcomes. The introduction of minimal core outcome set would facilitate the comparison of 
the wide range of the evaluated interventions and improve implementation of the composite 
outcomes. Gestational weight gain was found to be associated with the odds of delivering 
LGA infant and caesarean section. Future research should aim to collect and report a minimal 
set of outcomes, and ensure better reporting of study conduct and its findings. 
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Chapter 1 Introduction 
1.1. Evidence synthesis of randomised trials and its role in the modern health care 
Decisions in health care and medicine to effectively inform clinical practice should be based 
on all available body of evidence.1 ‘Evidence synthesis’ is a term used to describe a formal 
way of systematic and critical appraisal of information. For over three decades it has played a 
pivotal role in medical decision making and has constituted the basis of Evidence-Based 
Medicine (EBM).2 The overarching aim of the evidence synthesis is to inform clinical 
practice, identify new research questions, and improve the design of future studies.3,4 
 
While evidence synthesis refers to a broader concept of data synthesis, a systematic review is 
a process of identification, evaluation, and provision of a summary of the findings from all 
studies relevant to the prespecified question.5 The key strengths of this approach, in contrast 
to the traditional review, are transparency and reproducibility. This systematic and transparent 
approach to bringing together all of the available evidence on a given subject, and minimises 
bias arising from an unwarranted emphasis on ‘exciting’ studies.5-7 Additionally, it 
incorporates formal quality appraisal of trial design and conduct.5,7,8 In the hierarchy of 
evidence, a systematic review with meta-analysis of randomised controlled trials (RCTs) is 
being considered the highest level of evidence synthesis when assessing the effectiveness of 
interventions9 (Figure 1.1). 
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Figure 1.1 Hierarchy of evidence in medical research 
 
 
Systematic reviews identify research gaps and are a key part of research grant applications. 
Moreover, they are used to inform policy making and health care guideline.3,10 Leading health 
organisations such as the World Health Organisation (WHO) worldwide 11, National Institute 
for Health and Clinical Excellence (NICE)12,13, Scottish Intercollegiate Guidelines Network 
(SIGN)14 in the UK in their guidelines development process rely on the best available 
evidence synthesised and reported following rigorous methods. 
1.2. Challenges in evidence synthesis 
The exponential increase in the volume of currently available evidence with varied 
reporting15, results in systematic reviews being redundant or irrelevant16. Around 65% of 
systematic reviews on the same topic failed to include any additional outcomes16. Meta-
analysis was introduced to quantify the summary estimates, and to interpret the overall body 
of evidence.8,17 Furthermore, meta-analysis can improve the precision of effect estimates in 
comparison to individual studies, quantify true differences in the estimated effect between the 
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studies, detect problems with existing evidence and generate new hypotheses.17 The greatest 
advantages of this method its inexpensiveness and accessibility to researchers without 
advanced statistical skills. The majority of meta-analyses uses data extracted from trials 
publications or obtained directly from study authors in a summary form.5,7 However, study 
level summaries have reduced power to identify patients who benefit the most from 
interventions.18 
 
Subgroup analyses within systematic reviews could assess the effects in particular groups of 
patients, nonetheless, they are subject to availability of data in trials’ publications.19 Such 
findings are usually considered to be a hypothesis-generating exercise 20. Another approach is 
to identify factors (e.g. participant characteristics) that modify the response to the 
intervention, through meta-regression. Due to difficulty in disentangling the study-level and 
individual-level associations,20-22 both methods are susceptible to ecological fallacy, 23 and can 
lead to incorrect conclusions. 
 
The study-level meta-analysis depend on the quality of trial reporting therefore being 
vulnerable to biases arising from inaccurate or incomplete reporting. Reporting bias arises 
when the research findings are revealed selectively due to their nature.5 Trials with 
undesirable or unimpressive findings tend to be published with happens with a significant 
delay or not published at all. It has been recognized that ‘positive’ trials (with a significant 
findings) have a greater chance of being published sooner, in English and in a high impact 
journal rather than the ‘negative’.24 This extreme case of reporting bias, referred to as 
‘publication bias’, over the years has been extenivelly discussed in the methodological 
literature25-30, however, it is not as prevalent as other reporting-related issues hampering 
evidence synthesis. 
 
Selective or incomplete reporting of outcome data can potentially have a substantial impact on 
the validity of a systematic review.31,32 An evaluation of Cochrane reviews showed that 37% 
   
 
24 
of pre-specified outcomes were later not reported in trials publications.33 Furthermore, two-
third of Cochrane reviews was missing some percentage of participants’ data on a single 
primary outcome.34 Other research has shown an association between positive result for the 
outcome and the completeness of its reporting.35 Outcomes are not being reported (or are 
reported only partially), defined and measured in various ways making evidence synthesis, 
and drawing meaningful conclusions difficult.36 
 
Outcomes in clinical trials and evidence synthesis should be selected based on their 
importance and relevance to patient care. However, the challenge with collections of 
important health outcomes in the trials is that might rarely occur or be expensive to measure.37 
Surrogates of important health outcomes are frequently used in clinical trials to overcome 
those constraints.38 They are based on an assumption of a direct link between the surrogate 
and the important health outcomes.37 However, they are frequently reported inadequately39 
and for many surrogates this link might be questionable as the response to the intervention on 
the surrogate might be different in comparison to the main outcome of interest e.g. cholesterol 
level and stroke rates40,41. 
1.3. Methods to improve evidence synthesis 
The recently published EBM manifesto call for the tools to eradicate the systematic bias and 
error in the research underpinning health care.42 Meta-analysis using individual participant 
data (IPD) is one of the tools that have the potential to fulfil the EBM manifesto’s goals. By 
overcoming the limitations of the study-level synthesis, IPD meta-analysis earned a status of a 
‘gold standard’ in evidence synthesis of effectiveness trials.43-45 The advantages of this 
advanced approach to meta-analysis are numerous,43,45,46 such as the ability to account for the 
correlation between multiple endpoints, deal with missing data, or verify results presented in 
the original study reports. Access to IPD allows addressing outcome-related problems in 
evidence synthesis such as outcome reporting bias.45,46 When more than one clinical outcome 
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is considered to be relevant or events are infrequent use of composite outcome seems to be a 
reasonable option.47-49 However, this type of meta-analyses are prone to challenges due to data 
acquisition (availability bias) and the statistical analysis requires more advanced methods and 
skills than meta-analysis using data extracted from the articles.45 A recent study showed that 
only 25% of evaluated IPD meta-analyses obtained 100% of eligible trial data with the most 
frequently lack of specific reason for IPD unavailability.50 The meta-analysis using IPD is a 
costly and time-consuming approach to evidence synthesis what potentially contributes to 
their low uptake in clinical decision making.51 
 
Variation in choice of trial outcomes and the quality of their reporting recently gained more 
attention on the medial research agenda.52-54 In response to the problems associated with use 
and reporting of outcomes in primary and also secondary studies a concept of a core outcome 
set (COS) has been established.52 COS is a minimal list of critical outcomes identified through 
a robust and transparent way. The outcomes from such a list should be routinely collected and 
reported in all trials in a specific clinical area.52 It has been indicated 34,55 and subsequently 
demonstrated56 that introduction of COS has the potential to address the problems with 
selection and reporting of trial outcomes therefore improving the evidence synthesis and the 
health care.57 
1.4. Obesity and high weight gain in pregnancy 
Maternal obesity and Body Mass Index (BMI) above 25 kg/m2 in pregnancy have been linked 
with an increased risk of poor health outcomes for the women and her child.58-60 Obese 
women are a higher risk of a miscarriage, problematic labour or metabolic and cardiovascular 
disorders.61 Whereas, their children are deemed to be at risk of prematurity62 and major 
congenital malformation63, and in the long-term childhood obesity and associated with it 
illnesses.60 Advice on the optimal gestational weight gain and ways to achieve it are among 
the main controversies around the management of obesity in pregnancy.64 The evidence also 
   
 
26 
suggests that high weight gain in pregnancy is associated with an increased chance of 
maternal and fetal complications65-67 even for women entering pregnancy with BMI within the 
normal range.68,69 Furthermore, women with a high gestational weight gain in their first 
pregnancy are more likely to enter subsequent pregnancies heavier putting themselves and 
their future offspring at a higher risk of health problems.70  
 
The most frequently referenced guidelines on the amount of weight gain in pregnancy to 
avoid poor pregnancy outcomes are issued by the Institute of Medicine (IOM). The IOM 
recommendations initially released in 1990, then updated in 2009, advise women entering 
pregnancy to gain 11 16 kg, 7 – 11 kg or 5 – 9 kg if they entered pregnancy with normal BMI, 
overweight or obese, respectively.71 However, the health policy makers worldwide do not 
always recommend these ranges due to the low certainty of the evidence used to inform the 
IOM guidelines.72-74 The studies evaluating the relationship between gestational weight gain 
and the adverse pregnancy outcomes are limited by similar factors. 
1.5. Effect of diet and physical activity based interventions in pregnancy 
Acceptable and safe interventions to manage women’s weight in pregnancy have been sought 
with diet, physical activity, weight gain monitoring and behavioural change techniques being 
at the forefront. Over 40 systematic reviews of RCTs (eight Cochrane reviews including their 
updates) evaluating the effects of diet and physical activity based interventions in pregnancy 
have been published between 2003 and 2017. The reviews included from none up to 61 trials 
evaluated the effects of the interventions overall or individually grouping them as ‘diet only’, 
‘physical activity only’, or a combination of both diet and physical activity. The main 
outcomes of interest were gestational weight in pregnancy and gestational diabetes (GDM) 
with a wide range of secondary maternal and offspring outcomes. The interventions were 
evaluated in various population – women across entire spectrum of BMI values or in its 
particular spectrum (overweight, obese), women at risk of pregnancy complications, etc. The 
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majority of them concluded that the findings are either inconclusive or uncertain. The main 
limitations were poor quality of identified trials, clinical and statistical heterogeneity of the 
pooled effects that could not be address by subgroup analysis or in meta-regression, variation 
in the type of evaluated outcomes and interventions (components, duration, and frequency). A 
tabulated summary of the aims, populations and results of the individual systematic reviews 
with their references is available in Appendix 1.1. 
1.6. IPD meta-analysis and establishment of collaborative group 
A systematic review commissioned by the National Institute for Health Research (NIHR) of 
44 RCTs on diet and physical activity based interventions showed a significant reduction in 
gestational weight gain (review’s primary outcome) with the diet and physical activity-based 
interventions when compared to a routine antenatal care.75,76 The evidence synthesis also 
showed some evidence of the positive effect of the interventions in the reduction of pre-
eclampsia and shoulder dystocia.76 The subgroup analysis of diet-only studies showed a 
greater reduction in gestational weight gain that all interventions combined. The limitations of 
the systematic review were similar to others limited namely the substantial statistical 
heterogeneity in the pooled effects, uneven reporting of important clinical outcomes across the 
studies, and lack of information on the effects of interventions by potential intervention effect 
modifiers like booking BMI, women’s age or ethnic origin. 
 
A collaborative group of investigators involved in the primary trials with diet and physical 
activity based interventions in pregnancy was established in 2011 with a successful grant 
application for an IPD meta-analysis of RCTs with diet and physical activity that followed 
soon after77(Figure 1.2). Within the next years, the international Weight management In 
Pregnancy (i-WIP) collaboration brought together over 50 researchers from 16 countries 
across five continents.78 The primary objective of the i-WIP IPD meta-analysis was to 
determine the differential effects of weight management interventions in pregnancy on 
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maternal weight gain and composite maternal and composite fetal outcomes in subgroups 
women based on BMI at booking, age, parity, ethnicity and underlying medical conditions. 
The study’s secondary aim was to address an issue of the relationship between the amount of 
weight gained during pregnancy and the risk of adverse pregnancy accounting for women’s 
BMI at the beginning of pregnancy.79 
 
Figure 1.2 Work leading to Individual Participant Data meta-analysis on effects of diet and 
physical activity based intervention in pregnancy 
 
IPD, Individual Participant Data 
 
1.7. Aims and objectives of the thesis 
The overarching aim of this thesis was to evaluate the use and impact of advanced methods of 
research synthesis when applied to RCTs of the effects of diet and physical activity based 
interventions in pregnancy. The specific objectives of this thesis were as follows: 
 
1) Develop composite outcomes for assessing effects of diet and physical activity based 
interventions in pregnancy in order to perform the i-WIP IPD meta-analysis 
2) Assess overall summary effects of the interventions on pregnancy outcomes using 
IPD and study-level meta-analysis 
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3) Assess the modifying effect of maternal booking BMI on the treatment effect using 
meta-analysis based on IPD and study-level meta-analysis 
4) Assess the variation in reporting of trial outcomes in RCTs with diet and physical 
activity in pregnancy 
5) Evaluate the gestational weight gain and corresponding adherence to the IOM 2009 
recommendations80 as a surrogate of clinically important outcomes 
 
The following techniques were applied to address the above questions concerning effects of 
diet and physical activity based interventions in pregnancy: Delphic surveys, IPD collation, 
IPD meta-analysis variants, meta-regression to explore study heterogeneity, and multivariable 
models for evaluating associations.  
 
In my thesis, I will not attempt to quantify the potential gains from accessing IPD in 
comparison to aggregate-data for meta-analysis of effectiveness trials. Furthermore, as the 
impact of potential sources of heterogeneity such as non-compliance or risk of bias in 
individual studies has been covered in detail in the HTA NIHR report, it will not be discussed 
within the scope of this thesis.  
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Chapter 2 Overview of methods used in the thesis 
2.1. Introduction 
The aim of this chapter is to describe and explain methods used to address the overall aims of 
this thesis. The individual objectives of the chapters and the methods are outlined in Table 
2.1. I first describe the process of developing a composite outcome to be used in i-WIP IPD 
meta-analysis (section 2.1). Next, I describe the systematic review methodology used to 
address objectives 1 to 4 of this thesis on effectiveness of intervention (section 2.2). The 
section explains the general principles guiding systematic review process and explains how it 
is applied in individual chapters. Further details on the methods are provided in Chapters 4, 5 
and 6. Thirdly, I provide description of the statistical methods used to pool together by using 
a) study-level data extracted from the studies’ publications, and b) participant-level data 
obtained from original trials where possible. The fourth section discusses sources of bias in 
evidence synthesis in particular the outcome reporting and availability bias, and impact of 
effect estimates from small trials (‘small-study effects’). In the final section of this chapter, I 
described development of regression models presented in this thesis. 
 
  
   
 
31 







Objective I: Development and use of composite outcome in IPD meta-analysis 















Objective II: Overall effect of interventions: IPD and study-level meta-analysis 
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Objective III: Modifying effect of booking BMI: IPD and study-level meta-analysis 
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Objective V: Relationship between gestational weight gain and adverse pregnancy outcomes 
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2.2. Development of composite outcome using Delphi methodology 
2.2.1. Rationale for composite outcome 
One of the main reasons for using composite outcomes in medical research is the problem of 
selecting just one outcome important to patient care.47 More commonly the choice in not 
obvious and varies from researcher to researcher. Secondly, outcomes perceived as critically 
important e.g. maternal mortality or eclampsia are rarely encountered what makes it difficult 
to power any study to detect an effect of the intervention on these without recruiting 
thousands of women and making study logistically challenging. The introduction of 
composite outcomes allows addressing above pitfalls; however, it comes with certain 
challenges. Composite outcomes, frequently used in cardiovascular research, have been 
accused of leading to exaggerated estimates of observed treatment effects and difficulty with 
their interpretations.41,81 
 
In order to ensure that the composite outcome will be a valid one, it needs to include 
outcomes that are relevant and critically important to a given research question. Historically, 
the importance of the outcomes was defined by a panel of experts led by the ones with the 
greatest seniority. The introduction of Delphi methodology to harvest opinions and prioritise 
them introduced an egalitarian spirit and allowed the less senior specialist to have their saying. 
Delphi methodology has been used to prioritise outcomes by their relevance to patient care 
when evaluating diet and physical activity based interventions in pregnancy and subsequently 
develop composite outcomes, separately for the women and the offspring, for use in i-WIP 
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2.2.2. Delphi methodology  
The Delphi survey consists of a predefined number of iterations. The survey usually begins 
with an open-ended question that is circulated to a group of experts and opinion leaders on the 
topic. After obtaining the responses from the pannelists, they are analysed in a qualitative way 
aiming to tease out common themes. The finding of the initial survey is used to inform the 
subsequent, more structured questionnaire. The second questionnaire tends to ask to rate or 
rank presented items and facilitates a quantitative analysis of the responses. Convergence in 
the consecutive rounds of the survey indicates a consensus among the panellists’ 
responses.82,83 The primary list of outcomes (equivalent to an open-ended questionnaire) was 
derived from a systematic review and a previous Delphi survey75. The panel of experts was 
established by inviting to the surveys the researchers involved in development and conduct of 
RCTs evaluating the effects of diet and physical activity based interventions on pregnancy 
outcomes. The invitation was also extended on to researchers involved in the conduct of the i-
WIP IPD meta-analysis.79 The majority of the panellists belongs to the i-WIP Collaborative 
Group (section 1.6). 
 
2.2.3. Application of Delphi method in the thesis 
The survey was run in two stages between June and September 2013. On the first stage, the 
researchers were invited to score the previously established list of maternal and offspring 
outcomes. Each outcome, on the list was provided with the median and Inter Quartile Range 
(IQR) for its importance as derived from the previous work.75 The panellists could score the 
outcomes between one and nine; a score of 9 is considered to be critical, and 1 is of limited 
importance to patient care (Likert scale). During this round the responders were presented 
with an opportunity to add outcomes they considered to be important, yet not appearing on the 
list. In the case of lack of response, the panellist received two reminders after two, and four 
weeks from the date when the survey was sent initially. Those who did not respond in the first 
   
 
34 
round were not invited to a subsequent one. All available responses were assessed, and the 
medians and IQR of received scores were calculated for individual outcomes. 
 
In the second round, the panellists received the average scores from round one collated with 
their individual scoring. They were asked to reflect on the scoring and again assign ranks to 
the outcomes. An IQR of two or less was assumed to indicate a consensus among the 
responses. The panellists were unaware of other responders’ scores throughout the entire 
process. I was responsible for sending the surveys, collating the data and was the only person 
who knew the responses of the individual panellists. After both rounds the scores for 
individual outcomes were collated and summarised. 
 
2.2.4. Criteria of composite outcome’s components  
The outcomes with a median response score of seven or more accompanied by IQR of 2 or 
less indicating consensus among the responders in the Delphi survey were considered 
candidates for the development of the composite outcomes. The outcomes in order to be 
considered a component for inclusion in the composite outcome had to meet the following 
criteria:  
a) Considered to be critically important by the Delphi panel 
b) Outcomes of equal importance 
c) With similar rates of occurrence 
d) Independent of each other, and 
e) Based on prior evidence of the same direction of the intervention effect.47,49 
 
The composite outcome of adverse events was developed separately for the women, and the 
offspring and the outcomes considered surrogate of women’s or offspring’s morbidity and 
mortality were eliminated from the process.  
 




2.3. Systematic review of the effectiveness trials 
A systematic review is a process of identification, evaluation and summary of the findings 
from all studies relevant to the prespecified question.84 There are five main steps of a 
systematic review: framing a clearly defined and focused question, systematic and 
comprehensive literature search, assessment of study quality, a summary of evidence and their 
interpretation. The review earns term “systematic” whenever it followed above process85 and 
the key strengths of this approach, in contrast to traditional review, are transparency and 
reproducibility.11,84 The systematic review is guided by a structured question describing 
population, intervention of interest, comparator and outcome(s) (PICO acronym). It is 
important to evaluate how the each of them can differ between existing trials as this will 
substantially impact subsequent steps of the review process e.g. study selection and evidence 
synthesis.85 The review question should be defined before embarking on the systematic review 
and not substantially changed during the entire process.7,86 The authors are also encouraged to 
register their work prospectively to avoid duplication of efforts, reduce bias and to promote 
transparency.87 
 
Identification of relevant evidence in the systematic review should be extensive and 
performed in relevant electronic databases of medical literature supplemented by a manual 
search of the grey literature. This approach prevents cherry-picking of the studies and allows 
to generate a comprehensive list of citations to address the question. There should be no 
language and time restriction unless there is a clear rationale for implementing them e.g. 
intervention changed substantially over the years. The assessment of citations and full text of 
potentially eligible publications should be done by independent individuals, exclusion and 
inclusion reasons documented and the entire selection process described.88  
 




2.4.1. Methods applied in this thesis 
Both systematic reviews conducted in this thesis followed PICO question (Table 2.2). The aim 
of the review in chapter 4 was to evaluate the effect of diet and physical activity based 
interventions in pregnancy of gestational weight gain and adverse pregnancy outcomes. It was 
guided by a prospectively developed and registered protocol (PROSPERO registration 
number: CRD42013003804). The aim of the systematic review in chapter 6 was to evaluate 
the range and frequency of outcomes reported in trials on diet and physical activity based 
interventions in pregnancy. When reporting results in chapters 4 and 6, I complied with the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards89,90. 
 
The systematic reviews conducted in this thesis were based on a comprehensive literature 
search without language restrictions. The search strategy was based on the structure developed 
in the previous work76 and combined search terms (and their variants) such as ‘pregnancy’, 
‘body mass index’ and ‘randomised controlled trials’ (Appendix 2.1). The searches were 
performed in databases such as Medline, Embase, Cochrane Database of Systematic Reviews, 
Database of Abstracts of Reviews of Effects, Cochrane Central Register of Controlled Trials 
and Health Technology Assessment Database between October 2013 and March 2015, and 
updated in January 2016 and February 2017. Search updates extended onto three additional 
databases i.e. PsycINFO, Scopus, and Web of Science. Additionally, non-systematic methods 
were used to identify any potentially relevant non-indexed reports and supplement the 
databases searches. These comprised of hand search, an Internet search using general engines, 
and inquiry among the members of the i-WIP Collaborative Group about any potentially 
relevant trials. 
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Table 2.2 Components of structured question for systematic reviews in the thesis 
Question Components  Chapter 4 Chapter 6 
Population Pregnant women with BMI ≥ 18.5 kg/m2  
without diabetes or early onset GDM 
Interventions Diet, physical activity or mixed approach  
(diet, physical activity, weight gain monitoring or  
behaviour modifying technique) 





Gestational weight gain, maternal 
composite outcome, offspring 
composite outcome 
Individual components of maternal 
composite outcome 
Individual components of offspring 
composite outcome 
Type of clinical outcomes 
Study design Randomised controlled trial (full-scale, pilot and feasibility studies with 
clustering on individual or centre level) 
Publication type Conference abstracts and posters, 
full-scale trial publications 
Only publications from full-scale 
trials 
BMI, Body Mass Index; GDM, gestational diabetes; 
 
2.4. Meta-analysis of effectiveness trials 
Meta-analysis is a quantitative method allowing for pooling of the numeric data across all 
relevant studies.91,92 The aim of the meta-analyses performed in chapters 4 and 5 was to 
synthesis the evidence on the overall effects of diet and physical activity in pregnancy on 
gestational weight gain and maternal and offspring outcomes, and in subgroups of women 
based on the pre- or early pregnancy BMI. Meta-analysis methods was also used in chapter 7 








2.4.1. Study and participant level meta-analysis 
Most frequently, meta-analyses are based on study-level data extracted from trials’ 
publications or obtained directly from study authors. Alternatively, it can be performed using 
participant-level data.18,45 In study-level data meta-analysis, data for binary outcomes is 
extracted to two-by-two tables and for continuous outcomes mean and standard deviations 
(SD) are sought. IPD meta-analysis uses data on particpant rather than study or group level 
can be code in binary or categorical ways or as a discreat values. For example in IPD meta-
analysisparticpant age would be analyesd as a individual values for each particpant in a study 
rather than as an average age of all the particpants in that study. There are two equivalent 
approaches to IPD meta-analysis– one and two-stage.93,94 In a two-stage approach the 
estimates (and their variances) of interest the IPD from individual trials are analysed 
separately accounting for the clustering of participants within trials. This step produces 
summary estimates for each study that are subsequently pooled together using appropiate 
models as in a typical meta-analysis of study-level data.  
 
It is paramount importance to preserve clustering of participants with the original studies as 
neglecting this may lead to incorrect estimation of the effect estimates and flawed 
conclusions95. In the one stage approach, IPD from individual datasets is used in the same 
model while accounting for the within-study clustering. The two-stage is a more laborious 
approach to IPD meta-analysis, however easier to implement than the one-stage94. The later 
one is quicker but more prone to technical problems due to the complexity of models. In both 
types (IPD and study-level data meta-analysis) the data is being pooled using random or fixed 
effects model to obtain summary estimates – risk ratio (RR) or odds ratio (OR) for 
dichotomous outcomes, and mean difference (MD) or standardised mean difference (SMD) 
for the continuous outcome with their 95% Confidence Intervals (CIs). 
 




2.4.2. Exploration of between study heterogeneity  
Studies included in systematic reviews inevitably differ from each other. Their recruited 
participants across different health care settings were guided by different protocol etc. 
Examining those differences and defining the generalizability of findings is one of the most 
important tasks when conducting meta-analysis.96 Commonly the variability in studies 
characteristics is described using term ‘heterogeneity’ – clinical (variability in participants’ 
characteristics, interventions, etc.) or statistical. The statistical heterogeneity is encountered 
when the difference between the effects pooled across the studies are greater than one would 
expect due to pure chance.97 However, the observed variation in the estimated effect sizes can 
be misleading, as it comprises of a true variation in effect sizes and the random error. 
 
The inconsistencies between the effects across the studies can be formally quantified using 
measures such as Q statistic (a measure of weighted squared deviations), τ2 (the between-study 
variance) or I2 (the proportion of true heterogeneity to total observed variation).98  The 
measure frequently used to assess inconsistency across the studies in systematic reviews is I2. 
With its scale ranging from 0 and 100%, it is not sensitive to the metric of the effect size and 
the number of pooled studies. Alternativelly, τ2 as the measure of between-studies variance or 
τ (standard deviation of the true effects) can be used. In contrast to I2 metric, those measures 
reflect the scale of the effect size (e.g. log odds) and are not sensitive to the number of pooled 
studies. 
 
When interpreting the heterogeneity the choice of the effect measure should be considered, as 
in some instances observed heterogeneity may be an artificial consequence of an inappropriate 
choice of the effect measure. For example, in case of binary outcomes when the baseline risks 
in the control groups vary across the studies, the homogeneous relative effect estimates (odds 
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ratios or risk ratios) are accompanied by a heterogeneous absolute estimates (risk differences), 
and vice versa.5 
 
In study-level data meta-analysis, exploration of between-study heterogeneity is frequently 
done through a subgroup analysis or a meta-regression.99,100 The subgroup analysis involves 
grouping extracted data according to characteristic of interest e.g. participant’s age or 
intervention does, in order to make comparisons between them.19 Meta-regression is an 
extension to the subgroup analysis used to explore the impact of continuous and categorical 
characteristics even in the same statistical model.99 In principle, the method is analogous to a 
simple regression; hence, it is generally advice to use this approach only if there are ten or 
more studies in meta-analysis.101 The coefficient obtained from meta-regression describes 
how the intervention effect changes with an each a unit increase in the explored characteristic. 
Subgroup analyses as well as meta-regression should be predefined and carefully planned as if 
not performed correctly they can lead to incorrect conclusions.102 
 
There are various methods available to address the issue of heterogeneity in the intervention 
effects in IPD meta-analysis. The modifying effect of participants’ or intervention’s 
characteristics can be explore by pooling of within-trial covariate interactions, in a one-stage 
model including the interaction term between the characteristic and the intervention effect, 
through testing for difference between covariate subgroups in their pooled treatment effects or 
by combining the pooling of within-trial covariate interactions with meta-regression.103 The 
choice of correct methods is crucial as they may lead to substantially different findings.  
 
2.4.3. Methods applied in this thesis 
The meta-analyses conducted to address objectives specified in chapters 4 and 5 were 
performed in accordance with current recommendations for performing study-level data and 
IPD meta-analysis for effectiveness research questions.93,94 For each outcome, a two-stage 
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IPD meta-analysis was performed to obtain summary estimates and 95% confidence intervals 
for the intervention effects and the interactions (subgroup effects). The two-stage approach 
was used rather than a one-stage approach due to the large numbers of studies, the need to 
deal with both parallel group and cluster randomised trials, and the need to adjust for baseline 
factors. In all analyses (unless otherwise stated) the IPD and study-level data were pooled 
using random-effects model (REML), to obtain summary estimates (MD for a continuous 
outcome, and OR for dichotomous outcomes) with their 95% CIs.  
 
The random-effects model was applied to all analyses allowing to account for unexplained 
between-study heterogeneity in effects between studies, therefore derived summary estimates 
are average effects across studies. Following Cochrane Handbook, I formally quantified the 
between-study heterogeneity using the I2 metric with the cut-offs of 25%, 50%, and 75% as 
indicators of ‘low’, ‘moderate’, and ‘high’ degrees of heterogeneity, respectively.5 I chose the 
I2 measure over other indicators e.g. τ2 as it is easy interpretation and comparability between 
analyses. 
 
The IPD meta-analysis framework can be also used to explore secondary questions in 
comparison to the main assessment of intervention effectiveness.46 In this thesis the IPD meta-
analysis methodology was used to evaluate the association between gestational weight gain 
(surrogate of maternal morbidity) and important clinical outcomes (chapter 7). The analyses 
follow the same framework as for the effectiveness questions maintaining clustering of 
participants within the original study. Analyses in all chapters were performed using Stata 
statistical software (version 12.1, StataCorp, College Station, TX, USA) with statistical 
significance of effects considered at the 5% level. More details on the specifics of the analyses 
and the models are available in methods’ sections of the relevant chapters. 
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2.5. Investigating bias in evidence synthesis 
Before drawing a conclusion from findings of any systematic review it is paramount to 
evaluate any factors that potentially could have distorted them.104 The validity of the 
systematic review can be assessed in two ways: whether the study asks a suitable research 
question, and if it answers the question correctly and in an unbiased way. The later one in 
often describes as study’s ‘internal validity’ and refers to the methodological quality of 
individual studies as well as the methodology of the systematic review and meta-analysis. 
 
2.5.1. Quality assessment of randomised trial 
The synthesis of evidence is as good and informative as the quality of included individual 
studies. The ‘quality’ of the study can be understood as the level to which appropriate 
measures were employed to reduce bias and error in study design, conduct, and analysis.7 Any 
systematic error, or deviation from the truth, in results or inferences is a label with a term 
‘bias’5. The term ‘risk of bias’ is more commonly used than the bias itself as the study 
findings may be unbiased despite methodological defects.  
 
In RCTs, the key aspects determining the quality of the trials are a method of participants’ 
allocation to study arms, study conduct, detection of the events of interest, attrition from the 
study and its reporting.105 Allocation to the study groups is usually assessed by looking at 
randomisation procedures and the methods implemented to ensure concealment of the 
participants’ allocation. Studies with incorrectly conducted randomisation and those where the 
personnel knew the allocation sequence tends to show greater and more positive results rather 
then those where the randomisation and allocation concealment were implemented correctly. 
Sequence generation in order to correctly balance the characteristics of participants between 
the study groups should be truly random namely there is no way of predicting based on the 
clinical characteristics or other factors to which arm the participant will be allocated to. 




Biases that might arise during the trial (performance and detection biases) are down to the 
difference in the care provided to the participants depending on the study arm they were 
allocated to. A way to address this issue is by ensuring that all involved in the studies are not 
aware of the intervention allocation status during the course of the trial. This procedure is 
commonly known as blinding or masking. Depending on the nature of the intervention, 
blinding of participants and personnel during the course of the trial is not always possible. 
However, it is possible to ensure that the researchers assessing the final health outcomes and 
the statistical team are unware of the original allocation. Bias due to attrition is assessed by 
looking at the numbers of participants that left the study and the reasons for dropping out. 
Bias in trial design and conduct can also arise due to other inaccuracies such as failure to 
deliver allocated intervention due to poor compliance, poor quality assurance or misconduct at 
the stage of data analysis (lack of statistical plan or its change post data collection).     
 
Typically, systematic review with meta-analysis relay on the data extracted from trial report, 
therefore an important source of bias to consider is one arsing due to poor or inaccurate 
reporting. Flawed, partial or even lack of reporting of any of the study elements and especially 
the health outcomes can have a major impact on the findings of any evidence synthesis. The 
risk of bias due to the selective outcome reporting arises whenever there is a suspicion that the 
decision about which and how to report the trial outcomes was made post-hoc and basing on 
the statistical significance of the findings. These mechanisms leads to over reporting of 
positive results that distort the magnitude of the pooled effect estimate in meta-analysis.36,106 
 
Reporting biases arise when the nature and direction of results influences their dissemination. 
This might occur on the within-study level or on the study-level. The former one, commonly 
known as outcome reporting bias, frequently affects trial outcomes that are analysed 
differently than initially specified in the trial protocol, or not reported at all. The later one, an 
extreme case of reporting bias, is referred to as ‘publication bias’.5 




2.5.2. Small study effects 
Publication bias as important concern in meta-analysis as the over-representation of ‘positive’ 
findings can distort the summary effect estimate and lead to over optimistic conclusions. 
Universally presented graphic of contribution of individual studies to the summary effect is 
funnel plot; a scatter graph of the effect estimates derived from individual studies against a 
measure of each study’s size or precision (standard error).24 The term ‘funnel plot’ has been 
coined to describe the graphic presentation of the relationship between the effect estimates 
and their precision with the precision of the effect estimates improving with the growing 
sample size of the study (Figure 2.1).  
 
Figure 2.1 Symmetrical structure of funnel plot 
 
The loss of lot’s symmetrical shape indicates probability of bias in the pooled effects due to 
over representation of positive or negative effects from studies with small sample size28. 
However, the observed asymmetry is not synonymous with ‘publication bias’, as it can arise 
due to other factors such as between-study heterogeneity or poor compliance with an 
intervention in smaller trials in comparison to larger ones.24 Discussed asymmetry can be 
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examined in a formal statistical way; however, it is generally recommended for those test to 
be applied if ten or more studies is available for meta-analysis.24 
 
2.5.3. Availability bias in IPD meta-analysis 
A source of bias affecting meta-analysis using IPD is the number and the nature of studies 
from which participant-level data is not available.107,108 Availability bias is discussed only in 
the case of IPD meta-analysis as it addressed the issues of variable access to the IPD. The 
current guidance on the appraisal of IPD meta-analyses of randomised trials advocates 
checking for the proportion of trials from which IPD was obtained.46 The rationale behind this 
recommendation is that the studies for which IPD is not available might be substantially 
different making the group of IPD studies not representative of the entire evidence base e.g. 
studies with not available IPD might be small and of a lower quality. Furthermore, the 
guidelines recommend assessing the impact of unavailable data on the pooled effect through a 
sensitivity analysis combining the effect estimates derived from IPD studies with those from 
study-level data extracted from publications for studies where IPD was not available.46 
 
2.5.4. Investigation of bias in this thesis 
Out of a wide range of sources of bias that can affect the summary effects, in my thesis I will 
focus on the ones most relevant to IPD meta-analysis i.e. outcome reporting bias (addressable 
thanks to access to IPD) and availability bias (unique to IPD meta-analysis). The quality of 
RCTs was assessed using Cochrane risk of bias tool where one of three grades (low, high or 
unclear risk of bias) was assigned to each of the domains.98 As the impact of the trials’ quality 
on the pooled effect estimates is not the subject of my work, it will not be presented and 
discussed in this thesis. The assessment of small studies effects was performed by generating 
funnel plots and where the number of available records allowed using suitable statistical tests 
– Peter’s test for the binary and Egger’s test for the continuous outcome.24 The availability 
bias was assessed by comparing the summary estimates from IPD studies alone with those 
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with the addition of non-IPD studies. Further details on the investigation of biases are 
available in section 4.2. 
 
2.6. Examining associations 
The objective of many studies in health care research is to analyse the association between an 
exposure and an outcome of interest. The goal of any work of this kind is to obtain an 
unbiased estimator for this association. The statistical method used to address this type of 
research question is regression modelling.109,110 Depending on the type of the outcome 
variable, the regression can be logistic (binary outcomes), linear (continuous outcomes), 
Poisson (counts) or Cox (time-to-event outcomes). Nevertheless, regardless of the regression 
type, the modelling strategy aims to obtaining the best fitting model to represent the examined 
association. 
 
Before embarking on the modelling, it is paramount to examine the relationship between our 
exposure and the chosen outcome, as it can be affected by the external factors. The 
relationship can be obscured by a factor not lying directly on the exposure-outcome pathway, 
however, independently linked with both the exposure and the outcome – a confounder. 
(Figure 2.2). If the factor transmits the effect of the exposure onto the outcome, we classify it 
as a mediator. The observed relationship can also vary by different levels of the examined 
factor. In this case, we observe a modifying effect and the factor of inquest an effect modifier. 
In principle, when modelling, we aim to control for all relevant confounders and examine 
effect modifiers (exposure – covariate interactions) to identify relevant risk groups while 
mediators are not included in the modelling strategies. 
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Figure 2.2. Developing regression model - choosing confounders and effect modifiers  
 
There are various conceptual strategies of building regression models to examine 
associations.110 The model examining the association can be adjusted for relevant confounders 
including them as independent terms in the in the multiple regression equation; however, 
doing so we risk the overfitting of the model. Alternatively, we can begin with a crude model 
(the exposure and the outcome) and gradually develop it by adding identified confounders, 
examining their significance level and the change in the coefficient (stepwise forward 
selection). In the reverse process (backward elimination), we begin with a full model from 
which we drop the covariates depending on how their removal change the coefficient and the 
significance level of other covariates. If the model includes interaction term (exposure and 
potential effect modifier) the decision about is retention or removal from the model depends 
only on the interactions significance level. Generally, the significance level for the 
interactions is higher than one for the confounders.110 




2.6.1. Examining associations in this thesis   
In this thesis, exploration of the relationship between an exposure or a factor, and an outcome 
has been performed in two chapters. In chapter 6, using linear regression models, I explored 
the relationship between publication features and quality of outcome reporting score. The 
applied modelling strategy was a backward elimination of the candidate factors until a final 
model that included only relevant exposures and identified confounders with or without 
interaction terms. In chapter 7, I explored the relationship between the gestational weight gain 
outside the IOM recommendations and adverse pregnancy outcomes. I used multilevel logistic 
regression with an interaction term between the degree of departure from the recommended 
range (each kilogram of deviation) and its direction (above or below the recommendation 
limits). The associations estimated were reported as crude odds ratios and adjusted for as 
many confounders as possible taking into account their availability and outcome event rate. 
More details description of models and modelling strategies are provided in the methods 
sections of the relevant chapters. 
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Chapter 3 Development and use of the composite outcomes 
in Individual Participant Data meta-analysis 
3.1. Introduction 
Meta-analysis using IPD in comparison to study-level data has greater power to detect any 
differential treatment effect across groups. This avoids issue of ecological fallacy, and has the 
ability to model the individual risk status across participants within trials, to explain 
variability in outcomes at the participant-level.45,46,93 The i-WIP Collaborative Group was 
established to assess the effects of diet and physical activity based interventions in pregnant 
women on maternal, offspring outcomes using IPD meta-analysis.79 
 
Identification of the appropriate outcome (s) for evaluation of the interventions effect in 
pregnancy is challenging, as frequently more than one outcome is considered to be clinically 
important. Furthermore, the analysis is often limited by the low incidence of individual 
outcomes, and it is difficult to predict the number of trials for which IPD will be obtained. A 
recent study showed that only a small proportion (25%) of IPD meta-analyses obtains 100% 
of eligible IPD.50 
 
Composite outcome measures are used in primary trials to overcome the problem of low 
frequencies and clinical importance.47,49 The development of such outcomes should be based 
on clear pre-specified criteria with transparency in reporting. Currently, a robustly developed 




The aim of the work presented in this chapter is to develop composite maternal and composite 
offspring outcomes for evaluation in i-WIP IPD meta-analysis. 




The details of the methods used to develop the composite outcomes are available in section 
2.2. The effect of interventions on the composite outcome was assessed using IPD meta-
analysis methodology (sections 2.4 and 4.2). The composite outcome was available for the 
analysis if all its components were recorded for the given participant. For example, the 
maternal composite was available if data on GDM, preterm birth, caesarean section and 
hypertensive disorder were collected in a given study. Following current guidelines on the use 
and analysis of composite outcomes in medical studies, the effects of diet and physical 
activity based interventions were presented for the composites (maternal and offspring) and 
their components.111 The analyses with the maternal composite outcome excluded participants 
with baseline diabetes mellitus, GDM or pregnancy induced hypertension, as these baseline 
medical conditions are components of the outcome. 
3.3. Results 
3.3.1. Characteristics of the Delphi panel 
The Delphi panel comprised of 26 clinicians and clinical academics from 11 countries with 
expertise in diet and lifestyle interventions in pregnancy. This included 16 obstetricians, four 
physiotherapists, two nutritionists, two midwives, one epidemiologist, and an endocrinology 
specialist. Majority of the panellists are involved in research in high-income countries 
Australia (3), Europe (18), North America (3), and two from an upper-middle income country 
(Brazil). Over 90% (24/26) of the panellists have experience of conducting randomised trials 
on diet and lifestyle interventions. Overall, the panel members have been responsible for five 
diet based, seven physical activity based, and 12 mixed intervention studies. Twenty-six 
panellists ranked the maternal outcomes and 25 ranked the offspring outcomes for their 
importance to patient care. Details on the rounds of the Delphi survey and development of 
composite outcomes are presented on the flow chart (Figure 3.1). 
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Figure 3.1 Rounds of Delphi survey and selection of outcomes for composite outcomes 
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3.3.2. First round 
All panellists, (100% 26/26) completed the questionnaire consisting of 34 maternal outcomes 
and 27 offspring outcomes in the initial list. Fifteen (15/34, 44%) maternal outcomes were 
scored as critical to patient care and 19 (19/34, 56%) outcomes were scored as important but 
not critical (Figure 3.2). The outcome threatened miscarriage was not considered to be critical 
to patient care (median <6). Eleven (41% 11/27) offspring outcomes were scored as critical to 
patient care and 16 (59%, 16/27) outcomes were scored as important (Figure 3.3). The 
panellists suggested consideration of pre-eclampsia and pregnancy induced hypertension to be 
two distinct outcomes and this was added to the list of rating in the second round. Similarly, 
the panel advised that elective and emergency caesarean section to be considered separately, 
and these were added to the list for scoring in the second round. Neurodevelopment at two 
years of age and fetal cord blood (insulin or c-peptide) were added to the second round based 
on the recommendations of the panellists. 
 
The individual scores showed some minimal variation (IQR ≤ 2) for twelve of the critical 
maternal outcomes, namely pre-eclampsia, pregnancy induced hypertension, gestational 
diabetes mellitus, preterm birth, elective caesarean, emergency caesarean section, 
thromboembolism, admission to High Dependency Unit (HDU)/ Intensive Therapy Unit 
(ITU), miscarriage, need for resuscitation at delivery, physical activity, and dietary behaviour. 
For the eleven critical offspring outcomes there was minimal variation (IQR≤2) shown in: 
stillbirth, SGA, LGA, admission to NICU, shoulder dystocia, occurrence of less than one 
perinatal complication, birth trauma, long term neurological sequelae, long term metabolic 
sequelae, hypoglycaemia, and respiratory distress syndrome. 
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3.3.3. Second round 
Twenty-five (96%, 25/26) panellists took part in the second iteration. Eighteen (18/36, 50%) 
maternal outcomes had a median score of ≥7 and were considered to be critical to patient care, 
while 18 outcomes had a median score of ≥4 and were considered to be important. There was 
a narrowing of IQR for the seventeen of the outcomes showing consensus between panellists 
(Figure 3.2). Eleven (38%, 11/29) offspring outcomes scored between 7 and 9, and were 
considered to be critical to patient care. The offspring outcomes that progressed to the second 
round are shown in Figure 3.3.  
 
The scoring of maternal and offspring outcomes between the previous and the current panel 
was overall congruent (Appendix 3.1).  Miscarriage, physical activity, postpartum weight 
retention, quality of life, and breast-feeding were considered to be critically important in the 
current Delphi panel but only important in the previous panel. Instrumental delivery and failed 
instrumental delivery were critically important in previous Delphi panel but only important in 
this panel. Threatened miscarriage was of limited importance to patient care in the previous 
Delphi but considered as important by the current Delphi panel. Abnormal cord pH was 
critically important in the previous panel but only important in the current panel. 
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Figure 3.2 Maternal outcomes 
 
HDU, High Dependency Unit; ITU, Intensive Therapy Unit  
   
 
55 
Figure 3.3 Offspring outcomes 
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3.3.4. Selection of the components 
Nine maternal and nine offspring outcomes with a score ≥8 were evaluated for their inclusion 
as components of the composite outcomes (Figure 3.2 and Figure 3.3). The following 
maternal components were included: PE or PIH, GDM, elective or emergency caesarean 
section, and preterm birth. Outcomes that occurred rarely such as thromboembolism, not well 
reported such as admission to HDU or ICU, or surrogate for maternal morbidity such as 
gestational weight gain were not included in the final list. 
 
The following offspring components fulfilled the selection criteria for inclusion in the 
composite: stillbirth, SGA infant, LGA infant, and admission to NICU. Given the long time 
frame required to assess the risk of long-term metabolic sequelae and neurodevelopment of 
the baby, they were excluded from the offspring composite. Rare outcomes such as shoulder 
dystocia and birth trauma significant overlap with LGA, and were poorly reported, leading to 
their exclusion. Finally, the outcome of more than one perinatal complications was excluded 
as it was considered to be significantly dependent on the other offspring outcomes. 
 
3.3.5. Use of the composite outcomes in IPD meta-analysis 
The composite outcomes were used in IPD meta-analysis of 36 RCTs with diet and physical 
activity based interventions described in details in chapter 4. The maternal composite outcome 
was available in two-third (24/36) and offspring composite outcome in half (18/36) of studies 
with IPD (Table 3.1). Components of the maternal composite were available in more than half 
studies with the least frequently available outcome being the occurrence of hypertensive 
disorders (22/36 studies). The availability of the components of the offspring composite was 
less balanced with a high availability of two outcomes (SGA and LGA) for the majority of the 
studies. The other two components – stillbirth and admission to NICU – were available in less 
than half of the studies with only two studies out of 22 (Table 4.3) with the data on stillbirth 
rates included in the IPD meta-analysis of individual components of the composite outcomes. 
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The directions of the interventions’ effect on the individual components of the maternal 
composite was consistent with the effect on the composite. The effect on the offspring 
composite and its components was less consistent, however the point estimates of the effects 
on the individual outcomes were within the 95% CI for the effect on the offspring composited. 
  
Table 3.1 Effects of diet and physical activity based interventions on pregnancy outcomes 
summarised using Individual Participant Data 
Outcome 
Number of studies  
(Number of events/ 
participants) 
OR (95% CI) I2 (%) 
Maternal composite outcome 24 (3 733/ 8 851) 0.90 (0.79, 1.03) 26.7 
Gestational diabetes 27 (855/ 9 427) 0.89 (0.72, 1.10) 23.8 
Hypertensive diseases in pregnancy 22 (1 155/ 9 618) 0.95 (0.78, 1.16) 24.2 
Preterm birth 32 (677/11 676) 0.94 (0.78, 1.13) 17.3 
Any caesarean section 32 (3 033/ 11 410) 0.91 (0.83, 0.99) 0.0 
Offspring composite outcome 18 (2 034/ 7 981) 0.94 (0.83, 1.08) 0.0 
Stillbirth 2 (20/ 3 719) 0.81 (<0.01, 256.69) 0.0 
Small for gestational age 33 (1 341/ 11 666) 1.06 (0.94, 1.20) 0.0 
Large for gestational age 34 (1 503/ 12 047) 0.90 (0.76, 1.07) 38.0 
Admission to NICU  16 (581/ 8 140) 1.01 (0.84, 1.23) 0.0 
OR, odds ratio, CI, confidence intervals; NICU, Neonatal Intensive Care Unit 
 
3.4. Discussion 
3.4.1. Main findings 
The composite outcomes comprise of four maternal (gestational diabetes, hypertensive 
disorders in pregnancy, preterm birth, caesarean section) and four offspring outcomes 
(stillbirth, SGA, LGA, and admission to NICU). The maternal composite outcome was 
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available in two-third and offspring composite in half of the studies available for the IPD 
meta-analysis with RCTs on diet and physical activity in pregnancy. The point estimates of 
the pooled effect were consistent for the maternal composites and its components and variable 
for the offspring composite and its components. 
 
3.4.2. Strengths and limitations 
In the presented work to develop composite outcomes, I implemented robust and validated 
methods. The outcomes were prioritised through a consensus involving leading 
multidisciplinary clinicians and researchers in the field and subsequently assessed for their 
eligibility to become components of the composite according to recommended criteria.49 This 
is the first formally developed composite measure for evaluation of antenatal diet and physical 
activity based interventions in IPD meta-analysis. One of the major strengths of this project 
was the use of Delphi methodology. The two-stage survey described in this chapter validated 
the work of the prior panel75, thus increasing the reliability and reproducibility of the 
developed composites outcomes. The panels were independent and comprised of experts with 
relevant expertise in the area of the weight management in pregnancy. The second Delphi 
panel widened the area of expertise by involving researchers from wider disciplines and had a 
global reach. Furthermore, the majority of the panellists have experience in clinical trials with 
diet and physical activity in pregnancy. The response rate to the surveys was of over 90% in 
both rounds. 
 
The list of maternal and offspring outcomes used in the survey was firstly identified through a 
systematic review and evaluated by the first panel75. The Delphi panel methodology improved 
the panel’s work and avoided counterproductive group dynamics such as domination of 
discussion by senior members. Finally, all the critically important outcomes were evaluated in 
a systematic manner against pre-specified rigorous criteria (section 2.2) prior to their inclusion 
in the final composite outcomes. 




The findings are based on individual and group opinions and are strongly dependant on the 
composition of the panel. Any potential bias was minimised through validating the findings of 
one panel against another that comprised of the international experts in the field. However, it 
needs to be noted that a different consensus group may have chosen other components for 
inclusion in the composite. The optimal size of a Delphi panel to generate consensus is not 
defined.83,112 Decision regarding the size of the panel was based on the pragmatic balance 
between good representativeness of the clinical opinions and the minimisation of the dropout 
rate113. A small panel might not represent a good range of opinions on the topic, and a larger 
panel may lead to low response and high drop-out rates83. 
 
The number of studies with available IPD is difficult to predict before embarking on IPD 
meta-analysis. Therefore, the use of a composite outcome seems a sensible solution to 
overcome the issue of low event rates. Even though frequently used in primary studies, 
composite outcomes receive their share of criticism.41,81 An alternative method allowing 
evaluating the effects of the interventions on multiple outcomes in IPD meta-analysis 
exist114,115; however, the complexity of the models and the methods used in their development 
might make them difficult to apply in all IPD meta-analyses.  
 
Not all collected outcomes data could be used in IPD meta-analyses. In some analysis, with 
stillbirth being the extreme example, the statistical models excluded studies with zero events 
and imbalances between the compared arms. There are statistical methods allowing forcing 
studies with zero events into the models116; however, decision on their application needs to be 
balance against the validity of obtained summary effect estimates. 
  





Composite outcomes developed to use in IPD meta-analysis on the effects of diet and physical 
activity based interventions in pregnancy comprise of major maternal and offspring 
complications. The components of both composite outcomes were identified using Delphi 
methodology and with the involvement of the international group of experts in the field 
increasing composites credibility. The maternal composite comprises of systemic diseases 
developing during pregnancy (GDM and hypertensive diseases) and delivery-related 
complications (preterm birth and caesarean section). All outcomes included in the composites 
received a score of eight or more with the majority having an IQR of one or less indicating 
consensus among the panellists’ responses. The prevalence of the majority of the 
complications is currently on the rise117-119, and their occurrence poses a major challenge for 
the health care due to their short and long-term consequences.120 The frequency varies 
between individual outcomes with the caesarean section being the most frequent and 
hypertensive diseases the rarest event. 
 
The offspring composite outcome encompasses stillbirth, infant’s growth and the need for 
infant’s admission to NICU. All offspring outcomes were ranked by the panellist as critically 
important to the management of women’s weight in pregnancy. However, their frequency and 
subjectivity differ. Stillbirth is the rarest of the all offspring outcomes with the global average 
of 18 occurrences per 1000 births in 2015.121 Admission to NICU is commonly used as an 
indicator of neonatal morbidity, but in the light of recent research, its validity is 
questionable.122 SGA and LGA are clinically used indicators of a small or an excessive infant 
size capturing cases from the opposite extremes of the growth spectrum.  
 
The decision on the inclusion of described components in the composite was a balance 
between rigorous and pragmatic criteria. It was intended to adhere to the pre-specified criteria 
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as closely as possible, but also abstain from including components that were not commonly 
available. This resulted in the inclusion of outcomes perceived as subjective, e.g. admission to 
NICU or caesarean section. It could be argued that when participants and personnel cannot be 
blinded to the type of intervention they receive, one should refrain from using clinician driven 
outcomes. As above mentioned outcomes are highly relevant to women’s antenatal 
management (both classified as critically important) and uniformly reported across trials, I 
decided to include them in the composites. Nevertheless, the nature of those outcomes needs 
to be acknowledged when interpreting the results of the analysis 
 
The main challenges in using composite outcomes in IPD meta-analysis on diet and physical 
activity based interventions in pregnancy were the variation and availability of the outcomes 
in the individual trials. Access to IPD facilitated computation of unavailable outcome data for 
SGA, LGA and preterm birth thanks to the availability of variables with gestational age and 
birth weight; however, this was not possible for all outcomes. Critically important events such 
as thromboembolism or admission to HDU or ICU for the maternal composite outcome, and 
shoulder dystocia and birth trauma for the offspring composite could not be included in the 
composites due to their rare collection in the primary trials. 
 
The acceptability of the composite outcome rests on the assumption that the effect (its 
direction and magnitude) observed on the composite applies to all of its components.49 The 
effect of the diet and physical activity based interventions on the maternal composite had the 
same direction and similar magnitude as on the individual components, however, lacked 
statistical significance. The effect of the interventions on the offspring composite and its 
components was more variable with no statistically significant findings. The rationale for 
development and use of the composite outcome in the i-WIP study was to address the issue of 
multiple outcomes and a low number of events for the individual outcomes. When the IPD 
meta-analysis was planned, the anticipated number of participant records available for the 
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analysis was lower than the one eventually assembled. The patchwork nature of the 
amalgamated IPD set led to a general smaller amount of data the composite outcomes than for 
the individual components. This trend is especially visible for the offspring outcomes with the 
weakest component of the composite being stillbirth. The extremely wide confidence intervals 
around the interventions’ effect on this outcome are caused by low event rate and lack of any 
events in over 90% of the trials that recorded this outcome. 
 
3.4.4. Conclusions 
The i-WIP IPD meta-analyses evaluated the effect of diet and physical activity based 
interventions in pregnancy on the composite maternal and offspring outcomes. In order to 
maintain methodological rigour, the effect of the interventions on the components of the 
composites was investigated in a sensitivity analysis. The composition and implementation of 
the composite in the IPD meta-analysis were strongly determined by the availability of the 
individual components and their frequency in the individual trials that contributed the IPD. 
 
The restrictions in the implementation of the composites in IPD meta-analyses resulting from 
lack consensus on which outcomes should be collected in trials with diet and physical activity 
in pregnancy could be reduced by two strategies. Firstly, by developing minimum core 
outcome sets for reporting in primary clinical trials. This concept is strongly promoted by The 
Core Outcome Measures in Effectiveness Trials (COMET) and the Core Outcomes in 
Women’s Health (CROWN) initiatives.52,53 Secondly, by designing prospective IPD meta-
analyses with pre-specified relevant outcomes as in the case of early-onset intrauterine growth 
restriction.123 
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Chapter 4 Understanding the differences in the results from 1 
study-level and individual participant data meta-analysis: an 2 
empirical example of diet and physical activity based 3 
interventions in pregnancy 4 
4.1. Introduction 5 
Decisions in health care to effectively inform clinical practice and health care should ideally 6 
be based on all available body of evidence.1 Systematic reviews with meta-analysis are 7 
considered the highest quality of the evidence for questions on the effectiveness of 8 
interventions.4,9 A systematic review identifies all available evidence on a given topic and 9 
meta-analysis formally combines the data increasing the power and precision of the 10 
intervention effect.92,124 Most frequently the method relies on study-level data extracted from 11 
trial publications making them prone to limitations due to poor reporting of primary trials.18 12 
An alternative approach to meta-analysis uses participant rather than study-level data.18,125 13 
This approach facilitates more powerful statistical analyses, gives the ability to detect any 14 
potential interactions between intervention effects and participants’ characteristics, and allows 15 
to overcome the limitations associated with trial reporting.43,45 Furthermore, access to trial 16 
data and direct contact with the researchers who conducted it facilitate an extensive data 17 
integrity checks that enhance the robustness of obtained estimates.  18 
 19 
Despite being a powerful tool and labelled a ‘gold standard’ for the synthesis of effectiveness 20 
research, IPD meta-analysis is not free from constraints. By relying only on the raw trial data, 21 
the approach is at risk of not incorporating all available evidence on the subject (totality of 22 
evidence) and so called ‘availability bias’.108 In light of recent findings showing that only 25% 23 
of published IPD meta-analyses gained access to IPD from all eligible trials50 the potential 24 
bias due to availability of IPD cannot be ignored. Yet, the evaluation of 199 IPD meta-25 
analyses showed that only around 17% of studies combined IPD with study-level data from 26 
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studies where IPD was not available.107 Moreover, findings from meta-analyses based on 27 
study-level data and IPD may differ, leading to different conclusions regarding the effect of 28 
interventions45 even when based on identical trials126. A recent Cochrane review formally 29 
compared effect estimates and their precision for 190 comparisons of study-level and IPD 30 
meta-analyses. The review found that 20% of comparisons disagreed on the statistical 31 
significance. Those with concordant results with respect to significance level, 15% disagreed 32 
in direction of effect.126 33 
 34 
Obesity and high weight gain in pregnancy put women and their offspring at an increased risk 35 
of short and long-term poor health outcomes60,127. The number of women who enter pregnancy 36 
with BMI above 25 kg/m2 or exceed the amounts of gestational weight gain recommended by 37 
Institute of Medicine (IOM) is on a rise.128 Acceptable and safe interventions to manage 38 
women’s weight in pregnancy are needed, with interventions targeting women’s diet and 39 
physical activity currently being extensively explored. Within the last ten years over 40 40 
systematic reviews have looked at the effects of diet and physical activity based interventions. 41 
The reviews varied in their scope by the population of interest (different BMI groups), type of 42 
primary outcome, and derived conclusions; however, their limitations tend to be similar, 43 
namely a substantial heterogeneity in the pooled effects, variation in the type of evaluated 44 
outcomes, and variability in the type of evaluated interventions (Appendix 1.1). 45 
 46 
4.1.1. Aims 47 
The i-WIP IPD meta-analysis was conducted to address an unexplained heterogeneity in the 48 
pooled effects obtained from a study-level meta-analysis, and to explore the modifying effect 49 
of women’s characteristics such as BMI, age or parity.76,79 The work presented in this chapter 50 
reports the findings of the i-WIP IPD meta-analysis and contrasts them with results obtained 51 
from study-level meta-analysis. The emphasis was especially placed on the following 52 
questions: (a) What are the effects of diet and physical activity based interventions using IPD 53 
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meta-analysis? (b) How does inclusion of previously unreported outcomes alter the findings 54 
of meta-analysis in the group of trials where IPD was available? (c) What is the impact of the 55 
availability bias when evidence is synthesised using only  IPD meta-analyses? (d) Compared 56 
to meta-analysis using only study-level data, what is the added value of IPD meta-analysis 57 
combined with study-level data from studies without access to IPD? 58 
 59 
4.2. Methods 60 
The systematic review and meta-analyses described in this chapter were conducted as outlined 61 
in the methods section 2.3. The studies were selected in a two-stage process. The citations 62 
identified through a systematic search of electronic databases were first assessed at the title 63 
and abstract level for their eligibility. The full texts of identified candidate citations were 64 
obtained and once more assessed for their eligibility as outlined in section 2.3. Trials which 65 
recruited women with gestational diabetes at baseline, studies that involved animals or 66 
reported only non-clinical outcomes, and studies that were published before 1990 were 67 
excluded. Where possible, both steps were repeated independently by a second reviewer (see 68 
the acknowledgements). The datasets with IPD from eligible trials were further refined by 69 
excluding pregnant women with multiple gestations, and women with BMI below 18.5 kg/m² 70 
(counter indication for limiting gestational weight gain). 71 
 72 
The effects of the interventions in the IPD meta-analysis were evaluated on gestational weight 73 
gain, maternal and offspring composite outcomes.79 The composite outcomes could not be 74 
used to investigate the differences in meta-analyses based on study-level and raw trial data. 75 
Therefore, I investigated the effects of interventions on the individual components of the 76 
composite outcomes, except for stillbirth and hypertensive diseases. The effect of the 77 
interventions on stillbirth rates could not be assessed due to a small number of studies 78 
available for meta-analysis. The effect on the hypertensive diseases was not explored as the 79 
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outcome in the primary trials was reported as an occurrence of pre-eclampsia or PIH or a 80 
combination of both. 81 
 82 
4.2.1. IPD meta-analysis 83 
Acquisition of participant-level data was guided by a pre-defined list of data items (Appendix 84 
4.1). The initial assessment of data availability lead to refinement of the data list and retrieval 85 
of most frequently collected participants’ characteristics and outcomes. All originally obtained 86 
datasets were uploaded and stored on a secured server hosted by Centro Rosarino de Estudios 87 
Perinatales (CREP) (Rosario, Argentina), and can be accessed via a web-based gateway.78 88 
CREP is a WHO Collaborative Centre in Child and Maternal Health with extensive expertise 89 
in data collection and maintenance. All data manipulations followed a standard operating 90 
procedure (Figure 4.1), and were performed and documented within the environment provided 91 
by CREP. 92 
 93 
The final format of data in the dataset used in the IPD meta-analysis was selected based on the 94 
most frequent denominator and accounting for the number of studies with a given format and 95 
sample size. Loss of information through dichotomizing was balanced with the number of 96 
studies that could be included using a certain format. Details of the key variables grouping can 97 
be found in Appendix 4.2. Range and consistency checks were performed on all datasets. 98 
Where possible, the randomisation ratio, baseline characteristics and outcomes were 99 
compared with the values reported in trials publications. Any inconsistencies or coding 100 
ambiguities were checked with the dataset contributor, recorded on the data query sheet and 101 
amended where necessary.  102 
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Figure 4.1 Flow chart of data harmonisation in the i-WIP IPD meta-analysis 103 
 104 
In all analyses any multiple treatment arms were combined into one intervention arm. The 105 
booking BMI values were grouped according to the WHO classification into normal (18.50 – 106 
24.99 kg/m²), overweight (25 – 29.99 kg/m²), and obese (≥ 30 kg/m²) categories.129 The 107 
women’s educational status was used as an indicator of her socioeconomic status and women 108 
were categorised as “low” (did not complete secondary education to A-level), “medium” 109 
(completed secondary education to A-level or equivalent), and “high” (women completed any 110 
education higher than secondary). Parity, smoking in pregnancy, and any diabetes-related 111 
events were all coded in a binary way (1 “yes”, 0 “no”). 112 
 113 
Gestational weight gain was defined as the difference between the final available weight and 114 
early or pre-pregnancy weight (if the early one was not available) and reported in 115 
kilogrammes. Definitions of GDM, caesarean section, and admission to NICU were adopted 116 
as per definitions in the original studies. Definitions of preterm birth, SGA and LGA were 117 
unified across all trials for which the outcome data were available. Preterm birth was defined 118 
as delivery before 37 weeks of gestational age. SGA and LGA with birth weight below the 119 
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10th and over the 90th centile respectively were adjusted for the mother’s BMI, parity and 120 
gestational age at delivery.130  121 
 122 
A two-stage IPD meta-analysis was carried out in accordance with current standards and 123 
following the framework described in section 2.4. A two-stage rather than a one-stage 124 
approach was implemented due to the large number of studies, and the need to deal with both 125 
parallel group and cluster randomised trials. A random intercept for a unit of randomisation 126 
was used when analysing cluster-randomised trials. Gestational weight gain was analysed 127 
using analysis of covariance (ANCOVA) in each trial to regress the final weight value against 128 
the intervention while adjusting for baseline weight and centres in cluster-randomised trials. 129 
For dichotomous outcomes for each trial a logistic regression model was used individually, 130 
where intervention allocation was considered a covariate. 131 
 132 
The IPD was combined with study-level data from trials where IPD was not available (later 133 
referred to as non-IPD trials) following a three-step approach. Firstly, the effect estimates and 134 
their variances were obtained from individual trials where IPD was available. Subsequently, 135 
the effect estimates and their variances were derived from study-level data extracted from trial 136 
publication (non-IPD trials). Finally, the effect estimates and their variances from both steps 137 
were pooled using the random-effects model, as described in section 2.4. 138 
 139 
4.2.2. Study-level meta-analysis 140 
Data for dichotomous and continuous outcomes were extracted as described in section 2.4. 141 
Numeric data presented in a different format then desired were transformed accordingly and a 142 
record of those transformations was made. All information reported in the studies’ 143 
publications was extracted into designated data collection forms. Where possible, the 144 
extraction was performed by a second independent reviewer. Any disagreements were 145 
resolved by consensus or by a third reviewer (see the acknowledgements). 146 




When referring to ‘study-level meta-analysis’ throughout the thesis, this signifies a meta-148 
analysis using study-level data extracted from trials’ publications, unless otherwise stated. All 149 
the study-level meta-analyses followed the framework described in section 2.4 and 2.5. The 150 
group sizes used for binary outcomes were used as reported for the main analysis in the 151 
publications from the individual trials. In order to assess the robustness of the summary 152 
effects for the binary outcomes, I also performed a sensitivity analysis using the numbers of 153 
randomised participants as the group sizes. The incorporation of cluster-RCTs was planned 154 
according to currently recommended methods.5  155 
 156 
4.2.3. Comparisons 157 
The effects of diet and physical activity based interventions in pregnancy obtained from IPD 158 
meta-analyses were used in three comparisons. Firstly, to examine the impact of including 159 
previously unreported outcomes from trials that shared IPD, by comparing the results of 160 
study-level (A) vs. IPD (B). Secondly, to examine the impact of availability bias in the 161 
findings of IPD meta-analysis, by comparing the only IPD (B) vs. IPD supplemented with 162 
study-level data, where IPD is not available (C). Finally, I compared the results of a study-163 
level meta-analysis of all published trials (D) vs. the results obtained from meta-analysis 164 
combing IPD supplemented with study-level data (C). The number of trials contributing to the 165 
analyses A to D varied and they are given in Table 4.1. 166 
 167 
In all comparisons the findings of meta-analyses were assessed for the following: the direction 168 
and the magnitude of summary effect estimates; width of 95% CI and its position with respect 169 
to the value of no-difference (zero for MD, one for OR); statistical heterogeneity (I2); and 170 
funnel plot structure with a formal statistical assessment of its asymmetry, where possible. 171 
 172 
  173 
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Table 4.1 Meta-analyses of trials on diet and physical activity based interventions using IPD 174 
and study-level data 175 
Group Description of data Meta-analysis 
Number 
of trials 
A Study-level data from trials that shared IPD  Study-level 35 
B 




Participant level data from trials that shared 
IPD and study-level data extracted from 





Study-level data extracted from publications of 
all eligible trials regardless of whether they 
shared IPD or not 
Study-level 102 
IPD, Individual Participant Data 176 
 177 
4.3. Results 178 
There were 103 eligible trials on diet and physical activity based interventions delivered 179 
antenatally (Figure 4.1). One trial was identified through direct communication with the 180 
collaborating research team131, and its results were never published. The authors of 58 181 
trials131-188 were invited to join the i-WIP Collaborative Group and contribute their trial data 182 
with 36 teams responding positively to the invitation and collectively contributing data from 183 
12 526 pregnant women randomised to their trials131,132,134,138-140,142,146,147,150-152,155,157-159,162,164-184 
170,172,173,175-178,181,184-188. The most frequent reason for not obtaining the IPD in 22 of 58 185 
approached trials was a lack of any response to the invitation and a lack of an alternative way 186 
to contact research team (11/22 studies). The remaining 45 trials (9 945 women) 189-233 were 187 
identified past the data acquisition deadline through two subsequent literature updates in 188 
January 2016 and February 2017 (Figure 4.1). Overall, the IPD was available from 35% of 189 
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eligible trials (36/103); however, the number of randomised women in and outside the IPD 190 
was balanced (12 526 vs. 12 960 women). 191 
 192 
Figure 4.1 Selection of trials with antenatal diet and physical activity based interventions 193 
 194 
  195 
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4.3.1. Characteristics of the included trials 196 
The majority of the eligible trials were published within the last ten years (Figure 4.2). The 197 
median of publication year was 2011 for IPD trials, 2008 for the trials that authors were invited 198 
to share that data without success, and 2015 for newly identified studies. The IPD and non-IPD 199 
trials were comparable with regards to the type of recruited women, evaluated interventions and 200 
countries of trial conduct. (Table 4.2) 201 
 202 
Among the IPD trials, 11.1% (4/36) had more than one treatment arm.142,150,176,188 The one 203 
unpublished IPD trial was a small physical activity feasibility study conducted in the United 204 
States. Out of all IPD trials, 38.9% (14/36) of the trials shared the IPD from a less women 205 
than the declared number of the randomised in the trial. The median discrepancy between the 206 
randomised and contributed number of participant records is 9% (range 1% – 44%). The 207 
characteristics of all IPD trials, and also those that did not contribute IPD are provided in 208 
Appendix 4.3. 209 
 210 
Figure 4.2 Trials with diet and physical activity based interventions published between 1990 211 
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Out of seven evaluated outcomes, the most frequently reported outcomes in the included trials 216 
were gestational weight gain 75% (77/103), followed by caesarean section 56% (58/103), and 217 
GDM 49% (50/103). The frequency of reported outcomes in the group of IPD and non-IPD 218 
studies (publication-level) was comparable (Table 4.3). 219 
 220 















Number of studies  











Publication year  
median (IQR) 
2013 (5) 2011 (2) 2014 (7) 2008 (9) 2015 (2) 
Population      
All BMI values,†  
(n, %) 
67, 65.0% 22, 63.9% 44, 65.7% 16, 72.7% 28, 62.2% 
Overweight and obese,  
(n, %) 
19, 18.4% 5, 13.9% 14, 20.9% 2, 9.1% 12, 26.7% 
Obese only, 
(n, %) 
17, 16.5% 8, 22.2% 9, 13.4% 4, 18.2% 5, 11.1%  
Intervention type      
Diet-based,  
(n, %) 
15, 14.6% 4, 11.1% 11, 16.4% 7, 31.8% 4, 8.9% 
Physical activity-based,  
(n, %) 
47, 45.6% 15, 44.4% 31, 46.3% 8, 36.4% 23, 51.1% 
Mixed approach§,  
(n, %) 
41, 39.8% 16, 44.4% 25, 37.3% 7, 31.8% 18, 40.0% 
Country of conduct      
Lower-middle income,  
(n, %) 
4, 3.9% 1, 2.9% 3, 4.5% 1, 4.5% 2, 4.4% 
Upper-middle income,  
(n, %) 
19, 18.4% 5, 14.3% 14, 20.9% 5, 22.7% 9, 20.0% 
High income,  
(n, %) 
80, 77.7% 30, 85.7% 50, 74.6% 16, 72.7% 34, 75.6% 
IQR, Inter Quartile Range; BMI, Body Mass Index; †Li 2014 trial recruited women with BMI only within normal 223 
range; §Renault 2013, Simmons 2016 classified as mixed approach trials 224 
 225 
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Outcome availability in the group of the studies with IPD differed between the publication 226 
and dataset level. The number of trials where the outcome data were available on the dataset-227 
level improved for all of the evaluated outcomes. The greatest gain in outcome data 228 
availability was observed for two offspring outcomes (SGA and LGA). Out of 35 studies that 229 
share IPD, SGA was reported in 14.3% (5/35) in comparison to 94% (34/36) of the dataset 230 
with available event rate of this outcome. Ten studies (28.6%) reported occurrence of LGA 231 
while the event rate of this outcome was available in all 35 datasets. Despite the increase in 232 
the number of studies where data on the admission to NICU on the dataset-level (IPD) in 233 
comparison to publication-level, the outcome had the lowest availability (58%) among all 234 
seven assessed outcomes.   235 
 236 
Table 4.3 Availability of outcome data in the trials with diet and physical activity based 237 





(N = 102) 
IPD available  Non-IPD* 
Study-
level* 
(N = 35) 
IPD 
(N = 36) 
Overall 




(N = 22) 
Published 
after  
(N = 45) 
Gestational 
weight gain (kg) 
77, 74.8% 27, 77.1% 33, 92% 48, 71.6% 19, 86.4% 29, 64.4% 
GDM 50, 48.5% 18, 51.4% 30, 83% 32, 47.8% 7, 31.8% 25, 55.6% 
Preterm birth 34, 33.0% 17, 48.6% 34, 94%  17, 25.4% 6, 27.3% 11, 24.4% 
Caesarean section 58, 56.3% 23, 65.7% 34, 94% 35, 52.2% 10, 45.5% 25, 55.6% 
SGA 16, 15.5% 5, 14.3% 34, 94% 11, 16.4% 3, 13.6% 8, 17.8% 
LGA 21, 20.4% 10, 28.6% 36, 100% 11, 16.4% 2, 9.1% 9, 20.0% 
Admission to 
NICU 
10, 9.7% 5, 14.3% 21, 58% 5, 7.5% 2, 9.1% 3, 6.7% 
IPD, Individual Participant Data; GDM, Gestational diabetes mellitus; SGA, Small for gestational age infant;  239 
LGA, Large for gestational age infant NICU, Neonatal Intensive Care Unit; 240 
*trial publication 241 
 242 
 243 




4.3.2. Characteristics of participants in IPD trials 245 
Over 80% of participants in the IPD trials were classified as Caucasian and around half of 246 
them had obtained a higher degree. The average age comparable between intervention and 247 
control arms being around 30 years. Women were mostly in their first pregnancy and not 248 
physically active prior their pregnancy. A detailed comparison of participant characteristics 249 
in both arms of IPD trials is available in Appendix 4.4.  250 
 251 
4.3.3. Quality assessment 252 
Overall, included trials were assessed as being of a low risk of bias in random sequence 253 
generation (75%, 73/103). Over 90% (34/36) of the trials that contributed to the IPD meta-254 
analysis were assessed as being of a low risk of bias in this domain in comparison to 58% of 255 
those that did not (28/67). Two IPD (2/36) and one non-IPD (3/67) trials were considered high 256 
risk for allocation concealment. Blinding of outcome assessment was appropriate in 44% 257 
(16/36) and 33% (22/67) of IPD and non-IPD trials, respectively. Fewer IPD trials (5/36) were 258 
assessed as high risk of bias for incomplete outcome data compared to the non-IPD trials 259 
(15/67). A detailed assessment of the study quality for individual trials is provided in 260 
Appendix 4.5. There were no major issues during the IPD quality check that could not be 261 
resolved with the IPD contributor assistance. All discrepancies between the data reported in 262 
the trials’ publications and contributed IPD were documented. 263 
 264 
4.3.4. Findings of IPD meta-analysis 265 
Based on IPD meta-analysis, diet and physical activity based interventions resulted in 266 
significantly less gestational weight gain compared to routine antenatal care (MD -0.70 kg, 267 
95% CI -0.92, -0.48 kg, I2 = 14.1%, 33 studies, 9 320 women), after adjusting for baseline 268 
weight and clustering. There was a significant reduction in number of caesarean sections (OR 269 
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0.91, 95% CI 0.83, 0.99, I2 = 0%; 32 studies, 9 250 women), with the interventions compared 270 
to routine care. (Table 4.4) 271 
 272 
Figure 4.3 Risk of bias assessment for all eligible trials, trials where IPD was available, and 273 
those without access to IPD 274 
 275 
  276 
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Table 4.4 Meta-analyses of trials with diet and physical activity based interventions provided 277 
in pregnancy 278 
Outcome Meta-analysis 










(A) Study-level of only IPD trials  27 (8 697) -1.01 (-1.41, -0.61) 61.0 0.14 
(B) IPD 32 (9 320) -0.70 (-0.92, -0.48) 14.1 0.04 
(C) IPD and study-level 81 (17 530) -1.10 (-1.46, -0.74) 73.8 0.61 
(D) Study –level of all published trials 74 (16 599) -1.29 (-1.70, -0.88) 77.2 0.15 
GDM 
(A) Study-level of only IPD trials  18 (8 898) 0.84 (0.63, 1.12) 52.8 0.04 
(B) IPD 27 (9 427) 0.89 (0.72, 1.10) 23.8 0.03 
(C) IPD and study-level 59 (16 885) 0.76 (0.65, 0.89) 36.8 0.03 
(D) Study –level of all published trials 50 (16 356)  0.75 (0.64, 0.88) 44.0 0.03 
Preterm 
birth 
(A) Study-level of only IPD trials  17 (9 003) 0.79 (0.63, 0.99) 7.9 0.64 
(B) IPD 32 (11 676) 0.94 (0.78, 1.13) 17.3 0.32 
(C) IPD and study-level 49 (14 339)  0.92 (0.79, 1.08) 8.7 0.63 
(D) Study –level of all published trials 34 (11 666)  0.80 (0.67, 0.95) 1.2 0.86 
Caesarean 
section 
(A) Study-level of only IPD trials  23 (9 178) 0.91 (0.82, 1.01) 0 0.13 
(B) IPD 32 (11 410) 0.91 (0.83, 0.99) 0 0.88 
(C) IPD and study-level 66 (18 041) 0.89 (0.83, 0.96) 16.2 0.98 
(D) Study –level of all published trials 58 (15 858) 0.90 (0.83, 0.97) 6.5 0.90 
SGA 
(A) Study-level of only IPD trials  5 (2 807) 1.19 (0.83, 1.71) 0 NA 
(B) IPD 33 (11 666) 1.06 (0.94, 1.20) 0 0.74 
(C) IPD and study-level 44 (12 937) 1.05 (0.94, 1.18) 0 0.33 
(D) Study –level of all published trials 16 (4 078) 1.10 (0.87, 1.40) 0 0.03 
LGA 
(A) Study-level of only IPD trials  10 (5 583) 0.90 (0.69, 1.19) 27.8 0.72 
(B) IPD 34 (12 047) 0.90 (0.76, 1.07) 38.0 0.86 
(C) IPD and study-level 45 (13 348) 0.86 (0.71, 1.04) 41.0 0.71 
(D) Study –level of all published trials 21 (6 884) 0.82 (0.62, 1.10) 39.6 0.93 
Admission 
to NICU 
(A) Study-level of only IPD trials  5 (5 387) 1.02 (0.84, 1.13) 0 NA 
(B) IPD 16 (8 140) 1.01 (0.84, 1.23) 0 0.44 
(C) IPD and study-level 21 (9 498) 0.97 (0.82, 1.14) 0 0.16 
(D) Study –level of all published trials 10 (6 745) 0.99 (0.85, 1.15) 0 0.06 
*Mean Difference for gestational weight gain and Odds Ratio for binary outcomes; CI, Confidence Interval 279 
#Statistical test for the funnel plot asymmetry (Egger’s for gestational weight gain, Peter’s for binary outcomes); 280 
funnel plots available in Appendix 4.6 281 
GDM, gestational diabetes; SGA, small for gestational age infant; LGA, large for gestational age infant;  282 
NICU, Neonatal Intensive Care Unit; NA, not applicable due to less than 10 observation283 
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The reduction in other maternal outcomes such as gestational diabetes (OR 0.89, 95% CI 0.72, 
1.10, I2 = 23.8%; 27 studies, 9 427 women), and preterm birth (OR 0.94, 95% CI 0.78, 1.13,  
I2 = 17.3%; 32 studies, 11 676 women) were not statistically significant. There was no strong 
evidence that diet and physical activity based interventions had an effect on offspring 
outcomes such as SGA infant (OR 1.06, 95% CI 0.94, 1.20, I2 = 0%; 33 studies, 11 666 
women), LGA infant (OR 0.90, 95% CI 0.76, 1.07, I2 = 38.0%; 34 studies, 12 047 women), 
and admission to NICU (OR 1.01, 95% CI 0.84, 1.23, I2 = 0%; 16 studies, 8 140 women). The 
effect estimates and their standard errors by individual studies are available in Appendix 4.7. 
 
4.3.5. Impact of unreported outcomes  
The direction of the summary effects, in the subgroup of studies that shared IPD, was 
consistent between study-level (A) and IPD meta-analyses (B) across all evaluated 
outcomes. The summary effects derived from study-level data were greater in magnitude in 
comparison to IPD in four out of seven evaluated outcomes (Table 4.4). The difference in 
the effects on the gestational weight gain was 0.31 kg (MD -1.01 kg, 95% CI -1.41, -0.61 
study-level IPD trials versus MD -0.70 kg, 95% CI -0.92, -0.48 directly from IPD). Among 
the binary outcomes, the greatest discrepancy in the pooled effect was observed for preterm 
birth (OR 0.79, 95% CI 0.63, 0.99 study-level versus OR 0.94, 95% CI 0.78, 1.13 IPD) and 
SGA (OR 1.19, 95% CI 0.83, 1.71 study-level versus OR 1.06, 95% CI 0.94, 1.20 IPD). 
However, in all comparisons, the point estimates lied within each other CIs. 
 
The precision of the summary effects was greater in the IPD meta-analysis. For two 
outcomes of the seven evaluated, the statistical significance of the derived effects differed 
between the meta-analysis using study-level and that using IPD. For preterm birth, the CIs 
around the pooled effect derived from study-level data did not cross the line of no-difference 
for OR (95% CI 0.63, 0.99). In the IPD meta-analysis, the CIs spanned from 0.78 to 1.13. 
The opposite was seen in case of the caesarean section where 95% CIs around the pooled 
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effect estimates (OR 0.91 in both cases) were from 0.82 to 1.01 in the study-level data meta-
analysis, and from 0.83 to 0.99 when IPD was used. All the IPD meta-analyses showed low 
to moderate between-study heterogeneity. The same heterogeneity was seen in the study-
level data meta-analysis, except for gestational weight gain and GDM where the I2 was 
greater than 50%. 
 
The comparison of the funnel plots between two approaches was not possible for SGA and 
admission to NICU as the study-level meta-analysis included insufficient number of trials for 
a meaningful assessment of the plots asymmetry. However, in the cases of both outcomes, the 
formal test for the funnel plot asymmetry using IPD did not show any significant asymmetry 
in the scatter of the effect sizes and their standard errors. For the remaining outcomes, only in 
the case of gestational weight gain did the funnel plot asymmetry tests differ between the two 
approaches – Egger’s test for meta-analysis using study-level IPD trials and IPD trials was 
0.14 and 0.04, respectively. 
 
4.3.6. Impact of data availability 
Overall, the meta-analyses with combined IPD and non-IPD trials (C) contained more studies 
and returned the summary effect estimates of a greater magnitude than meta-analysis with IPD 
alone (B). The direction of the summary effect estimates was consistent between IPD meta-
analyses with and without non-IPD trials. The effect on gestational weight gain was greater by 
0.31 kg in the meta-analysis with IPD and non-IPD trials (MD -1.10 kg, 95% CI -1.46, -0.74), 
compared to IPD alone (MD -0.70 kg, 95% CI -0.92, -0.48) (Table 4.4) 
 
Among the binary outcomes, the greatest discrepancy in the value of the summary effect 
estimates was noted for GDM with OR 0.89 (95% CI 0.72, 1.10) from the IPD meta-analysis 
and OR 0.76 (95% CI 0.65, 0.89) in the IPD meta-analysis with non-IPD trials. (Figure 4.4)  
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Figure 4.4 Forest plot with the pooled effect of the interventions on gestational diabetes from 
combined meta-analysis with IPD and study-level data from trials with unavailable IPD  
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The meta-analyses for this outcome also differed regarding the statistical significance moving 
from not statistically significant effect in IPD meta-analysis to statistically significant effect in 
IPD meta-analysis with non-IPD trials. The between-study heterogeneity increased with the 
addition of non-IPD trials in four outcomes did not change in two outcomes and decreased in 
one outcome. Formal assessment of the funnel plot asymmetry was possible for all outcomes. 
The addition of non-IPD trials in IPD meta-analyses changed the funnel plot asymmetry from 
skewed to symmetrical in the meta-analyses of the gestational weight gain (Egger’s test p = 
0.61). 
 
4.3.7. Totality of evidence on the effects of the interventions 
Overall, the meta-analyses that combined IPD and non-IPD trials (C) contained more trials 
than meta-analyses with the study-level data (D). The direction of effects was consistent 
across the comparisons for all outcomes. The summary effects derived from the combined 
meta-analyses (IPD and non-IPD) tended to be more modest than the effects obtained from 
the study-level meta-analysis. The pooled effects for gestational weight gain differed between 
the meta-analyses by 0.14 kg with a greater reduction observed on the study-level (MD -1.24 
kg, 95% CI -1.64, -0.84) (Table 4.4). Among the binary outcomes, the greatest discrepancy in 
the summary estimates was noted for preterm birth, with OR 0.92 (95% CI 0.79, 1.08) in the 
combined meta-analysis and OR 0.80 (95% CI 0.67, 0.95) in the study-level meta-analysis. 
The CIs around the summary effects were narrower in the combined meta-analyses for two 
outcomes (SGA and LGA). The statistical significance differed between the two approaches 
for preterm birth. The study-level meta-analysis suggested 20% statistically significant 
reduction in the odds of premature birth (OR 0.80, 95% CI 0.67, 0.95), in comparison to 8% 
non-statistically significant reduction (OR 0.92, 95% CI 0.79, 1.08) with combined IPD and 
non-IPD meta-analysis.  
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The level of the between-study heterogeneity was comparable between the two approaches, 
with low to moderate heterogeneity for the majority of the outcomes. Only for gestational 
weight gain, the heterogeneity estimate was above 50%. The comparison of the funnel plot 
asymmetry was possible for all the outcomes with an observed change in the statistical 
significance of the scatter distribution in one case. The funnel plot asymmetry for SGA was p 
= 0.03 and p = 0.33 (Peter’s test) for the meta-analysis using study-level published trials and 
IPD with non-IPD trials, respectively. For the study-level meta-analyses, the pooled estimates 
obtained using number of randomised participants did not differ from the estimates obtained 
using sample sizes as reported in the publications (Appendix 4.8). Forest plots with the effect 
estimates derived from the study-level data are available in Appendix 4.9. 
 
4.4. Discussion 
4.4.1. Main findings 
The findings for the IPD meta-analysis of 36 RCTs with over 12 500 women that showed diet 
and physical activity based interventions in pregnancy having a statistically significant effect 
in moderately reducing gestational weight gain. There was evidence that the odds of having a 
caesarean section were significantly lowered with the interventions, in comparison to routine 
antenatal care. Although the summary estimates favoured a reduction in all individual 
maternal outcomes, the findings were not statistically significant. There was no effect of the 
intervention on the evaluated offspring complications.  
 
In contrast to data reported in the published reports, access to IPD from 36 RCTs allowed to 
incorporate more trials into the meta-analysis for all evaluated outcomes. Incorporation of 
previously unavailable data returned modest summary effects compared to the effects 
obtained using study-level data from publication of trials that contributed IPD to the i-WIP 
study. The statistical significance of the pooled effect changed in two cases and had no clear 
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impact on the heterogeneity level. The addition of study-level data from non-IPD trials 
changed the magnitude and the statistical significance of the summary effects in the meta-
analysis for GDM, and changed the funnel plot structure in the meta-analysis for gestational 
weight gain. In most cases, incorporation of study-level data from trials where IPD was not 
available increased the between-study heterogeneity. The study-level meta-analyses and IPD 
meta-analysis with the addition of non-IPD trials (study-level data) provided comparable 
results with similar levels of between-study heterogeneity. The statistical tests for the funnel 
plot asymmetry were mostly coherent between the two approaches except for one outcome 
(SGA). 
 
4.4.2. Strengths and limitations 
The work presented here addresses important issues on the impact of unreported data, 
availability bias, and merits of performing IPD meta-analyses of RCTs on the effect of diet 
and physical activity in pregnancy. The meta-analyses complied with the current standards for 
their conduct and provided a comprehensive range of sensitivity analyses, allowing 
investigating the robustness of the summary effect estimates. The evidence synthesis included 
103 RCTs, of which IPD was available from 36 RCTs with data from half of all women 
randomised to those trials. Out of 67 studies where IPD was not available, 45 were identified 
past the data acquisition time meaning that around two-thirds of those studies were not 
available due to logistics rather than the nature of their findings. Despite comprehensiveness 
of the searches, two studies were not picked up in the searches.234,235 However, their impact on 
the analyses was insignificant. 
 
Evaluated interventions comprised of a wide range of components such as different types of 
physical activity, diets, weight monitoring, and behaviour modifying techniques (Appendix 
4.10). The complexity of the evaluated interventions was one of the major limitations for 
interpretation of the findings due to difficulty in disentangling the impact of trial type (diet, 
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physical activity, or mixed approach) from a true impact of unreported outcome data or study 
availability bias. Furthermore, the access to IPD allowed adjusting for baseline weight using 
analysis of covariance in each trial, which was not possible for the trials without access to 
IPD. Nevertheless, despite the heterogeneous environment, the tendency towards a greater 
magnitude of the summary effects with study-level published trials was visible for all 
evaluated outcomes. The between-study heterogeneity was formally quantified using I2 
measure. Despite potential concerns over dependency of this measure on the sample size, I did 
not observe an impact of the number of participants in the analyses and the I2 value. For 
example, in the meta-analyses with preterm birth or gestational weight gain the increase in the 
sample sizes across the comparisons was not followed by substantial change in the value of I2 
measure. 
 
A small proportion of all eligible trials (around 7%) did not contribute data to the quantitative 
synthesis of evidence. No attempt was made to contact authors of trials published in a format 
of conference abstracts. Also, no contact was made with the authors of non-IPD trials for 
more accurate trial design assessment, in case of lack of sufficient details in the publications 
or trial protocols. The risk of bias assessment of IPD trials was additionally supported by 
information obtained directly from the trials’ authors.  
 
It was not always possible to match the trials’ populations where the IPD was available 
between the publications and records contributed to IPD meta-analysis. The discrepancies 
between the numbers of randomised and contributed participants records were queried with 
the trials’ authors, and in most cases explained by loss to follow-up. Trial level discrepancies 
in the effect estimates reported in the publications and derived from IPD were rare and 
occurred mostly in small trials (Appendix 4.11). The comparison between the effect estimates 
was not done using formal methods and did not account for clustering of intra-study outcomes 
(more than 75% of trials studies contributed to more than one meta-analysis). Trials overlap 
also exists between the meta-analyses in all described comparisons, which might have led to a 
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dilution of the true effects. All the aspects discussed above should be taken into account when 
interpreting the findings of this work. However, observed trends are consistent with those 
reported in the literature for the comparisons between IPD and study-level meta-analyses.126 
 
4.4.3. Interpretation 
Within-study selective reporting of differences between evaluated interventions depending on 
statistical significance is one of the most important sources of bias affecting clinical trials.26 
Access to IPD in a meta-analysis of trials on diet and physical activity in pregnancy showed 
that around 30% of collected outcome data are not reported in the trial reports, such as 
admission to NICU not being reported in over two-thirds of studies. Preterm birth, SGA, and 
LGA were generated using gestational age and birthweight at delivery, if not captured in the 
originally contributed dataset. The ability to compute the outcome data facilitate incorporation 
to the meta-analyses number of trials that could not be analyses on the study-level. Yet, 
availability of the outcome data did not always lead to their inclusion in the meta-analysis. For 
example, a low number of stillbirths or lack of weight gain measures (baseline and final) 
hampered inclusion of all trial data for these outcome in the IPD meta-analysis. Gestational 
weight gain is perceived as a surrogate of maternal morbidity.236 However, around 40% of 
included trials were powered to detect the effect of the intervention on this outcome. The 
variability in the magnitude of the effect, heterogeneity and small study effects across the 
meta-analyses might be more of an indicator of the quality of the data analysis in the primary 
trials rather than the impact of unreported outcome data.  
 
Although the analyses found little or no evidence of the effect for diet and physical activity 
based interventions on the composite outcomes (maternal and offspring) this cannot be 
interpreted as ‘evidence of no effect’. Despite wide confidence intervals crossing the null, 
there was a consistent summary effect estimates favouring the intervention on some of the 
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assessed outcomes. A more in-depth exploration of the effect estimates in individual trials and 
their direction could help to gain a better idea of the certainty of the intervention effect. 
 
The consistent skewness in the funnel plot asymmetry in the meta-analyses for GDM could be 
due to failure to collect or report this outcome in the smaller studies. The reasons for not 
reporting GDM might be numerous e.g. obtaining an undesirable effect on the outcome 
(reporting bias). The other explanation could be that the trialist did not consider the outcome 
important enough in the context of the research question e.g. trials with physical activity 
based interventions among the obstetric outcomes reported GDM less frequently than labour 
or delivery related events (disucssed in detail in chapter 6, Table 6.1). The variability in 
outcome definition could partially explain the moderate heterogeneity in the GDM meta-
analysis. Diagnosis of GDM in the group of IPD trials was based on a broad range of 
guidelines that algorithms and reference standards did not always overlap with each 
other.237,238 This problem could not be addressed even in IPD meta-analysis during data 
harmonisation due to the limited time and complexity of the task. 
 
The authors of guidance on the appraisal of IPD meta-analyses of randomised trials advocate 
checking for the proportion of trials from which IPD was obtained.46 Yet, only 25% of IPD 
meta-analyses manages to obtain IPD from all identified trials.50 Since the publication of the 
systematic review that laid the grounds for the i-WIP IPD meta-analysis76, there has been a 
significant increase in the number of trials evaluating the effects of diet and physical activity 
based interventions in pregnancy. With 45 new trials published within the last 3 years 
achieving the goal of being current and obtaining the majority of, if not all, IPD is virtually 
impossible. This emphasizes, the importance of sensitivity analysis in studies using an IPD 
approach to meta-analysis where IPD is combined with study-level data from trials, where IPD 
was not available due to refusal or study’s time frames. 
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4.4.4. Conclusion 
Interventions with diet and physical activity in pregnancy have the potential to reduce the 
gestational weight gain and the reduction of the risk of cesarean section. The effect of the 
interventions in reducing the odds of cesarean section was consistent regardless of the range 
and type of meta-analysis. My work showed that the effect of interventions without access to 
IPD and incorporation of unreported outcomes would be inflated. Furthermore, not 
incorporating trials with unavailable IPD would probably lead the researchers to abandon 
further exploration of the effect of the interventions on GDM.  
 
The synthesis of only study-level and a combination of study-level and IPD for the totality of 
evidence mostly led to similar conclusions on the effects of diet and physical activity based 
interventions on the pregnancy outcomes. As an IPD meta-analysis is time and resource 
consuming approach to evidence synthesis, therefore the rationale for embarking on it needs 
to return tangible benefits. Evaluation of the summary effect might not be a sufficient 
justification for implementing IPD meta-analysis approach to evidence synthesis however it 
improves its robustness. 
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Chapter 5 Meta-regression and individual participant data 
meta-analysis to assess treatment-covariate interactions: 
empirical example of BMI influence on the effect of diet and 
physical activity 
5.1. Introduction 
Studies included in a systematic review inevitably differ from each other. All those 
differences contribute to heterogeneity in the pooled effect estimates and might prevented the 
formal pooling of the effects across the studies in extreme cases.97 Exploration of the 
heterogeneity in the pooled effect is an essential aspect of evidence synthesis.96 One of the 
main reasons, for high heterogeneity, is the characteristic of populations in the individual 
studies. The concept that subgroups of patients might benefit more from the interventions than 
the general because of their particular characteristics lies at the basis of stratified medicine.100 
Identification of such groups should be clinically based and defined a priory to prevent data 
dredging.19 
 
Meta-regression and subgroup analysis are commonly used in study-level meta-analysis to 
explore the heterogeneity or identify subgroups of clinical relevance.97,99 In meta-regression 
the influence of specific factors (e.g. participant characteristics) is examined in regression 
analysis against the effect estimates. Subgroup analyses are used when data for subgroups of 
patients of interest are available for each study. However, the findings of both methods might 
be misleading for two main reasons. Firstly, results extracted from trial publications are 
average estimates of the population in the study, and subgroup effects (‘treatment-covariate 
interactions’) are rarely reported in sufficient detail. Secondly, meta-regression that examines 
the across-trial association between overall treatment effect and average patient characteristics 
(e.g. mean age) has low power to detect genuine subgroup effects and is also prone to study-
level confounding.20,101,239 Meta-analysis using IPD has the potential to overcome the 
   
112 
limitations of the methods relying on study-level data.43-45 Access to participant-level data in 
IPD meta-analysis allows deriving the effects of interventions for a particular subgroup 
directly from participant records. This substantially increases power to detect the effect of 
participants’ characteristics truly modifying the effect of the interventions.240,241 
 
Diet and physical activity based interventions have been extensively studied for their potential 
to achieve better pregnancy outcomes. These studies involve women with varied BMI values 
(see Appendix 1.1). A comprehensive systematic review of the RCTs on diet and physical 
activity showed that the interventions were effective in reducing gestational weight gain, with 
potential to improve pregnancy outcomes.76 However, the findings were limited by the 
inability to explain heterogeneity of effects for important outcomes, and the paucity of 
published detail on the effects of interventions in various BMI groups, and other clinically 
important characteristics. One of the main recommendations that arose from the project was 
the need to synthesise participant-level data to assess any differential effect of the benefits 
observed with interventions in various groups of women including BMI category.76 
 
The i-WIP IPD meta-analysis summarised the effects of diet and physical activity based 
interventions on gestational weight gain, adverse composite maternal and composite offspring 
outcome, and determined whether the effects deferred according to women’s characteristics.79 
The i-WIP study collected data from 36 RCTs with over 12,500 participant records. 
 
5.1.1. Aims 
The aim of work presented in this chapter was to investigate potential differences between the 
study-level and IPD meta-analysis approach to detect the modifying effect of woman’s BMI 
on the effects of diet and physical activity based interventions in pregnancy on maternal and 
offspring outcomes. 
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5.2. Methods 
Trials and IPD used to address chapter’s objective have been identified and obtained through 
a process described in detail in sections 2. In the IPD meta-analysis, continuous characteristics 
were summarised as means (with SD), and dichotomous and categorical as frequencies. 
Gestational weight gain, the only continuous outcome, was kept as pre- or early pregnancy 
weight and the last available weight before the delivery. The maternal and offspring 
complications were coded in a binary way (Yes/No). For details of IPD acquisition and 
handling see section 4.2. On the study-level, women’s characteristics were used as reported in 
the publications of the eligible trials. Where possible, women’s BMI was captured as an 
average value of all the women included in the individual trial, and as a proportion of women 
with normal BMI, overweight and obese. Gestational weight gain was extracted as mean with 
accompanying SD, remaining maternal and offspring outcome were recorded as event rates 
and extracted to two-by-two tables (see section 2.4). 
 
5.2.1. IPD meta-analysis 
As specified in section 2.4, a two-stage approach to IPD meta-analysis was applied accounting 
for cluster design, if necessary. For the continuous outcome of weight gain, the analysis of 
covariance was performed in each trial to regress the final weight value against the 
intervention while adjusting for baseline weight value. For the binary outcomes, a logistic 
regression was applied in each trial separately with intervention as a covariate. All models 
were extended to include interaction terms between participant-level covariates and the 
intervention. The characteristic of interest (women’s BMI) was used as a continuous and a 
categorical covariate (normal, overweight, and obese). The coefficients for binary outcomes 
were log transformed to OR with their respective 95% CI. 
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5.2.2. Study-level meta-analysis 
For the study-level analysis, a meta-analysis without pooling of the effect estimates (OR for 
binary outcomes and MD for gestational weight gain) was first performed to obtain the effect 
estimates and their respective standard errors (SE) on the individual trial level.242 For the 
binary outcomes, the OR were log-transformed and their SE calculated. Secondly, I fitted 
weighted least-squares linear regression models with the respective effect estimates as the 
outcome variable, the covariates as predictors, and the weights equal to the inverse of the 
variance of the effect estimates.243 The models for dichotomous outcomes were not corrected 
for lack or imbalance in the event rates. The study-level BMI data were used as an average 
BMI of women in the study (continuous) or as a proportion of normal, overweight, and obese 
women. For easier interpretation of the coefficients, the originally extracted proportions of 
women in the respective BMI groups were multiplied by 10 (10% change in the proportion of 
women). The coefficients for binary outcomes were again transformed to OR with their 
respective 95% CI. Where possible, a sensitivity analysis was performed using study-level 
data from the group of studies that contributed to IPD-meta analysis.  
  
5.2.3. Comparisons 
The comparison between study-level and IPD exploration of modifying the effect of women’s 
BMI on the effects of interventions in was performed for gestational weight gain and 
individual maternal and offspring outcomes. Similarly to work presented in chapter 4, the 
composite outcomes could not be used to investigate the differences between the meta-
analyses based on study-level and IPD. Therefore the comparisons were made for the 
gestational weight gain, GDM, caesarean section, preterm birth, SGA, LGA and admission to 
NICU. Stillbirth and hypertensive diseases were not used for the reasons given in section 4.2. 
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Firstly, I obtained the interactions between women’s BMI and the effects of interventions 
using IPD from the trials that contributed to the i-WIP study. Secondly, I performed a meta-
regression using the study-level data extracted from all eligible trials where the outcome and 
the covariate of interest were available. The results of both approaches were compared for the 
significance of the modifying effect of the covariates on the effects of the diet and physical 
activity in pregnancy on the maternal and offspring outcomes. 
5.3. Results 
5.3.1. Studies characteristics  
Out of 103 RCTs with diet and physical activity based interventions in pregnancy (Figure 4.1 
in section 4.3) data from 89 was available for study-level meta-regression. The remaining 14 
studies could not be used due to lack of outcome data or incomplete reporting of BMI value at 
baseline. The majority of 89 trials recruited women regardless of their BMI value, 20% 
included only obese and overweighed, and 14.6% only obese women (Table 5.1). The average 
BMI was 27.8 kg/m2 and was provided in 73 out of 89 trials. The proportion of women in 
respective BMI categories were was reported in more than half of the trials (50/89) with 38% 
(19/50) reporting inclusion of some proportion of women with normal BMI, 74% (37/50) of 
overweight and 90% (45/50) of obese women. 
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Table 5.1 Characteristics of studies used in meta-regression  
Baseline characteristics 
Number of studies  
(Number of women) 
Proportion of studies 
or Average value 
BMI inclusion criteria† 
Any BMI 55 (15 180) 61.8% 
Only normal BMI 1 (160) 1.1% 
Normal and overweight 2 (211) 2.2% 
Obese 13 (3 517) 14.6% 
Overweight and obese 18 (4 804) 20.2% 
Weight recorded   
Pre-pregnancy 36 (7 443) 40.4%  
Early pregnancy 27 (8 346) 30.3% 
Pre or early pregnancy 1 (382) 1.1% 
Unclear or not given 25 (7 701) 28.1% 
Weight, kg 46 (12 500) 75.1 
BMI, kg/m2 73 (20 347) 27.8 
Proportion of women in a given BMI category†  
Normal BMI 19 (2 941§) 22.8 
Overweight 37 (3 423§) 26.5 
Obese 45 (6 431§) 48.9 
BMI, Body Mass Index; † as reported in the study; §numbers estimated basing on the reported proportion of women 
 
In the group of trials where IPD was available, 23 included women regardless of their early or 
pre-pregnancy BMI, five included only obese and overweight women, and eight included only 
obese women. The data on women’s BMI was available for the majority of the studies (34/36) 
with the average value of 29.2 kg/m2 (SD 6.6). Over two-third of women included in those 
trials were obese, 31.7% had normal BMI, and 25.8% were overweight (Table 5.2) 
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Table 5.2 Characteristics of studies with available Individual Participant Data 
Baseline characteristics 
Number of studies  
(Number of women) 
Frequencies or 
Mean (SD) 
BMI inclusion criteria† 
Any BMI 23 (6 742) 63.9% 
Obese 8 (2 897) 22.2% 
Overweight and obese 5 (2 704) 13.9% 
Weight, kg 33 (11 748) 80.0 (19.0) 
BMI, kg/m2 34 (12 031) 29.2 (6.6) 
Proportion of women in a given BMI category: 
Normal weight 24 (12 031) 3816, 31.7% 
Overweight 32 (12 031) 3101, 25.8% 
Obesity 34 (12 031) 5114, 42.5% 
Gestational weight gain (kg) by BMI category   
Normal weight 21 (3376) 11.9 (4.6) 
Overweight 29 (2574) 11.1 (5.2) 
Obesity 31 (3335) 8.4 (5.7) 
Weight, kg   
Pre-pregnancy  23 (2 406) 73.1 (17.9) 
Early pregnancy 26 (3 482) 79.1 (18.5) 
BMI, Body Mass Index (kg/m2) 
 
5.3.2. IPD meta-analysis 
The IPD meta-analysis showed no evidence of an interaction between women’s BMI and the 
effects of diet and physical activity based interventions in case of gestational weight gain. The 
interaction was not significant whether the BMI was used as a continuous covariate (-0.02 kg 
change in intervention effect per 1-unit increase in BMI, 95% CI -0.08, 0.04). The results 
were similar when in the comparison between the categories: overweight vs. normal (-0.11 kg, 
95% CI -0.77, 0.55), obese vs. normal (0.06 kg, 95% CI -0.90, 1.01), and obese vs. 
overweight (-0.09 kg, 95% CI -1.05, 0.86) (Table 5.3).  
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Table 5.3 Interactions between the effects of diet and physical activity based interventions and 
early or pre-pregnancy Body Mass Index for gestational weight gain using IPD meta-analysis  
Covariate 
Number of studies 
(Number of women) 
Pooled interaction term,  
95% CI 
I² (%) 
BMI continuous* 31 (9 285) -0.02 (-0.08, 0.04) 39.8 
Overweight vs normal 21 (5 178) -0.11 (-0.77, 0.55) 32.0 
Obese vs normal 21 (4 221) 0.06 (-0.90, 1.01) 32.7 
Obese vs overweight 28 (5 426) -0.09 (-1.05, 0.86) 46.9 
BMI, Body Mass Index (kg/m2); CI, Confidence Interval  
*change in the effect per unit increase in covariate (BMI) 
 
 
The analyses did not show any evidence of an interaction between the women’s BMI and the 
effects of the interventions for any of the maternal and offspring outcomes (Table 5.4). The 
analyses with categorised BMI differ in the number of studies and participants as not all trials 
recruited women across all three groups. The between-study heterogeneity for interaction 
terms was low to moderate with the I2 above 25% present for all the models with the 
gestational weight gain.  
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Table 5.4 Interactions between the effects of diet and physical activity based interventions and 
early or pre-pregnancy Body Mass Index for predefined outcomes using IPD meta-analysis 
Outcome Covariate 
Number of studies  
(Number of women) 
Pooled interaction term 
OR, 95% CI 
I² (%) 
GDM 
BMI continuous* 25 (9 316) 1.00 (0.97, 1.02) 0.0 
Overweight vs normal 12 (3 503) 0.92 (0.40, 2.10) 16.4 
Obese vs normal 12 (2 849) 1.05 (0.44, 2.51) 1.6 
Obese vs overweight 13 (3 978) 0.99 (0.60, 1.65) 0.0 
Preterm 
birth  
BMI continuous* 31 (11 603) 0.98 (0.94, 1.02) 0.1 
Overweight vs normal 7 (2 660)  1.11 (0.42, 2.93) 0.0 
Obese vs normal 7 (2 143) 0.80 (0.24, 2.63) 0.0 
Obese vs overweight 11 (4 376) 0.56 (0.30, 1.06) 0.0 
Caesarean  
section 
BMI continuous* 32 (11 398) 1.00 (0.98, 1.02) 0.1 
Overweight vs normal 19 (5 217)  1.07 (0.76, 1.51) 0.0 
Obese vs normal 19 (4 248) 0.88 (0.55, 1.41) 0.0 
Obese vs overweight 28 (6 131) 0.91 (0.69, 1.2) 0.0 
SGA  
infant 
BMI continuous* 31 (11 556) 0.98 (0.95, 1.00) 0.0 
Overweight vs normal 16 (5 271) 1.01 (0.57, 1.81) 7.5 
Obese vs normal 16 (4 265) 0.68 (0.35, 1.31) 0.0 
Obese vs overweight 20 (5 467) 0.65 (0.42, 1.03) 0.0 
LGA 
infant 
BMI continuous* 32 (11 979) 1.00 (0.97, 1.02) 0.0 
Overweight vs normal 12 (3 881) 1.19 (0.7, 2.04) 29.0 
Obese vs normal 12 (3 067) 1.38 (0.79, 2.41) 0.0 
Obese vs overweight 21 (5 956) 1.04 (0.72, 1.50) 0.0 
Admission 
to NICU 
BMI continuous* 14 (7 725) 0.97 (0.92, 1.02) 0.2 
Overweight vs normal 7 (2 501) 0.83 (0.36, 1.92) 0.0 
Obese vs normal 7 (1 982) 1.45 (0.52, 4.08) 0.0 
Obese vs overweight 11 (4 383) 0.99 (0.35, 2.77) 23.7 
CI, Confidence Interval; OR, odds ratio; BMI, Body Mass Index (kg/m2); GDM, gestational diabetes; SGA, Small 
for gestational age; LGA, Large for gestational age; NICU, Neonatal Intensive Care Unit;  
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5.3.1. Study-level meta-analysis 
The effect of diet and physical activity based interventions on gestational weight gain was 
significantly modified by women’s BMI in the model where the BMI was coded as the 
proportion of women in the individual classes. The effects of the interventions was 
significantly modified by an increase in the proportion of obese women by each 10%  
(coeff. -0.22, 95% CI -0.33, -0.11) (Table 5.5) 
 
Table 5.5 Interactions between the effects of diet and physical activity based interventions and 





Coeff. (95% CI) 
I² (%) 
1-unit of change in the value of: 
Average BMI  63 -0.08 (-0.17, 0.21) 77.7 
10% change in the proportion of women in BMI strata of: 
Normal BMI 47 -0.11 (-0.27, 0.04) 
79.4 Overweight 47 -0.09 (-0.29, 0.11) 
Obese 47 -0.22 (-0.33, -0.11) 
CI, Confidence Interval; BMI, Body Mass Index (kg/m2); 
 
The modifying effect was not statistically significant for the other BMI groups or when the 
covariate was used as an study-level avaerage. The meta-regressions for the remaining 
maternal outcomes did not provide any evidence for a modifying effect of women’s BMI on 
the effect of diet and physical activity based interventions in pregnancy regardless whether an 
average BMI or a proportion of women in the particular BMI groups was used (Table 5.6). 
 
The exploration using study-level data was not possible for all three offspring outcomes. For 
admission to NICU, meta-regression was not possible as there were less than ten studies with 
the outcome and the covariate data. The analyses for SGA and LGA were limited meta-
regression only with BMI as an average from the individual trials. The interaction between the 
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study-level covariate and the interventions effects were OR 1.02 (95% CI 0.97, 1.08, I2 = 0%, 
15 studies) for SGA, and OR 1.03 (95% CI 0.97, 1.09, I2 = 33.4%, 19 studies) for LGA per 1-
unit of increase in the value of the average BMI. The study-level analysis limited to the 
studies that contributed to IPD meta-analysis was possible for only four maternal outcomes 
and only with BMI as a study-level average. None of the results was statistically significant. 
(Appendix 5.1)  
 
Table 5.6 Interactions between the effects of diet and physical activity based interventions and 




OR (95% CI) I² (%) 
 1-unit of change in the value of: 
GDM Average BMI 45 1.02 (0.98, 1.05) 24.5 
Preterm birth  30 0.98 (0.93, 1.02) 0.0 
Caesarean section  49 1.01 (0.99, 1.02) 0.0 
 10% change in the proportion of women in BMI strata of: 
GDM Normal BMI 35 1.01 (0.95, 1.07) 
33.9  Overweight 35 0.96 (0.90, 1.02) 
 Obese 35 0.98 (0.95, 1.01) 
Preterm birth Normal BMI 21 0.98 (0.92, 1.05) 
3.5  Overweight 21 1.03 (0.89, 1.19) 
 Obese 21 0.96 (0.91, 1.01) 
Caesarean section Normal BMI 33 0.98 (0.96, 1.01) 
0.0  Overweight 33 0.99 (0.96, 1.03) 
 Obese 33 1.00 (0.98,1.01) 
OR, odds ratio; CI, Confidence Interval; BMI, Body Mass Index (kg/m2); GDM, gestational diabetes 
 
The between-study heterogeneity for the interaction terms was low to high across the models. 
The most heterogeneous (I2 > 75%) results were among the models evaluating effect of the 
covariates on the interventions’ effect on the gestational weight gain. 
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5.3.2. Study-level versus IPD meta-analysis 
The study-level meta-analysis showed a statistically significant relationship between the 
proportion of obese women and the effects of the evaluated interventions on gestational 
weight gain. The relationship was not present in the IPD meta-analysis. The results of the 
study-level and IPD meta-analyses were concordant for the remaining outcomes regardless 
whether the women’s BMI was used as continuous or categorical value. In comparison to 
study-level meta-analysis, access to IPD allowed me to explore the modifying effect of 
women’s BMI, as a continuous and categorical covariate, on the interventions’ effect on all 
the offspring outcomes. The study-level meta-analysis for SGA and LGA could be performed 
only using BMI as an average value for the population recruited in the individual studies. The 
between-study heterogeneity for the interaction terms was more variable on the study-level 
and in the models with gestational weight gain much higher than on the IPD-level. 
 
5.4. Discussion 
5.4.1. Main findings 
Access to participant-level data allowed me to conduct a more profound and comprehensive 
exploration of the modifying effects of women’s BMI on the effects of diet and physical 
activity based interventions on maternal and offspring outcomes. The IPD meta-analysis 
shows that the effects of diet and physical activity based interventions on the maternal and the 
offspring outcomes did not differ by women’s BMI status. The results of the study-level meta-
regression indicate that the effect of interventions on minimising gestational weight gain may 
be stronger for the obese women than for overweight or women with normal BMI. The 
heterogeneity in the treatment-covariate interactions was lower when the IPD rather than 
study-level data were analysed. 
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5.4.2. Strengths and limitations 
The meta-analyses conducted in this chapter complied with the current standards and provided 
an empirical comparison between study-level and IPD meta-analytical approaches to effect 
modification by participant characteristics. The trials used in the comparisons were identified 
through a robust and systematic process. The IPD meta-analysis was guided by prospectively 
developed protocol and according to current standards of conducting this type of evidence 
synthesis.79 Access to IPD from 36 RCTs with diet and physical activity based interventions 
in pregnancy (> 12 500 participants) provided sufficient power (compared to individual trials) 
to estimate treatment-covariate interactions. It has allowed incorporation of unreported 
outcome data, and adjustment for baseline weight using analysis of covariance in each trial 
which is most suitable for the analysis of continuous outcomes.244 In comparison to other 
empirical explorations, I ensured that the study-level meta-analyses had a sufficient number  
of studies as per current recommendations for running meta-regression.240 
 
Diet and physical activity based interventions comprise of a wide range of complex 
components with various types of physical activity, modification of diet, etc. In contrast to 
work by Berlin et al.240 that explored the magnitude of the ecological bias on a drug example, 
the complexity of the interventions increased noise in the comparisons consequently limiting 
its power to quantify the ecological bias. The initial work plan envisaged to identify a group 
of studies with similar interventions regarding the components, type of delivery, frequency 
and duration that could be used for the study-level versus IPD comparison. The subgroup of 
trials on physical activity met those criteria; however, the variable reporting of the study-level 
data prevented me from pursuing this part of the exploration.  
 
Finally, it was not always possible to match the trials’ populations where the IPD was 
available between the publications and records contributed to IPD meta-analysis. However, 
almost two-thirds of the IPD trials shared the data from all randomised participants. The 
   
112 
comparison did not account for clustering of outcomes within-studies and the trial overlap 
between study-level and IPD meta-analyses. As I did not correct for multiple testing when 
considering BMI subgroups, observed statistically significant findings should be treated with 
caution due to increased risk of the type 1 error. 
 
5.4.3. Interpretation 
Investigating sources of heterogeneity in the summary effects or identification of subgroups  
of participants that benefit more from the evaluated interventions are important elements of 
evidence synthesis.96 Commonly used approaches such as subgroup analysis and estimation  
of treatment-covariate interaction in meta-regression lack the statistical power and are limited 
by the reporting of primary studies. Although meta-analyses using IPD is widely regarded as 
‘gold standard’ for evidence synthesis of effectiveness research43,45,46 it is logistically more 
challenging and resource intensive than study-level meta-analyses. It is important to ensure 
that the benefits are emerging from deploying this method outweighs its costs.239,245 
 
The study-level meta-analysis indicated that the effect of the interventions in the reduction of 
gestational weight gain might be stronger among obese pregnant women. Whereas, the meta-
analyses using IPD showed no evidence to support the belief that the women from any 
specific BMI class would benefit from the interventions more than the others. If the results of 
the IPD meta-analysis were not available, the findings of meta-regression could have been 
used to support the provision of a specific antenatal advice on diet and physical activity in 
pregnancy to minimise gestational weight gain only to this group of women. However, basing 
on presented findings from IPD meta-analysis, on average, these interventions reduce 
gestational weight gain with the comparable magnitude across BMI groups. Therefore, their 
provision only to obese women would have to be justified by other health benefits e.g. 
development of healthier eating habits.246  
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The significant interaction between the interventions’ effect and the categorical covariate in 
this work could have emerged due to poor reporting of primary studies, high between study 
variance in the characteristic of the categorical covariate, and study-level confounding. Only 
half of studies with reported average BMI also provided the number of women within the 
individual BMI classes. Nevertheless, the model with BMI as a proportion of women in 
individual BMI classes identified a statistically significant interaction. The trials that reported 
only the average BMI recruited women regardless of their BMI status across four continents 
while the studies in where the proportions were reported were conducted in predominantly in 
high income countries (US, Europe and Australia). 
 
Meta-regression is known for its low statistical power to detect interactions and depends on 
the variation in the covariates values within and between the studies.247 However, if the ranges 
of the covariate within studies are narrow, and the means are broadly spaced across the studies 
(between-study ranges) the power to detect potential modifying effect of this covariate in 
meta-regression is high.247 The variation in the within and the between study-level average 
BMI was much lower than for the covariate capturing the proportion of obese. Furthermore, 
almost one-third of the studies reporting the proportion of obese women recruited only from 
this BMI class with another one-third having more than 50% of women with BMI above 30. 
The trials with the obese participants were mostly conducted in the high income countries 
such as UK, Denmark, Belgium, Canada or US (Appendix 4.3) making it difficult to 
disentangle the effect of the high BMI from the ‘country’ effect. 
 
5.4.4. Conclusion 
The effect of diet and physical activity in pregnancy on maternal and offspring outcomes did 
not differ depending on women’s BMI pre or early in pregnancy. Meta-regression is well 
known for its limitations and this work provides another empirical example that the findings 
obtained with this methods should be interpreted with great caution. The IPD meta-analysis 
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provided a robust and less biased evidence for the treatment-covariate interaction then the 
study-level meta-regression.  
Chapter 6 Outcome reporting in trials with diet and physical 
activity based interventions in pregnancy 
6.1. Introduction 
Numerous RCTs have evaluated the effects of diet and physical activity based interventions in 
pregnancy on maternal and offspring outcomes with their main objective being to minimise 
morbidity and mortality. Given the relatively small number of severe complications, 
systematic reviews and meta-analysis are crucial to synthesise evidence from individual 
studies to provide robust estimates with precision. Selective reporting of trial results can 
seriously impair evidence synthesis, and its usefulness to inform clinical practice.31,36 Trials 
on diet and physical activity in pregnancy usually involve a multidisciplinary team of 
researchers from varied backgrounds e.g. obstetrics, dietetics, sport medicine, midwifery, etc. 
that may have an important impact on the choice of primary and secondary outcomes in the 
trials. A Delphi ranking of maternal and offspring outcomes according to their importance in 
the management of maternal weight in pregnancy has been previously used to inform a 
systematic review of medical literature for the main research institute in the UK.75 However, 
the proportion of published studies that have reported the prioritised outcomes has not been 
evaluated. 
 
The Consolidated Standards of Reporting Trials (CONSORT) statement was introduced to 
standardise and improve reporting of RCTs.248 The statement clearly specified how the design, 
conduct and analysis of RCTs should be described in a transparent and robust manner. Since 
its introduction in 1996248, the statement has been updated twice249,250 and became a 
mandatory requirement of article submission process for a number of medical journals.251,252 
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The findings of a systematic review of RCTs included in Cochrane reviews suggest that 
journal endorsement of CONSORT may benefit the completeness of reporting of RCTs.253 
However, the impact of (CONSORT) statement on the quality of outcome reporting has not 
been evaluated so far. 
 
6.1.1. Aims 
The aim of the work in this chapter was to address the knowledge gap and assess the 
variations in outcomes reported. The quality of the reported outcomes can be affected by 
miscellaneous factors related to study or journal where the trial findings were published.254,255 
Therefore, the second aim of the presented work was to assess the quality of outcome 
reporting in RCTs with diet and physical activity based interventions in pregnancy and 
explore the impact of those factors on that quality. 
 
6.2. Methods 
The systematic review used to inform this chapter followed the PICO question described in 
chapter 2.3. The search strategy used in the previous work was adopted to identify new 
studies.76 The search was performed from October 2013 to March 2015 in previously defined 
databases additionally including the Cumulative Index to Nursing & Allied Health Literature 
(CINAHL) database. The inclusion criteria for the review were RCTs with diet, and physical 
activity based interventions in pregnancy that enrolled women without diabetes at entry into 
the trial were modified for this systematic review. Previously identified studies and the new 
citations were assessed for their eligibility and excluded if reporting an only change in the 
consumption of particular food groups or metabolic indices of physical activity, trial 
protocols, and conference abstracts. 
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All reported outcomes were extracted into a data collection form and subsequently classified 
as ‘critically important’, ‘important’ or ‘not important’ in the management of maternal weight 
in pregnancy using the findings of two-stage Delphi survey as a reference.75 Trial and 
publication details such as country of trial conduct, year of publication, characteristics of the 
intervention(s) were collected and tabulated. The journals that published finding of the 
eligible trials were classified in two ways: a) as general (e.g. BMJ or JAMA) vs. specialist 
journals (obstetrics, diabetes, etc.), and b) as obstetrics focused vs. other specialities (dietetics, 
sports medicine, etc.). Where possible a journal impact factor as per The Thomson Reuters 
metrics256 was obtained for the given publication year e.g. an article published in BMJ in 2014 
would be assigned an impact factor of 16.3, and the one published in 2012 impact factor of 
17.22. The year of publication was additionally dichotomized into before and after the update 
of CONSORT statement in 2010249 (the cut-off year 2011). 
 
The quality of outcome reporting was evaluated following the approach adopted by Harman et 
al.257. The approach uses a 6-item questionnaire with the following questions:  
1. Was the primary outcome clearly stated? 
2. If the outcome was clearly stated as primary, was its definition provided? 
3. Was the secondary outcome(s) listed? 
4. If the secondary outcome(s) was clearly named as secondary, was it accompanied by 
a definition(s)? 
5. Was the explanation of the outcomes use in statistical analysis given?  
6. Was the description of methods used to enhance quality of the outcome measure, if 
available? 
 
Questions 1, 3, 5 and 6 ask for a yes/no response with 1-point assigned in case of positive 
response. When the outcome was not clearly defined as ‘primary’ or ‘secondary’ (questions 1 
and 3) the precision of its definition was not assessed (questions 2 and 4) and assigned ‘not 
applicable’ status. The final score indicating quality of the outcome reporting was defined as 
   
112 
the proportion of points out of a maximum of 6 points. The quality of outcome reporting score 
per published article was the proportion of the assigned points out of 6. The non-applicable 
items were treated as missing values. 
 
Extracted outcomes were evaluated, and a proportion of papers reporting individual outcomes 
was estimated. The results were stratified by predefined groups of outcomes ‘critically 
important’ and ‘important’ to women’s care. Furthermore, the proportions of outcomes were 
stratified by the intervention type evaluated by a given trial (diet only, physical activity only 
or mixed approach). Reporting of ‘critically important’ and ‘important’ outcomes by 
intervention type was formally compared using Pearson Chi2. All continuous data were 
examined for non-linearity and log transformed where necessary.  
 
The association of quality of outcome reporting score with study quality and journal 
characteristics (journal impact factor, year of publication) was initially assessed using 
Spearman’s rank correlation. Furthermore, the impact of the CONSORT statement on was 
assessed through a comparison of studies published before and after the statement update in 
2010. The multiple linear regression models with a bootstrapping sampling method (1000 
iterations, with a set seed) were used to explore the relationship between the pre-specified 
items and the quality of outcome reporting score.258 The bootstrapping method was used to 
address the non-normal distribution of the quality of outcome reporting score that could not be 
addressed using typically used methods (e.g. log transformation). The factors for the final 
multivariable analysis were selected following a step-down approach setting the p-value for 
the exit at p = 0.2. When eliminating categorical variables, the p-value for exit was the one 
with the lowest values for all the categories. The overall significance of the categorical 
variables was checked using global post-estimation tests (Wald tests). 
 
The sensitivity analysis examined the impact of adopting alternative approaches to calculating 
the quality of outcome reporting score and variable selection for the final multivariate model. 
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The final sensitivity analysis explored the impact of feasibility and pilot trials that were not 
powered to detect the intervention effect for the clinical outcomes. All analysis methods were 
defined a priori except the grouping of the publication according to their pre or post 
CONSORT 2010 status. 
 
6.3. Results 
6.3.1. Characteristics of included studies 
The systematic search of medical databases returned 3,551 potential citations. After the 
abstract and full text screening, 66 trials published in 78 papers met the inclusion criteria; 12 
publications reported results of secondary analyses of ten trials (). 
). 
 
The results of secondary analyses, on average, were published one year later than the primary 
findings. The main trial publications were often published in obstetrics journals (29/66). The 
majority of findings was published after the introduction of the CONSORT statement in 1996, 
and more than half of the trials (40/66, 60.6%) after its update in 2010 (Figure 6.2). The 
median impact factor in this group of publications was 3.04 (IQR 1.50, 4.39) with the impact 
factor ranging between 0 and 17 (Appendix 6.1). Eligible trials assessed the effect of diet 
based interventions in 12 instances, mixed (diet and physical activity) approach in 23, and 
physical activity only in 31 (Appendix 6.1). In comparison to the primary publications, the 
secondary analyses were published in journals with a lower impact factor. 
  
   
112 
Figure 6.1 Selection of studies and outcomes in trials with diet and physical activity based 
interventions in pregnancy 
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Figure 6.2 Number of primary and secondary publications from RCTs with diet and physical 
activity based interventions in pregnancy 
 
 
6.3.2. Variation in reported outcomes 
The trials on diet and lifestyle interventions in pregnancy reported 142 outcomes, half of them 
(72/142, 50.7%) appeared in the evaluated publications only once e.g. women’s anxiety was 
reported as an outcome in only one trial. The median number of outcomes reported per trial 
was 12 (IQR 8, 15). When stratified by intervention type, the median of outcomes per trial was 
13 (IQR 10, 18) in group of trials with mixed approach interventions, 11 (IQR 8, 15) in group 
of physical activity only trials, and the lowest in diet only group (median 10, IQR 6, 14). 
 
Using a ranking of outcomes derived from a previously conducted Delphi survey75, 142 
identified in this evaluation outcomes were classified as follows: 22 as ‘critically important’, 
23 as ‘important’ to women’s care, and remaining 97 were not listed (for details see Appendix 
6.2). Among the outcomes classified as ‘critically important’, the most frequently reported 







Table 6.1 Critically important outcomes reported in trials of diet and physical activity based interventions in pregnancy 
Outcome group Measured outcome Delphi rank* 
Diet 
(N = 12) 
Physical activity 
(N = 31) 
Mixed 
(N = 23) 
Total 
(N = 66) 
Maternal Gestational Diabetes Mellitus 8 6(50%) 11(35%) 21(91%) 38(58%) 
 Pregnancy-induced hypertension 8 3(25%) 12(39%) 8(35%) 23(35%) 
 Preeclampsia 8 3(25%) 5(16%) 10(44%) 18(27%) 
 Induction of labour 8 1(8%) 1(3%) 7(30%) 9(14%) 
 PIH or pre-eclampsia 8 1(8%) - 3(13%) 4(6%) 
 Thromboembolism 8 - - 1(4%) 1(2%) 
 Caesarean section 7 6(50%) 19(61%) 15(65%) 40(61%) 
 Preterm birth 7 7(58%) 11(35%) 14(61%) 32(48%) 
 Instrumental delivery 7 1(8%) 10(32%) 4(17%) 15(23%) 
 Post-partum haemorrhage 7 1(8%) 1(3%) 1(4%) 3(5%) 
 Dietary habits (Mother) 7 - - 2(9%) 2(3%) 
 Threatened abortion 7 - 1(3%) - 1(2%) 
Infant Small for gestational age  8 1(8%) 6(19%) 5(22%) 12(18%) 
 Stillbirth and neonatal death 8 3(25%) 2(6%) 3(13%) 8(12%) 
 Admission to NICU 8 1(8%) 1(3%) 5(22%) 7(11%) 
 Shoulder dystocia 8 - - 3(13%) 3(5%) 
 Birth trauma (Infant) 8 - - 2(9%) 2(3%) 
 Composite: newborn complications 8 - 1(3%) - 1(2%) 
 Large-for-gestational age 7 1(8%) 5(16%) 12(52%) 18(27%) 
 Blood pH (Infant) 7 - 2(6%) 1(4%) 3(5%) 
 Hypoglycaemia (Infant) 7 - - 3(13%) 3(5%) 
 Resuscitation at birth 7 - - 1(4%) 1(2%) 
*according to published Delphi ranking75, N, number of publications; NICU, Neonatal Intensive Care Unit; PIH, Pregnancy-induced hypertension  
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Table 6.2 Important outcomes reported in trials of diet and physical activity based interventions in pregnancy 
Outcome group Measured outcome Delphi rank* 
Diet 
(N = 12) 
Physical activity 
(N = 31) 
Mixed 
(N = 23) 
Total 
(N = 66) 
Maternal Gestational weight gain 6 10(83%) 23(74%) 23(100%) 56(85%) 
 Miscarriage 6 3(25%) 3(10%) 16(70%) 22(33%) 
 Antepartum level of physical activity 6 - 6(19%) 12(52%) 18(27%) 
 Post-partum weight retention 6 3(25%) 2(6%) 7(30%) 12(18%) 
 Body leanness (Mother) 6 - 8(26%) 2(9%) 10(15%) 
 Low back pain 6 - 4(13%) - 4(6%) 
 Length of labour 6 1(8%) 3(10%) - 4(6%) 
 Postnatal depression 6 - 1(3%) 3(13%) 4(6%) 
 Perineal trauma 6 1(8%) 1(3%) 1(4%) 3(5%) 
 Quality of life 6 - 1(3%) 1(4%) 2(3%) 
 Preterm rupture of membranes 6 - 1(3%) 1(4%) 2(3%) 
 Post-partum infection (Mother) 6 1(8%) - 1(4%) 2(3%) 
 Haemorrhage antepartum 6 - - 1(4%) 1(2%) 
 Antepartum infection (Mother) 6 - - 1(4%) 1(2%) 
 Breastfeeding 5 - - 3(13%) 3(5%) 
 Anxiety level 5 - - 1(4%) 1(2%) 
Infant Birthweight 6 11(92%) 27(87%) 20(87%) 58(88%) 
 Apgar score 6 5(42%) 21(68%) 6(26%) 32(48%) 
 Body leanness (Infant) 6 1(8%) 5(16%) 2(9%) 8(12%) 
 Fetal biometry 6 2(17%) 3(10%) - 5(8%) 
 Hyperbilirubinemia (Infant) 6 - - 2(9%) 2(3%) 
 Encephalopathy (Infant) 6 - - 1(4%) 1(2%) 
 Infant's size 5 3(25%) 10(32%) 5(22%) 18(27%) 
*according to published Delphi ranking75, N, number of publications;  
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In the ‘important’ group those were gestational weight gain (56/66, 84.5%), infant weight at 
birth (58/66, 87.9%) and Apgar score (32/66, 48.5%) (
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Table 6.1). No significant difference has been noted in the proportion of ‘critically important’ 
or ‘important’ outcomes reported by studies grouped by their intervention type (diet only, 
physical activity only or mixed approach) (Pearson Chi2, p = 0.11). 
 
6.3.3. Quality of outcome reporting 
The primary outcome was clearly specified in more than a half of assessed primary 
publications (39/66). When reported, outcome description allowed its reproducibility in most 
of the cases (34/39, 87.2%). The outcomes described as ‘secondary’ were mentioned in 42% 
of assessed primary publications (28/66), with 20 of 28 (71.4%) providing outcome 
definitions that would allow for their reproducibility. The authors of the included publications 
explained the statistical methods used to analyse outcomes in 48 primary publications 
(72.7%). Methods of quality improvement of outcome measure in the trial (e.g. staff training) 
was reported in one-third (22/66, 33.3%) of the evaluated primary publications (Error! Not a 
valid bookmark self-reference.). Overall, the median score of quality of outcome reporting 
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Figure 6.3 Quality of outcome reporting in trials with diet and physical activity based 
interventions in pregnancy 
 
 
6.3.1. Factors influencing outcomes’ quality 
The results of a univariate analysis indicate a significant positive correlation between the 
outcome quality score and publication features such as year of publication, and journal’s 
impact factor (Table 6.2). The outcome quality score was negatively correlated with two of 
the trial’s design features: allocation concealment and incomplete outcome data. None of the 
factors when evaluated in the multivariate regression model preserved the statistically 
significant association with quality of outcome reporting (Table 6.2).  
 
The comparison of the trials published before and after update of the CONSORT guideline 
in 2010 showed a statistically significant difference in the quality of outcome reporting 




Table 6.3 Association between study and publication factors with quality of outcome reporting 
Factor Coeff. 95% CI p-value Coeff. 95% CI p-value 
 Univariate Multivariate 
Journal characteristics     
Year of publication 0.02 (0.01,0.04) <0.01 - - - 
Impact Factor^ 0.02 (-0.00,0.05) 0.05 - - - 
Journal Type       
specialized vs general -0.06 (-0.29,0.17) 0.59 - - - 
obstetric vs non-obstetric -1.1e-4 (-0.16,0.16) 0.99 - - - 
Trial quality assessment (Risk of bias)    
Random sequence 
generation 
Unclear vs Low -0.05 (-0.24,0.15) 0.64* - - - 
High vs Low -0.44 (-0.64,-0.23) <0.01* - - - 
Allocation concealment 
Unclear vs Low -0.22 (-0.37,-0.07) <0.01** -0.18 (-0.34,-0.01) 0.03 
High vs Low -0.29 (-0.75,0.17) 0.22** -0.26 (-0.66,0.15) 0.21 
Blinding of participants 
and staff 
Unclear vs Low 0.03 (-0.08, 0.14) 0.63 - - - 
High vs Low 0.06 (-0.53, 0.17) 0.31 - - - 
Blinding of outcomes 
assessment 
Unclear vs Low -0.12 (-0.29,0.04) 0.14 - - - 
High vs Low 0.02 (-0.18,0.21) 0.86 - - - 
Incomplete outcome data 
Unclear vs Low -0.09 (-0.37,0.19) 0.55* -0.06 (-0.33,0.22) 0.68 
High vs Low -0.27 (-0.43,-0.11) <0.01* -0.21 (-0.39,-0.03) 0.03 
Selective reporting 
Unclear vs Low 0.14 (-0.15,0.45) 0.34 - - - 
High vs Low -0.009 (-0.22,0.27) 0.94 - - - 
Type of intervention     
Exercise vs Diet 0.13 (-0.08,0.34) 0.26 0.12 (-0.08,0.32) 0.24 
Mixed approach vs Diet 0.26 (0.21,0.58) 0.02 0.19 (-4e-3,0.39) 0.05 
^ For 6 studies we were unable to extract impact factor; therefore for analysis of impact factor N = 60 




6.4.1. Main findings 
Trials examining the effects of diet and physical activity based interventions in pregnancy 
reported various maternal and offspring outcomes. ‘Critically important’ outcomes e.g. GDM 
or caesarean section are reported less often in comparison to ‘non-critical’ ones like 
gestational weight gain or birth weight. The overall quality of outcome reporting varied 
between trials. The least frequently provided aspect of outcome description was the methods 
implemented to improve the quality of outcome measures. This work was not able to detect an 
impact of study or journal-specific characteristics on the overall quality of outcome reporting 
in the primary publications from trials with diet and physical activity based interventions in 
pregnancy. 
 
6.4.2. Strengths and limitations 
The work in this chapter carefully evaluated the diversity and the quality of outcome reporting 
in RCTs on diet and physical activity based interventions in pregnancy following recognized 
standards for evidence synthesis. An existing ranking of pregnancy outcomes importance was 
applied to assess the relevance of identified outcomes. The identification of relevant 
publications was made through a systematic database search without language restrictions. 
The quality of study design was assessed using the Cochrane risk of bias.105 All steps of the 
quality assessment were completed by two independent reviewers. In the areas where there 
are no formal guidelines (quality of outcome reporting), we adhered to principles of conduct 
of rigorous scientific research and the impact of all the assumptions was explored through a 
set of a priori defined sensitive analyses. 
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Although, the studies were limited to those published after 1990, the majority of the trial 
publications on diet and physical activity based intervention in pregnancy were published 
within the last twenty years. Nevertheless, the number of studies available for the 
investigation of the link between publication features and the quality of outcome reporting 
score was insufficient to detect statistically significant associations in the multivariate 
analysis. 
 
The outcomes were ranked for their importance to weight management during pregnancy 
through the Delphi survey conducted among clinicians with the expertese in the topic. It is 
possible that a different panel would identified a different set of prioritised outcomes. Yet, the 
majority of the most frequently reported outcomes were captured by the survey and ranked as 
‘critically important’ or ‘important’ in the context of the antenatal care. 
 
The quality of outcome reporting was assessed using the questionnaire presented in Harman et 
al. paper.257 This has been successfully applied in other systematic reviews evaluating the 
variation and quality of outcome reporting.254,255,259 Nevertheless, the questionnaire has certain 
limitations such as not accounting for results published as a secondary analyses from the 
original trials or that the description of the primary or the secondary outcomes cannot be 
assessed, if outcomes in the publications are not clearly indicated. A more objective and less 




Medical research to guide and influence clinical practice and policy development needs to 
provide evidence on the effects of interventions on the outcomes relevant to all relevant 
stakeholders.41 In the work presented in this chapter showes a range of trial outcomes that 
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reflects the variety of specialities investigating the effect of diet and physical activity based 
interventions on pregnancy outcomes.  
 
The most commonly reported outcomes are surrogates for maternal and neonatal morbidity 
such as gestational weight gain and birthweight. None of the outcomes classified as ‘critically 
important’ to maternal or infant health had comparable reporting coverage as earlier 
mentioned surrogates. Even though data allowing to compute outcomes such preterm birth or 
birth of LGA or SGA infant (infant’s weight and gestational age at birth), appeared in the 
majority of evaluated publications. 
 
Reproducibility is a fundamental principle of scientific research.260 The aim of the CONSORT 
statement is to ensure reporting of randomised trials in a sufficient detail allowing their 
reproducibility.248 A clear description of primary and secondary outcomes in the trial allows 
other researchers to reevaluate the effect of the intervention in different settings on similar 
outcomes.36 The evaluation of the primary publications included in this work revealed that it 
would not be possible to reproduce the main outcome for more than one-third of the trials; the 
secondary outcomes were insufficiently reported in over half of publications. The weakest 
aspect of outcome reporting was a lack of sufficient detail in the description of methods used 
to enhance the quality of outcome measurements. This might not affect outcomes such as the 
type of delivery or occurrence of stillbirth, but may weaken the reliability of the outcomes 
where a thorough training and repeated measurements play a significant role, for example, 
high blood pressure or pre-eclampsia. 
 
In comparison to other studies in the area of women’s health254,255,259, I did not find any link 
between the quality of outcome reporting and the publication or journal features. The posthoc 
exploration of the articles published before and after the update of the CONSORT statement 
in 2010 seems to indicate an improvement in outcomes reporting. Though, this finding should 
be interpreted with cauction due to a post-hoc nature of this exploration.  




The range and variable frequency of outcomes reported in RCTs with diet and physical 
activity based interventions in pregnancy suggest a need for a consensus on the choice of the 
key trial outcomes. More effort needs to be invested in improving the communication between 
the various health care professions researching the effect of diet and physial activity on 
pregnancy outcomes. This could be achieved through the development and introduction of a 
COS, a minimum set of outcomes that should be collected and reported alongside other 
outcomes of research interest.52 This concept first introduced in the context of rheumatoid 
arthritis trials 261 developed by the COMET Initiative has strongly resonated with the 
researchers and journal editors in the women’s and newborn health area.53,262 
 
Despite clear guidance in CONSORT statement on how to report primary and secondary 
outcomes from RCTs a fair proportion of the trials failed to provide a satisfactory description 
of their outcomes. Researchers need to pay more attentions to the quality of trial reporting in 
order to improve the uptake of their trials in systematic reviews. Consequently, contributing to 
the improvement of the antenatal weight management through better quality evidence and 
reduction of research waste. 
 
  
   
161 
Chapter 7 Gestational weight gain as an indicator of 
important pregnancy outcomes 
7.1. Introduction 
Gestational weight gain is a frequently evaluated outcome in randomised trials of diet and 
physical activity based interventions. Even though weight gain in pregnancy is considered to 
be a surrogate of maternal morbidity80, around 40% of RCTs with diet and physical activity 
based interventions in pregnancy use it as their primary outcome.263 This rate is two-fold 
higher than the use of surrogates in other areas of medical research.39 
 
Weight gain in pregnancy is a natural response of women’s body to accommodate the 
growing fetus.71 However, the relationship between the gestational weight gain and the 
important health outcomes e.g. preterm birth or caesarean section, is ambiguous. Some 
evidence indicates that insufficient or excessive weight might lead to undesired or even 
serious health complications.236 Women’s pre-pregnancy BMI is a well-known risk factor for 
numerous pregnancy complications.72,80 Obese pregnant women are at higher risk of 
developing GDM, preeclampsia or postpartum weight retention, while their children of 
congenital malformation63, being born with a low Apgar score59 and childhood obesity.60 
 
As the combination of both those factors might led to an increase chance of pregnancy 
complications, the USA Institute of Medicine (IOM) issued in guidelines on the optimal 
weight gain in pregnancy.71 It aims to minimise the negative health outcomes due to 
inadequate gestational weight gain. The subsequent updated guideline in 2009 advice normal 
BMI, overweight or obese women entering pregnancy to gain 11.5 – 16 kg, 7 – 11.5 kg or 5 – 
9 kg, respectively.71 These cut-offs were identified through synthesis of evidence from large 
observational studies, some of them over 10 years old, and from experts’ input. The clinical 
outcomes taken into consideration were birth of LGA infant, birth of SGA infant, emergency 
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caesarean section and postpartum weight retention of more than 5kg.80 Nevertheless, not all 
policy makers worldwide follow the IOM recommendations owing to the low certainty of the 
evidence used to inform the IOM guidelines.73,74  
 
One of advocated advantages of accessing individual participant data from primary trails is 
the ability to use it to explore so call ‘secondary clinical questions’ for example a relationship 
between a surrogate and hard clinical outcomes. (ref) 
 
7.1.1. Aims 
The main aim of the work in this chapter was to examine the relationship between gestational 
weight gain and adverse pregnancy using i-WIP IPD of randomised trials on diet and physical 
activity based interventions in pregnancy.79 Specifically, we examined this association in the 
group of women gaining within the IOM recommendations, and quantified the impact of each 
kilogram of weight gain beyond the IOM recommended ranges on adverse outcomes. 
 
7.2. Methods 
For the purpose of the analyses in this chapter, I limited the IPD assembled to address the 
effectiveness question in chapters 4 and 5 to records from women randomised to standard 
antenatal care (non-treated arm), with singleton pregnancies and with early or pre-pregnancy 
BMI ≥ 18.5 kg/m2.  
 
Exposure 
Gestational weight gain (see section 2.4.2 for details) was grouped according to the IOM 2009 
criteria as below, within or above the recommendations by women’s booking BMI.80 For 
gestational weight gain outside the criteria (below or above), I calculated an absolute 
difference between the recorded and recommended value (degree of GWG outside the IOM 
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ranges) and coded the direction of the difference (above or below the recommended range). 
For example, for women with BMI between 18.5 – 24.9 kg/m2 (normal group) the 
recommended weight gain is 11.5 to 16 kg. Hence, weight gain of 18 kg was coded as 2 kg 
excess while weight gain of 10 kg as 1.5 kg deficit. Gestational weight coded as degree of 
gestational weight gain (excess or deficit) and its direction (above or below the IOM criteria) 
was the main exposure in the statistical models presented in this chapter. 
 
Outcomes 
Pregnancy complications (dependant variables) were derived from the maternal and offspring 
outcomes prioritized for their important to weight management in pregnancy (chapter 3). The 
analyses were performed for caesarean section, birth of LGA or SGA infant (dependant 
variables), and preterm birth. All outcomes except caesarean section could be standardised 
across all available datasets. LGA and SGA were defined using as growth above 90th centile 
and below the 10th centile.130 Preterm birth was defined as delivery before 37 weeks’ of 
gestational age.  
 
Models development 
For each outcome, we assessed the causal pathways to identify all relevant confounder 
candidates (section 2.6). The confounders were evaluated for their availability in the dataset 
and importance from the clinical perspective (Appendix 7.1). Owing to low numbers and an 
uneven distribution of identified confounders across the individual dataset it was possible to 
adjust the models only for the factors that were considered most important from the clinical 
perspective. Preterm birth was controlled for current smoking status (yes/no). Models with 
SGA were adjusted for current smoking status, women’s age (continuous), and parity 
(nullipara/multipara). Covariates in the analyses with caesarean section were any diabetes-
related event (yes/no), women’s age, gestational age at infant’s delivery (continuous), parity 
and curring smoking status; and LGA was adjusted for any diabetes-related events and 
women’s age (Appendix 7.2).   
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Statistical analysis 
For women gaining weight within IOM recommendation, I calculated the frequency of 
adverse outcome occurrence and then examined the impact of gaining weight within these 
ranges on the odds of predefined outcomes. For women gaining above or below the IOM 
recommended ranges, the difference between the observed weight gain and the limits of the 
reference ranges was computed. I used a one-stage IPD meta-analytical framework to quantify 
the relationship of each kilogram of GWG outside the IOM recommendations with pregnancy 
complications. Adopted model was the statistical model between the exposure and the 
outcome was assessed using a mixed-effects logistic regression model accounting for 
clustering of participants within studies and allowing random effects for study. The 
distribution of the random effects is assumed to be Gaussian. The models included an 
interaction term between the magnitude of the difference and its direction i.e. below or above 
the IOM recommendation (Appendix 7.2). All analyses were additionally stratified by 
women’s booking BMI and adjusted for relevant confounders. Only data from control arms of 
randomised trials included in the i-WIP database was used to inform the main analyses. No 
imputation of missing data was attempted. 
7.3. Results 
7.3.1. Characteristics of women 
Information on booking BMI was available in 35 trials (5 799 women randomised to control 
arms) collected in the i-WIP IPD meta-analysis. Data on adherence to IOM recommendations 
was available for 76.4% of women (4 429/ 5 799). The majority of women were of Caucasian 
origin (91.3%); over half were highly educated (55.8%) and were in their first pregnancy 
(51.3%). A detailed summary of characteristics of women for which data on gestational 
weight gain was available is summarised in Table 7.1  
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Overall 29.1% (1 291/4 429) of women allocated to the control arms of the trials gained less 
than recommended, and 37.1% (1 646/ 4 429) exceeded the IOM targets. The adherence 
varied across the BMI groups with 51.5% (641/ 1 245) of overweight and 44.5% (695/ 1 562) 
of obese women exceeding the recommended by IOM gestational weight gain in the 
comparison to 19.1% (310/ 1 622) in the group of women with normal BMI. A reverse trend 
was present for the gain below the IOM targets (Table 7.1). 
 
Figure 7.1 Proportion of women by BMI strata with respect to their adherence to the 




7.3.2. Gestational weight gain within the IOM recommendations 
 
One-third (33.7%, 1 492/4 429) of pregnant women randomised to control arms in trials on 
diet and physical activity gained in pregnancy according to the IOM recommended ranges. 
The most frequent adverse outcome was caesarean section 23.4% (340/1 456), followed by 
birth of SGA infant 10.6% (157/1 482), birth of LGA infant 9.1% (135/1 492), and preterm 
birth 3.8% (57/1 483). The order of outcome incidence was comparable across all three BMI 
classes. The frequency of caesarean section was the highest among the obese women (33.3%, 
152/456) in comparison to 21.7% among the overweight women (76/351) and 17.3% 
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Table 7.1 Characteristics of participants and pregnancy outcomes with known gestational 
weight gain  






Mean (SD) or 
Frequency (%) 
Baseline characteristics    
Age (years) 35 4424 30.1 (5.14) 
Height (cm) 31 4422 165.0 (7.0) 
Weight* (kg) 33 4445 77.13 (18.4) 
BMI (kg/m2) 34 4429 28.32 (6.37) 
BMI categories 33 4445  
Normal (BMI 18.5-24.99 kg/m2)   1 622 (36.6) 
Overweight (BMI 25-29.99 kg/m2)   1 245 (28.1) 
Obese (BMI ≥ 30 kg/m2)   1 562 (35.3) 
Ethnic origin 24 3536  
Caucasian   3 232 (91.3) 
Asian   87 (2.5) 
Black   70 (2.0) 
Central/South American   63 (1.8) 
Middle East   32 (0.9) 
Other   52 (1.5) 
Education level  28 3332  
Basic   453 (13.6) 
Intermediate   1 019 (30.6) 
Higher   1 860 (55.8) 
Parity 30 4317  
0   2 113 (51.3) 
1+   2 204 (48.7) 
Current smoker 27 3964 693 (16.5) 
Sedentary before pregnancy 25 2760 1 383 (50.1) 
Family history of diabetes 10 1784 708 (26.2) 
Hypertension at baseline 20 2154 53 (2.3) 
Any hypertensive event in pregnancy 25 3502 318 (9.1) 
Any case of diabetes* 31 4422 594 (10.4) 
Gestational age at delivery (weeks) 32 4419 39.6 (1.6) 
Normal vaginal delivery  31 4348 2 788 (64.1) 
Instrumental delivery 31 4348 439 (10.1) 
Delivery before 37 weeks 32 4423 187 (4.2) 
Any caesarean section 31 4353 1 121 (25.8) 
Elective   363 (8.3) 
Emergency    385 (8.8) 
Unspecified   373 (8.6) 
Small-for-gestational age infant 31 4414 462 (10.5) 
Large-for-gestational age infant 33 4445 500 (3.2) 
*Early or pre pregnancy; BMI, Body Mass Index  
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Crude and adjusted analyses did not provide any evidence that the weight gain (by a kilogram) 
within the IOM recommended ranges was associated with a change in the odds of evaluated 
adverse pregnancy outcomes (Table 7.3).  
 
7.3.1. Gestational weight gain outside the IOM recommendations 
Overall, about two-thirds (66.3%, 2937/4429) of women in the dataset did not meet the IOM 
recommended ranges for weight gain in pregnancy. Among the women who were not 
achieving their targets the highest deviation from the lower range value was noted for women 
with normal BMI (Table 7.2)  
 
Table 7.2 Difference between recorded and target gestational weight gain (kg) among women 
gaining below and above the recommendations of Institute of Medicine 
Weight gain  
by BMI group 
Number of 
women 
Kilograms of weight outside the IOM targets 
Median (25Q, 75Q) Range 
Below the IOM recommendations (lower limit) 
Normal BMI (11 kg) 649 3.4  (1.9, 5.0) 16.6 
Overweight (7 kg) 242 2.0  (0.9, 3.5) 12.3 
Obese (5 kg) 400 2.4  (1.1, 4.1) 14.6 
Above the IOM recommendations (upper limit) 
Normal BMI (16 kg) 310 2.0  (1.0, 4.6) 13.9 
Overweight (11 kg) 641 2.9  (1.1, 5.6) 29.5 
Obese (9 kg) 695 3.6  (1.8, 6.5) 21.0 











Number of events/ 
Number of women 
Crude OR 
(95% CI)  
Number of 
studies 
Number of events/ 
Number of women 
Adjusted OR  




Overall 30 57/1 483 0.97 (0.88, 1.07) 26 46/1 310 1.07 (0.86, 1.34) 
Normal 20  22/662 1.02 (0.78, 1.35) 18 17/553 1.04 (0.76, 1.43) 
Overweight 26 19/360 1.23 (0.81, 1.87) 23 15/333 1.33 (0.83, 2.13) 




Overall 30 157/1 482 0.94 (0.88, 1.00) 25 142/1 300 0.94 (0.83, 1.08) 
Normal 20 64/662 1.00 (0.85, 1.18) 18 58/549 1.00 (0.84, 1.19) 
Overweight 26 39/360 0.77 (0.57, 1.05) 23 36/333 0.77 (0.57, 1,06) 




Overall 30  340/1 456 0.93 (0.88, 0.98) 24  295/1 268 0.95 (0.86, 1.05) 
Normal 20  112/649 0.98 (0.85, 1.12) 17  97/533 0.98 (0.85, 1.12) 
Overweight 26  76/351 0.99 (0.80, 1.24) 22  70/323 0.95 (0.74, 1.20) 




Overall 31 135/1 492 1.06 (0.99, 1.14) 30 133/1 483 1.07 (0.93, 1.23) 
Normal 20 62/663 1.02 (0.85, 1.23) 19 62/658 1.02 (0.85, 1.23) 
Overweight 26 37/362 1.11 (0.83, 1.49) 25 36/360 1.16 (0.86, 1.56) 
Obese 31 36/467 1.16 (0.85, 1.59) 30 35/465 1.15 (0.84, 1.58) 
BMI, Body Mass Index; OR, odds ratio; CI, confidence intervals; 1. Adjusted for smoking; 2. Adjusted for smoking, age, and parity; 3. Adjusted for any event of diabetes, age, 
gestational age at delivery, smoking; 4. Adjusted for adjusted for any event of diabetes, age 
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Women who exceeded the most from the upper IOM limits had BMI above 30. The 
differences between the mean and the median in the difference between recorded and 
recommended weight gain were the most pronounced among women who exceeded the 
recommendations. The histograms on Figure 7.2 show that women most frequently exceed the 
limits by 2, 3 and over 3.5kg in normal BMI, overweight and obese groups, respectively. 
 
Figure 7.2 Histograms of gestational weight outside the IOM recommended targets by Body 
Mass Index group 
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The most frequent adverse outcome among women gaining below the IOM recommendations 
was caesarean section 21.8% (277/1 271), followed by SGA 14.5% (186/1 280), LGA 7.1% 
(92/1 291), and preterm birth 6.3% (81/1 286) (Appendix 7.3). The frequency of caesarean 
section among the overweight and the obese women (around 20%) was higher than for the 
women with normal BMI (13.1%, 83/636). The frequency of SGA was of 19.4% (77/397) 
among obese women, 13.7% (33/241) in the overweight and 11.8% (76/642) normal BMI 
groups. Caesarean section was also the most frequent outcome among women whose weight 
exceeded the IOM recommendations (31.1%, 503/1 618) followed by LGA (16.2%, 267/1 
646), and SGA (7.1%, 117/1 641). The overall frequency of preterm birth in this group was 
low with 49 events in the group of 1 643 women. 
 
None of the overall models, listed in Table 7.4, showed a statistically significant association 
between a kilogram of gestational weight gain below the IOM recommendation and the odds 
of examined maternal and offspring outcomes. The analysis within the BMI strata found 20% 
reduction in the odds of LGA (adjusted OR 0.80, 95% CI 0.65, 0.99) among the obese women 
with 1-unit of weight gain below lower IOM limit (5 kg) recommended for this BMI group. 
 
Overall, the odds of caesarean section and LGA increased by 4% (adjusted OR 1.04, 95% CI 
1.01, 1.08) and 8% (adjusted OR 1.08, 95% CI 1.05, 1.12), respectively, for each kilogram of 
weight gain above the upper IOM limits (Table 7.5). In the analyses within BMI strata the 
association between weight gain and caesarean section was statistically significant only in the 
overweight group with an 11% increased chance of outcome occurrence (adjusted OR 1.11, 
95% CI 1.05, 1.18) with one kilogram of increase in weight gain above the upper limit 
recommended for this BMI strata (11 kg).   
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Number of events/ 
Number of women 




Number of events/ 






Overall 30 81/1 286 1.02 (0.93, 1.12) 26 72/1 176 0.99 (0.90, 1.09) 
Normal 20 34/647 1.11 (0.98, 1.26) 18 28/578 1.09 (0.94, 1.25) 
Overweight 29 15/241 0.73 (0.50, 1.07) 25 15/229 0.74 (0.51, 1.08) 




Overall 30 186/1 280 1.06 (1.00, 1.13) 25 167/1 146 1.07 (1.00, 1.14) 
Normal 20 76/642 1.10 (0.99, 1.22) 17 68/564 1.11 (0.99, 1.25) 
Overweight 29 33/241 1.16 (0.97, 1.40) 24 29/216 1.21 (0.99, 1.48) 




Overall 30 277/1 271 0.94 (0.88, 1.00) 24 243/1 127 0.94 (0.88, 1.01) 
Normal 20 83/636 0.87 (0.77, 0.99) 16 74/549 0.85 (0.75, 0.98) 
Overweight 29 54/239 0.93 (0.78, 1.11) 23 42/213 0.91 (0.73, 1.12) 




Overall 31 92/1 291 0.91 (0.81, 1.01) 30 92/1 274 0.90 (0.81, 1.01) 
Normal 20 48/649 0.94 (0.80, 1.09) 19 48/636 0.95 (0.82, 1.11) 
Overweight 29 14/242 1.09 (0.83, 1.43) 28 14/239 1.11 (0.84, 1.47) 
Obese 31 30/400 0.80 (0.64, 0.98) 30 30/399 0.80 (0.65, 0.99) 
BMI, Body Mass Index; OR, odds ratio; CI, confidence intervals; 1. Adjusted for smoking; 2. Adjusted for smoking, age, and parity; 3. Adjusted for any event of 
diabetes, age, gestational age at delivery, smoking; 4. Adjusted for adjusted for any event of diabetes, age  
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Number of events/ 
Number of women 




Number of events/ 
Number of women 




Overall 30 49/1 643 0.95 (0.87, 1.04) 26 46/1 459 0.96 (0.88, 1.06) 
Normal 20 14/309 1.00 (0.84, 1.20) 18 13/256 1.05 (0.88, 1.26) 
Overweight 29 13/640 0.85 (0.67, 1.07) 25 12/564 0.87 (0.68, 1.10) 




Overall 30 117/1 641 0.96 (0.91, 1.02) 25 104/1 454 0.95 (0.89, 1.01) 
Normal 20 26/308 1.02 (0.90, 1.17) 17 24/254 1.02 (0.89, 1.18) 
Overweight 29 31/609 0.86 (0.74, 0.99) 24 30/564 0.86 (0.74, 1.00) 




Overall 30 503/1 618 1.05 (1.02, 1.08) 24 475/1 432 1.04 (1.01, 1.08) 
Normal 20 68/300 1.02 (0.93, 1.12) 16 66/248 1.06 (0.96, 1.17) 
Overweight 29 174/631 1.10 (1.04, 1.16) 23 166/554 1.11 (1.05, 1.18) 




Overall 31 267/1 646 1.08 (1.04, 1.12) 30 265/1 640 1.08 (1.05, 1.12) 
Normal 20 49/310 1.06 (0.96, 1.17) 19 48/309 1.05 (0.96, 1.17) 
Overweight 29 104/641 1.10 (1.04, 1.16) 28 103/638 1.11 (1.05, 1.17) 
Obese 31 114/695 1.07 (1.02, 1.13) 30 114/693 1.07 (1.02, 1.13) 
BMI, Body Mass Index; OR, odds ratio; CI, confidence intervals; 1. Adjusted for smoking; 2. Adjusted for smoking, age, and parity; 3. Adjusted for any event of 
diabetes, age, gestational age at delivery, smoking; 4. Adjusted for adjusted for any event of diabetes, age 
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Figure 7.3 The relationship between the weight gain outside the IOM recommendation and the 1 
odds of adverse pregnancy outcomes by Body Mass Index group 2 
 3 
 4 
In the stratified analysis for LGA the association was statistically significant in the group of 5 
women with BMI above 25 (Figure 7.3). The chance of giving a birth to LGA infant was 6 
increasing by 11% in overweight group (adjusted OR 1.11, 95% CI 1.05, 1.17) and 7% in the 7 
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obese group (adjusted OR 1.07, 95% CI 1.02, 1.13) with each 1-unit in weight gain beyond 8 
the upper IOM limits for these groups – 11kg and 9kg, respectively. The interaction between 9 
the amount of weight gain outside the IOM ranges and its direction (above or below the IOM 10 
ranges) was statistically significant (p < 0.05) in the models for SGA, LGA and caesarean 11 
section. 12 
 13 
7.4. Discussion 14 
7.4.1. Main findings 15 
Women who most frequently exceeded the IOM recommendation belonged to the overweight 16 
and the obese classes. Women whose BMI was within the normal range tended to gain less 17 
rather than exceed the recommended amounts. There was no evidence for an association 18 
between each kilogram of weight gained within the IOM range and the pregnancy 19 
complications. Each kilogram below the lower limit of the recommended amount was 20 
associated with the decreasing chance of giving birth to LGA infant among the obese women. 21 
Conversely, each kilogram of weight gain above the upper limits was associated with 22 
increased chance of caesarean delivery and birth of LGA infant regardless of women’s BMI 23 
status. 24 
 25 
7.4.2. Strengths and limitations 26 
The association between gestational weight gain and pregnancy complications was examined 27 
using IPD derived from and RCTs with diet and physical activity based interventions 28 
conducted in 16 different countries across three continents and guided by prospectively 29 
developed protocols. This way the work presented in this chapter avoids limitations of 30 
previous primary research usually constrained to a specific cohort of women (geographical or 31 
BMI limitations), and the previous secondary studies.66,128,264-267 Use of IPD allows 32 
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overcoming limitations of study-level meta-analyses such as ecological fallacy and detect true 33 
participant-level association rather than the study-level ones.241,268 Moreover, direct contact 34 
with the trials’ authors facilitated thorough check or data integrity and allowed to standardise 35 
definitions of three out of four evaluated outcomes (preterm birth, SGA and LGA). A one-36 
stage IPD meta-analysis approach was used to quantify the association between weight gain 37 
and the pregnancy complications within the IOM categories per current standards i.e. 38 
accounting for within-study clustering of the participant.95  39 
 40 
The confounders were identified through a non-systematic literature search and prospectively 41 
priorities from the clinical perspective. The infant’s birthweight was not considered as a 42 
confounder in any of the models. The reason for not accounting for birth weight was its 43 
entangling with the gestational and the individual outcomes. Namely, baby’s weight 44 
constitutes part of gestational weight gain, as well as a component used to identify SGA or 45 
LGA infants. The outcomes were selected from a group of maternal and offspring outcomes 46 
prioritised for their importance to women’s care in the context of gestational weight gain 47 
management (see chapter 3). The four critically important outcomes mostly overlap with those 48 
considered by the IOM committee when developing the recommendations on the optimal 49 
gestational weight gain (LGA, SGA, and caesarean section).80 Most of the research looking 50 
the validity of the IOM recommendations tends to lump together all the women not meeting or 51 
exceeding the target weight gain indicating that the risk of adverse outcomes are comparable 52 
for women who deviate from the target levels by one and by more than five or ten kilograms. 53 
The approach adopted in this work provided quantifying the relationship by a 1-unit of change 54 
in weight gain providing a more accurate description of the relationships between the 55 
gestational weight gain and the pregnancy complications. 56 
   57 
Use of data from women allocated to control arms improved the interpretability of the 58 
findings. The drawback of this decision was a smaller number of participants and events than 59 
collected that led to an inability to detect potentially meaningful associations i.e. the 60 
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relationship between gestational weight gain and preterm birth in the group of overweight 61 
women. The exploration of the association within the BMI strata was chosen over the 62 
inclusion of interaction term with women’s BMI due to the complexity of the statistical 63 
models with a three-way interaction resulting in potentially difficult to clinically interpret 64 
findings. The additional challenge posed a multifaceted nature of the dataset with a clustering 65 
of data within the original trials that recruited women across different spectrums of BMI 66 
values (Appendix 7.4). The statistical models could not be adjusted for all potentially relevant 67 
confounders due to low event rate, and inconsistent availability of important covariates in the 68 
individual trial datasets. 69 
 70 
The problem of uneven availability of the data also affected the examined exposure. It was not 71 
always possible to use the measurement at the same time point for the initial weight value (use 72 
of pre or early pregnancy weight) and ensure its unbiased recording (not self-reported). 73 
Moreover, gestational weight gain was not always available in the original datasets leading to 74 
a loss of 23.6% of available data from women allocated to the control arms. Furthermore, lack 75 
of multiple measurements of women’s weight in the original trials prevented me from 76 
exploring the relationship between the gestational weight gain and PIH, PE and GDM. In all 77 
three cases, the interventions provided after the diagnosis could meaningfully alter the weight 78 
gain and alter the potential association. This limitation also affects the evidence synthesis of 79 
observational studies62,66,128,265,269,270, and could have not been overcome despite access to IPD. 80 
The final limitation of this work is a lack of correction for multiple testing that should be 81 
taken into account when interpreting the analyses findings. 82 
 83 
This work is an extension of secondary analyses planned in the main i-WIP study.79 It was 84 
initially intended to incorporate fractional polynomial terms271 as the relationship between the 85 
weight gain in pregnancy, and the adverse pregnancy outcomes were expected to be non-86 
linear.79 Examination of data structure and its distribution lead me to assume a linear trend 87 
instead. The assumption of a linear relationship between gestational weight gain and the 88 
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pregnancy complications might not be describing the nature of the association in the most 89 
accurate way; however, it was a pragmatic decision compromising between the complexity of 90 
statistical analysis, and its feasibility and interpretability. 91 
 92 
7.4.3. Interpretation 93 
Weight gain within the IOM ranges is frequently used in the literature as the reference 94 
standard when examining the link between the weight gain in pregnancy with the pregnancy 95 
complications.65,66,128,265 The underlying assumption is that weight gain within the ranges will 96 
help women to achieve positive pregnancy outcomes taking into account their background 97 
risk.71 The IOM recommendation for each BMI group gives the flexibility of weight gain 98 
within the 5 kg range. Part of my work was to evaluate the frequency of individual outcomes 99 
in those ranges and examine if the odds of outcomes change with each kilogram within the 100 
5kg range. The frequency of deliveries through a caesarean section was consistent with the 101 
numbers reported in the observational studies. With the average of 26%, it is almost twice-102 
fold of the rate considered acceptable by the healthcare community.272 However, the value is 103 
consistent with the global caesarean rates trends that are on the rise since 1990.117 Conversely, 104 
the occurrence of preterm birth among the women adherent to the IOM recommendations was 105 
much lower than the global estimates.118 The fact that the majority of the trials recruited in 106 
high-income countries where the prevalence is lower than the world average could contribute 107 
to the low frequency of this outcome.273 The incidence of SGA and LGA were comparable to 108 
those reported in the literature.128 The analyses did not provide any evidence to support a 109 
belief that the odds of those outcomes altered with each kilogram within the recommended 110 
ranges. 111 
 112 
Weight gain below the IOM ranges was linked with increased odds of SGA infant and preterm 113 
birth, and decreased odds of giving birth to LGA infant128,264,265; however, the findings are 114 
inconsistent across the literature.62,274 In this research, the only statistically significant 115 
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relationship found was in the group of obese women between the low weight gain and 116 
decreasing chance of LGA infant. Obese pregnant women are a group of particular interest 117 
due to the high risk of short- and long-term complication.60 A systematic review of 18 cohort 118 
studies with obese women by Kapadia et al.265 evaluating the safety of weight gain below the 119 
IOM recommendation reported the decrease odds of LGA by 23% as well as caesarean 120 
section. As the authors relied on the study-level data, it is not known how many kilograms 121 
away from the lower limit were women in the individual studies, therefore who mainly drives 122 
the observed 23% decrease. The majority of obese pregnant women in the control arms of 123 
available RCTs were between 2 – 3 kg below the IOM lower limit for this BMI group (5 kg). 124 
The findings of the analysis suggest comparable to reported by Kapadia et al.265 reduction in 125 
the odds of LGA with kilogram below the lower limit; however, it needs to be treated with 126 
caution due to lack of adjustment for multiple testing and other than the linear relationship 127 
between the weight gain and the outcome odds.  128 
 129 
In line with the previous research, the analysis presented in this chapter supports the link 130 
between excessive weight gain and the increased odds of LGA and caesarean section. The 131 
odds of LGA reported in the literature range anything between 70% to over a four-fold 132 
increase, and between 30% and 80% increase for caesarean section.128,264,274 None of the 133 
previous studies describes the distribution of women exceeding the recommendations by each 134 
kilogram above the upper range. The odds of caesarean section and LGA in the analyses 135 
decreased with each kilogram above the upper limit regardless of the BMI group by 4% and 136 
8%, respectively. The strength and significance of the association varied between the BMI 137 
groups, however the subgroup differences were not formally compared.  138 
 139 
The majority of women in the control arms exceeded the upper IOM limits between 2 to 3.5 140 
kg depending on the BMI category. In combination with the potential nonlinear relationship 141 
between the weight gain and the complications, the association could be driven and most 142 
accurate for those exceeding the recommendation only by a few kilograms. The exploration 143 
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did not find evidence to support the link between the excessive weight gain and decreased 144 
odds of preterm birth or birth of SGA infants. There are no clear biologic mechanisms for the 145 
link between excessive weight gain during pregnancy and preterm birth69 with inconclusive 146 
findings from the prior studies.62,128,274 Unexpected is a lack of statistically significant 147 
association for SGA which decreased odds was consistently linked with the high weight gain 148 
in pregnancy.128,264,274  149 
 150 
Despite the clinical importance of GDM and hypertensive disease and their link with maternal 151 
BMI status, I was not able to examine the associations due to lack of weight measures at the 152 
point of diagnosis. This problem has been encountered previously by the IOM committee 153 
when assessing evidence for the recommendation on the optimal gestational weight gain.80 A 154 
study that addressed this problem, published year after the guideline update, suggest that high 155 
rates of gestational weight gain may indeed increase a woman’s risk of developing GDM.67 156 
The authors noticed that the association between the gestational weight gain and odds of 157 
GDM was primarily attributed to weight increase in the first trimester, and stronger in the 158 
obese and overweight groups, and among women of a non-Caucasian origin.67  159 
 160 
On average, the women in the control arms of RCTs with diet and physical activity more 161 
frequently did not achieve (29.1%) and less frequently exceeded (37.1%) with the IOM 2009 162 
targets in comparison to rates reported in the literature.128,264,274,275 Yet, this varied across the 163 
BMI groups with over two-third of women with normal BMI not achieving the recommended 164 
minimum of 11 kg, over half of overweight and 45% of obese women exceeding the 165 
maximum weight gain specified for their categories. A small proportion of women with 166 
normal BMI with high gestational weight gain (19.1%) lowered the overall percentage of 167 
women exceeding the recommendation. The overall proportion of the overweight and the 168 
obese women in this category is closer to the rates reported in the review by Goldstein et al.128 169 
The high non-achievers rate among women with normal BMI could be explained by women 170 
having healthier lifestyle habits than those of overweight and obese women who probably eat 171 
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less healthy and led more sedentary lifestyle prior their pregnancy.246,276 Secondly, the 172 
participation in the trials could be a factor on its own. A recent systematic review looking at 173 
the health outcome of women who participated in the RCTs in comparison to non-participants 174 
showed that on average participating women experience better outcomes than non-175 
participants.277 176 
 177 
7.4.4. Conclusion 178 
Women receiving usual care, i.e. in control arms of 36 trials on the effect of diet and physical 179 
activity in pregnancy, who started overweight or obese exceeded the IOM targets most 180 
frequently. A detailed exploration of the amounts of weight gained above the limits showed 181 
that the women mostly exceeded them by only a few kilograms. Nevertheless, each kilogram 182 
of weight gain above the recommended amount increased the odds of LGA and caesarean 183 
delivery regardless of the women’s BMI value at the beginning of the pregnancy.  184 
   185 
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Chapter 8 Conclusions and recommendations 186 
8.1. Summary of key findings 187 
The work presented in this thesis expands the research objectives defined in the HTA NIHR 188 
funded IPD meta-analysis utilising its materials (data and the collaborative group). In this 189 
thesis, I evaluated and synthesised data from 103 RCTs on diet and physical activity based 190 
interventions in pregnancy. Of these individual participant data were available from 36 RCTs 191 
with over 12 500 records. The work was supported by the members of the international i-WIP 192 
Collaborative Group that involved researchers from 16 countries and over 40 academic or 193 
research institutions. The summary of the key findings from this thesis in a structured format 194 
has been presented in Table 8.1.  195 
 196 
8.1.1. Composite outcome 197 
The aim of the work presented in chapter 3 was to develop composite outcomes for use in IPD 198 
meta-analysis of RCTs with diet and physical activity based interventions provided 199 
antenatally. The composite outcomes comprised of four individual maternal and four 200 
offspring outcomes. The components comprising maternal composite outcome was available 201 
in two-thirds, and for the offspring composite in the half of the studies in the i-WIP IPD meta-202 
analysis. The pooled point estimate of effect of interventions on the composites and their 203 
components was consistent for the maternal composite, and variable in case of the offspring 204 
composite. The main limitation is using a composites in the i-WIP study was the inconsistent 205 





Table 8.1 Summary of the key findings from the thesis 209 
Chapter  Objectives Method(s) Main findings 
3 Develop composite outcome 
to use in IPD MA 
Delphi methodology   The components of the composite outcomes are as follows:  
o Maternal composite: GDM, preterm birth, caesarean section, hypertensive disorders in 
pregnancy; 
o Offspring composite: stillbirth, SGA, LGA, admission to NICU. 
 The composite outcomes in IPD meta-analysis of RCTs of diet and physical activity were 
available for a lower number of participates than their individual components.  
 The point estimates of effect of the maternal composite and its components were in the 
same direction, but for the offspring composite and its components they were variable. 
4 Compare the effects of the 
interventions on pregnancy 
outcomes using IPD and 
study-level MA 
Systematic review 
Two-stage IPD MA 
Study-level meta-analysis 
 IPD MA analysis has shown a significant reduction in gestational weight gain and the odds 
of caesarean section with diet and physical activity based interventions in pregnancy in 
comparison to routine care 
 Incorporation of unreported outcome data in IPD MA lowered the magnitude of the 
summary effects in comparison to those observed on the study-level in the group of studies 
where IPD was available 
 The addition of study-level data from studies where IPD was not available changed the 
statistical significance of the interventions’ effect on GDM in most cases increasing the 
between-study heterogeneity. 
GDM, gestational diabetes; SGA, small for gestational age; LGA, large for gestational age; NICU, neonatal intensive care unit; RCT, randomised controlled trial; IPD, individual participant 210 
data; MA, meta-analysis; 211 
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Chapter  Objectives Method(s) Main findings 
5 Compare modifying effect 
of women’s BMI on the 
effect of interventions using 
IPD and study-level MA 
Systematic review 
Two-stage IPD MA 
Study-level meta-analysis 
(meta-regression) 
 There is no evidence that the effect of diet and physical activity based interventions on 
pregnancy outcomes alter depending on the women’s BMI  
 The results of study-level meta-regression could lead to incorrect conclusions that the effect 
of interventions on gestational weight gain is stronger in the class of obese women. 
6 Assess the variation in 
outcome reporting and the 
quality of outcome reporting 
in trials with diet and 




 ‘Critically important’ outcomes like GDM or caesarean section are reported less often in 
comparison to ‘non-critical’ ones e.g. gestational weight gain or birth weight. 
 The overall quality of outcome reporting varied between trials with the least frequently 
provided information on the methods to improve the quality of outcome measures. 
 The study and journal features were not associated with the quality of outcome reporting in 
the primary publication from trials on diet and physical activity in pregnancy. 
7 Examine the relationship 
between gestational weight 
gain and adverse pregnancy 
outcomes accounting for 
adherence to the IOM 
recommendations  
One-stage IPD MA  Women who most frequently exceeded the IOM recommendation belonged to the 
overweight and the obese groups.  
 Weight gain within the IOM ranges was not significantly associated with the evaluated 
pregnancy outcomes.  
 Not achieving the IOM range by seems to be associated with a decreasing odds of LGA 
among obese women. 
 Weight gain above the IOM limit seems to be associated with an increased odds of 
caesarean section and LGA regardless of BMI. 
BMI, body mass index; IPD, individual participant data; MA, meta-analysis; GDM, gestational diabetes; IOM, Institute of Medicine; LGA, large for gestational age;212 
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8.1.2. IPD meta-analysis 213 
Chapters 4 and 5 evaluated the summary effect of the interventions and the modifying effect 214 
of women’s pre or early pregnancy BMI of the summary effects, respectively; using meta-215 
analysis with IPD and study-level data. The findings of the IPD meta-analysis showed that 216 
diet and physical activity based interventions in pregnancy significantly reduced gestational 217 
weight gain and the odds of caesarean section in comparison to routine antenatal care. 218 
Although the summary estimates favoured a reduction in all individual maternal outcomes, the 219 
findings were not statistically meaningful. There was no effect of the intervention on the 220 
evaluated offspring complications. 221 
 222 
In comparison to data reported in the published reports, access to IPD from 36 RCTs allowed 223 
me to incorporate more trials into the meta-analysis for all evaluated outcomes. Incorporation 224 
of previously unavailable data returned a more modest magnitude of the summary estimates in 225 
comparison to effects obtained the study-level data of trials that shared IPD. The statistical 226 
significance of the pooled effect changed in two cases and no clear impact on the 227 
heterogeneity level. The addition of study-level data from non-IPD trials changed the 228 
magnitude and the statistical significance of the summary effects in the meta-analysis for 229 
GDM and changed the funnel plot structure in the meta-analysis for gestational weight gain. 230 
In most cases, incorporation of study-level data from trials where IPD was not available 231 
increased the between-study heterogeneity. The study-level meta-analyses and IPD meta-232 
analysis with the addition of non-IPD trials (study-level data) provided comparable results 233 
with similar levels of between-study heterogeneity.  234 
 235 
Furthermore, my work provides another empirical example supporting the notion that results 236 
of meta-regression need to be interpreted with great caution. Meta-analysis using IPD 237 
provided more robust and less biased evidence then the study-level meta-regression. There is 238 
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no evidence that the effect of diet and physical activity based interventions on pregnancy 239 
outcomes alter depending on the women’s BMI. 240 
 241 
Overall, the access to IPD improved the robustness of the evidence synthesis of trials with diet 242 
and physical activity in pregnancy. The main limitation of the meta-analysis using IPD was a 243 
low event rate and lack of baseline and final measures for continuous outcomes that prevent 244 
inclusion of individual trials in the meta-analysis. 245 
 246 
8.1.3. Variation in outcome reporting  247 
Chapter 6 contains the assessment of outcome reporting in trials examining the effects of diet 248 
and physical activity based interventions in pregnancy. The work has revealed a wide range of 249 
maternal and offspring outcomes evaluated in those trials that varies in frequecy and 250 
importance to women’s care. ‘Critically important’ outcomes e.g. GDM or caesarean section 251 
are reported less often in comparison to ‘non-critical’ ones like gestational weight gain or 252 
birth weight. The overall quality of outcome reporting varied between trials with the least 253 
frequently provided information on the methods to improve the quality of outcome measures. 254 
This work was not able to detect any impact of study or journal-specific characteristics on the 255 
overall quality of outcome reporting in the group of primary publications from trials with diet 256 
and physical activity based interventions in pregnancy. 257 
 258 
8.1.4. Gestational weight gain and pregnancy complications 259 
The aim of the final chapter was to examine the relationship between gestational weight gain 260 
and adverse pregnancy outcomes accounting for adherence to the IOM recommendations.  261 
The overweight and the obese women frequently exceeded the IOM recommendation while 262 
women with BMI within the normal range tended to gain less rather than exceed the 263 
recommended amounts. The exploration did not find any evidence for an association between 264 
each kilogram of weight gained within the IOM range and the pregnancy complications. The 265 
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weight gain (by one kilogram of change) below the lower limit of the IOM recommended 266 
amount was associated with the decreasing chance of delivering LGA infant in the obese 267 
class. Conversely, each kilogram of weight gain above the upper limits was associated with 268 
increased chance of caesarean delivery and birth of LGA infant regardless of women’s BMI 269 
status. 270 
 271 
8.2. Recommendations for research practice 272 
8.2.1. Composite outcomes in IPD meta-analysis 273 
Delphi methodology is a valuable method when prioritising of outcomes to develop composite 274 
outcomes. It is recommended to use outcomes as measured in the original trials rather than the 275 
composite endpoints as the availability of the individual components may vary between the 276 
original trials included in IPD meta-analysis, and access to IPD still not address the issue of 277 
the rarity of events. In the situation when the composite outcome is deployed, limitations of its 278 
use should be explained and the effect on the components presented and discussed. 279 
 280 
8.2.2. Assessing variation in outcome reporting 281 
The quality of outcome reporting in this thesis was assessed using the questionnaire presented 282 
by Harman et al.257 More objective and less ambiguous tools should be developed for the 283 
future evaluations of the quality of outcome reporting in clinical trials. Secondly, authors of 284 
the primary studies should provide more detail when describing the outcomes and 285 
participants’ characteristics. 286 
 287 
8.2.3. IPD meta-analysis 288 
Access to individual records increases the number of trials available for meta-analysis. Use of 289 
the elementary data for outcomes with relatively simple definitions should be planned for in 290 
order to generate data not collected in original trials. Mapping of definitions and additional 291 
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data that could help to standardise the outcome across the trials may not tackle the issues, but 292 
it can save time and make the IPD meta-analysis findings more current. The sensitivity 293 
analysis with the inclusion of non-IPD studies (availability bias) is an important element of 294 
IPD meta-analysis that should be mandatory if the proportion of studies where the IPD was 295 
not available is high. 296 
 297 
8.2.4. Gestational weight gain as a primary outcome 298 
There is evidence for the link between the gestational weight gain (low and high as per IOM 299 
standards) and the chance of delivering LGA infant. However, neither meta-analyses using 300 
IPD or the study-level data showed a meaningful effect of diet and physical activity based 301 
interventions on the LGA infant. Excessive weight gain was linked with the increased odds of 302 
the caesarean section which can be significantly reduced with the interventions. Taking into 303 
account the variation in the weight measurements and that the caesarean section is already 304 
frequently reported in the trials, there is no reason to justify powering of the future research to 305 
detect the effect of the interventions on the change in gestational weight gain. 306 
 307 
8.3. Recommendation for future research questions 308 
8.3.1. IPD meta-analyses 309 
The meta-analysis of IPD being a resource-demanding approach to evidence synthesis of 310 
RCTs requires a thorough and honest evaluation of what is achievable and what is not. We 311 
might need to accept that due to no uniform data coding some research is not usable for 312 
synthesis thus has been permanently lost. The efforts associated with obtaining IPD and its 313 
harmonisation need to be balanced by the potential gains achievable through a complex and 314 
profound statistical analysis. More guidance is needed on the impact of unavailable data and 315 
how to interpret it. Current guidelines recommend adding non-IPD studies to IPD meta-316 
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analysis when a substantial proportion of trials IPD was not obtained at the beginning of the 317 
project. In the areas of medical research where the new evidence emerges annually, staying 318 
up-to-date while conducting IPD meta-analysis is exceptionally challenging. Therefore, 319 
adding newly published trials is as important as incorporating the not shared ones.  320 
 321 
8.3.2. Effects of diet and physical activity in pregnancy 322 
The unwarranted variation of trials’ outcomes could be achieved through the development and 323 
introduction of a COS – a minimum set of outcomes that should be collected and reported 324 
alongside other outcomes of research interest.52 This concept strongly promoted by the 325 
COMET initiative has also been embraced by the researchers and editors of obstetrics and 326 
gynaecology journals.53,262 The CROWN initiative recognizes the limitations imposed by the 327 
variation in outcome reporting and promotes COS as a way to improve the evidence synthesis 328 
and to draw more meaningful conclusions. Furthermore, the introduction of COS in other 329 
medical areas has been shown to lead to improvement in the consistency of outcome 330 
reporting.56 The i-WIP Collaborative Group gathering researchers from various research 331 
specialities have a fantastic potential to pursue an effort towards the identification of COS for 332 
use and reporting from trials with diet and physical activity based interventions in pregnancy. 333 
Secondly, the group has the potential to lobby for standardisation of definitions for outcomes 334 
such as gestational diabetes and improvement in documentation of caesarean section as 335 
elective or emergency.  336 
 337 
The i-WIP IPD meta-analysis has shown that the interventions have the potential to 338 
moderately reduce gestation weight gain and decrease the chance of caesarean section. Further 339 
research, should focus on whether the effect differs for any subgroup of women and  340 
types of cesarean section. In my work, I did not explore the complexity of the evaluated 341 
interventions. Evaluation of any differential effects according to the individual components of 342 
the intervention (duration, frequency, provider, and setting) on the important health outcomes 343 
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is required to provide more detailed recommendations. The analyses of interventions 344 
components done so far were limited by the number of available studies and use of only 345 
study-level data.234,278 Access to IPD and direct contact with the research teams allows to 346 
overcome previous limitations, and apply advanced meta-analytical methods as it was done 347 
for the behavioural programs for type 2 diabetes mellitus.279 348 
 349 
Further to WHO priority research questions120, more evidence needs to be ascertained with 350 
large randomised trials on the effect of interventions in developing countries like China or 351 
Brazil which face similar obstetric complications as those encountered in high-income 352 
countries e.g. high rate of cesarean sections or gestational diabetes.117,119 The research 353 
conducted in the high-income settings should shift towards studies exploring the effective 354 
implementation of the interventions. Finally, it needs to be assessed whether the benefit of 355 
diet and physical activity observed on the short term outcomes translates to long-term benefits 356 
to the mother and the baby. 357 
 358 
8.4. Implication for clinical practice 359 
The findings of this work have the potential to influence national and international guidelines 360 
on healthy eating and physical activity during pregnancy to achieve better health outcomes. 361 
To-date, the findings of the i-WIP meta-analysis were used to inform the recommendations on 362 
the physical activity for pregnant women issued by the UK Chief Medical officer.280 363 
 364 
  365 
  366 
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Appendix 1.1 Overview of systematic reviews with meta-analysis evaluating effects of diet and physical activity based interventions in pregnancy in 1109 
comparison to routine care  1110 




Limitations and conclusions 
1 Kramer  
20021 
(Cochrane) 
To assess the effects of 
advising healthy pregnant 
women to engage in 
regular aerobic exercise on 
physical fitness, labour 
and delivery, and the 








eclampsia, duration of 
labour, and type of 







Effect on the main outcome  
Mother or infant outcomes (?) 
2 Leet  
20032 
To examine if differences 
in birthweight are 
dependent upon the 
physical conditioning of 
the mother previous to 
pregnancy, how long she 
continued to exercise 
during her pregnancy, and 







Birth weight  8 Limitations 
Only studies in English 
 
Conclusions 
Effect on the main outcome  
   
161 




Limitations and conclusions 
3 Liu  
20053 
To evaluate the 
effectiveness of 
interventions to prevent 





Mixed approach Proportion of women 
exceeding the upper 
limit of the IOM 
recommended 
gestational weight gain 
range 
3 Limitations 
Only studies in English 
Published 1980 – 2005 
Poor quality of included studies 
 
Conclusions 
Effect on the main outcome  
 
4 Kramer  
20064 
(Cochrane) 
To assess the effects of 
advising healthy pregnant 
women to engage in 
regular aerobic exercise, or 
to increase or reduce the 
intensity, duration, or 
frequency of such 
exercise, on physical 
fitness, the course of 
labour and delivery, and 








eclampsia, duration of 
labour, and type of 







Effect on the main outcome  
Mother or infant outcomes (?) 
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Limitations and conclusions 
5 Dodd  
20085 
To assess the benefits and 
harm of dietary and 
lifestyle interventions 
during pregnancy to 
improve maternal and 
infant outcomes for 
pregnant women who are 





Mixed approach Weight gain, maternal, 




No search limits 
Low number of eligible studies 
and lack of power to detect 
clinically important effects  
 
Conclusions 
Effect on the main outcomes (?) 
 
6 Kuhlmann  
20086 
To assess whether 
effective weight-
management interventions 




Physical activity Pregnancy weight gain 





Only studies in English 
Published 1985 – 2007 
Differences in measures, 
number of participants, follow-
up periods, design and reported 
information made comparisons 
and overall conclusions difficult 
 
Conclusions 
Effect on the main outcome  
 
   
161 




Limitations and conclusions 
7 Schlüssel  
20087 
To investigate the effects 
of physical activity during 











mode of delivery, fetal 
growth or 
development, birth 






Only studies in Portuguese, 
English, or Spanish 
Published 1980 – 2005 
Most included studies lacked 
any kind of standardization as to 
the type of activities what made 
it difficult to compare the 
studies’ results. 
Conclusions 
Effect on the main outcomes (?) 
8 Tieu  
20088 
(Cochrane) 
To assess the effects of 





Diet Primary: LGA, 
macrosomia, perinatal 
mortality, GDM, mode 
of birth (normal 
vaginal birth, operative 
vaginal birth, caesarean 
section) 
Secondary: various 




No search limits 
A small number of trials with a 
relatively small group of 
women, variation in reported 
outcomes, heterogeneity 
(mainly in gestational weight 
gain) and quality and reporting 
of included studies. 
 
Conclusions 
Effect on the main outcomes (?) 
 
   
161 




Limitations and conclusions 
9 Dodd  
20109 
To assess the benefits and 
harms of antenatal dietary 
or lifestyle interventions 
for pregnant women who 






Mixed approach Primary: LGA infant 
Secondary: various 




intensity), inconsistency in 
outcome reporting, not reporting 
of subgroups, poor quality of 
included studies 
Conclusions 
Effect on all evaluated 
outcomes (?) 
 
10 Skouteris  
201010 
identify, and evaluate the 
effect of key variables 
designed to modify risk 
factors for excessive 
weight gain in pregnant 
women that have been 
targeted in interventions 








Only studies in English 
Published 2000 – 2010 
Use of self-reported pre-
pregnancy weight and weight at 
37 weeks of gestation. 
Conclusions 






       
   
161 




Limitations and conclusions 
11 Ronnberg  
201011 
To determine if published 
trials of interventions to 
reduce excessive 
gestational weight gain are 






Mixed approach Primary outcome: 
Total gestational 
weight gain, rate of 
gestational weight gain 
per week, proportion of 





Only studies in English or any 
Scandinavian language 
Not reporting of the effect by 
BMI group, small sample size, 
heterogeneity in the mode, 
intensity, frequency and 
duration of the interventions, 
use of surrogate endpoints in all 
included trials  
Conclusions 
Effect on the main outcomes (?) 
 
12 Streuling  
201112 
To find out whether 
physical activity during 
pregnancy might help 




Physical activity Total gestational 
weight gain  
12 Limitations 
No search limits 
Heterogeneity and losses to 
follow up 
Conclusions 
Effect on the main outcome  
 
   
161 




Limitations and conclusions 
13 Tanentsapf  
201113 
Primary: evaluate the 
effect of dietary 
interventions for reducing 
GWG, Secondary: to 
examine the impact of 
these interventions on 







Diet Primary: % of women 
who gained above the 
IOM 
recommendations,  
% of women with 
excess GWG, total 
GWG or weekly GWG 
Secondary: various 




No search limits 
Inability to quantify the 
intensity of different 
interventions due to lack of 
details in the included papers; 
methodological quality of the 
studies (7/13 with high risk of 
bias); variation is measuring 
gestational weight gain; lack of 
power to capture intervention 
effects on some clinical 
outcomes; 
Conclusions 
Effect on the main outcome  
Effect on the secondary 
outcomes (?) 
        
   
161 




Limitations and conclusions 
14 Gardner  
201114 
To assess the effect of 
interventions aimed to 
reduce gestational weight 
gain through changes in 




Mixed approach Primary: gestational 
weight gain  
10 Limitations 
Only in English 
Published 1990 – 2010 
Women without any chronic 
health conditions 
Variation in characteristics of 
participants, the methodological 
quality of included studies and 
reporting of interventions 
components.  
Conclusions 
Effect on the main outcome  
15 Quinlivan  
201115 
To estimate whether 
antenatal dietary 
interventions restrict 
maternal weight gain in 
obese pregnant women 
without compromising 






Diet Primary outcome: 
Gestational weight gain 
Secondary outcome: 





Effect on the main outcome  
Effect on the secondary 
outcome  
 
   
161 








To investigate the health 
impact of improved 
management of weight 





Mixed approach Primary outcome: 
Weight-related 
outcomes, dietary and 
physical activity 
outcomes  






Published 1990 – 2008 
Small number of studies 
 
Conclusions 
Effect on the main outcome  
 
        
17 Nascimento  
201117 
To evaluate the effects of 
exercise on weight gain 
and perinatal outcomes 
among overweight and 









preterm birth, birth 




Published 1980 – 2010 
 
Conclusions 
Few studies confirmed the 
positive effect of exercise in 
controlling weight gain during 
pregnancy 
 
   
161 




Limitations and conclusions 
18 Sui  
201218 
Assess the benefits and 
harms of an exercise 
intervention for pregnant 
women who are 





Physical activity Primary: maternal 
gestational weight gain 
Secondary: various 




No search limits 
Variation in the nature of 
provided interventions, their 
timing, duration and 
compliance; studies with small 
sample sizes and 
methodological flaws. 
Conclusions 
Effect on the main outcome  
Effect on the secondary 
outcomes (?) 
19 Thangaratinam  
201219 
To evaluate the effects of 
dietary and lifestyle 
interventions in pregnancy 
on maternal and fetal 
weight and to quantify the 
effects of these 




Mixed approach Primary outcomes: 
Gestational weight gain 
Secondary outcomes: 
various maternal and 
infant outcomes  
44 Limitations 
No search limits 
Heterogeneity in the effects of 
the interventions, rarely 
reported subgroup effects, low 
quality of evidence for 
important obstetric outcomes. 
Conclusions 
Effect on the main outcome  
Effect on the secondary 
outcomes  
 
   
161 












weight gain during 




Mixed approach Primary: excessive 
weight gain 
Secondary: various 




No search limits 
Significant methodological 




Effect on the main outcome (?) 
 
21 Oteng-Ntim  
201221 
To determine the efficacy 
of antenatal dietary, 
activity, behaviour or 
lifestyle interventions in 
overweight and obese 
pregnant women to 







Mixed approach Gestational weight 
gain, GDM, Caesarean 




Low quality studies, small 
sample size, and lack of effect 
for BMI subgroups when a 
mixed group of obese and 




Effect on gestational weight 
gain  
Effect on GDM  
 
   
161 




Limitations and conclusions 
22 Choi  
201322 
To review the 
effectiveness of 
interventions with physical 
activity only and with diet 
in managing weight among 
overweight or obese 








Mixed approach Not pre-specified 7 Limitations 
Only studies in English or 
Korean 
Published 2000 – 2011 
Heterogeneity, variation in 
studies’ quality and reporting. 
 
Conclusions 
Effect on the gestational weight 
gain  
 
23 Lamina  
201323 
To assess the effect of 
aerobic training on 




Physical activity Gestational weight gain 11 Limitations 
Only studies in English 
Clinical heterogeneity, variation 
in recruitment period and not 
reporting effects by BMI 
subgroups in BMI mixed 
studies.   
 
Conclusions 
Effect on the main outcome  
 
   
161 




Limitations and conclusions 
24 Fuber  
201324 
(Cochrane) 
To evaluate the 
effectiveness of 
interventions that reduce 





Mixed approach Primary: Serious 
maternal morbidity, 
neonatal admission to 
NICU, Perinatal death 
Secondary: various 
maternal and infant 
outcomes 
 
0 No search limits  
No relevant RCTs 
25 Gresham  
201425 
To synthesized effects of 
dietary interventions 
before or during pregnancy 





Diet1 Primary outcomes: 
Neonatal and infant 
outcomes 
15 Limitations 
Small number of included trials, 
variation in reported outcomes, 
moderate to high heterogeneity 
for neonatal outcomes not 




Effect on the main outcomes (?) 
 
        
                                                     
1 And nutritional factors 
   
161 




Limitations and conclusions 
26 O’Brien  
201426 
To systematically review 
the literature on the use of 
technology supported 
lifestyle interventions for 
healthy pregnant women 






Mixed approach Primary: fasting 
maternal glucose, 
GDM, gestational 
weight gain  
Secondary: 
intervention uptake, 





Only studies in English 
The design of included studies 
(feasibility or acceptance 
studies), intensity and duration 
of interventions, and trials 
geographical location (mainly 
the Unated States).  
 
Conclusions 
Effect on the gestational weight 
gain  
The absence of data for 
important pregnancy outcomes 
(?) 
27 Elliott-Sale  
201527 
To review the evidence 
from studies employing 
exercise-only interventions 
for weight management 






Physical activity Primary: change in 
body weight 
5 Limitations 
Published 1990 – 2013 
Focus on physical activity only 
 
Conclusions 
Effect on the main outcome (?) 
 
   
161 




Limitations and conclusions 
28 Bain 201528 
(Cochrane) 
To assess the effects of 
combined diet and exercise 
interventions for 
preventing GDM and 
associated adverse health 
consequences for women 




Mixed approach Primary: GDM, mode 
of birth (normal 
vaginal, operative 








No search limits  
Variations in the trials’ quality, 
type of the interventions, 
assessed populations, and 
definitions of outcomes across 
the included trials. 
 
Conclusions 
Effect on GDM  








weight gain during 




Mixed approach Primary: excessive 
weight gain 
Secondary: various 




No search limits  
Included studies were mainly 
conducted in developed 




Effect on the main outcome  
derived from a High-quality 
evidence 
Effect on the other outcomes (?) 
 
   
161 









To assessing the 
effectiveness of physical 
exercise interventions 
during pregnancy to 
prevent GDM and 





Physical activity Pirmary outcome: 
GDM, excessive mean 
gestational weight gain 
13 Limitations 
Only studies in English or 
Spanish 
Non-blinded data extraction, 
medium to the low quality of 
included studies, and variation 
in reporting of studies’ findings 
and diagnostic criteria of the 
primary outcome (GDM).  
Conclusions 
Effect on the main outcomes  
31 O’Brien  
201631 
To systematically review 
effect of dietary and 
lifestyle interventions in 
pregnant women with a 
normal BMI on maternal 




Mixed approach Primary: total 
gestational weight 
gain, the proportion of 
women exceeding the 
IOM guidelines, 
weight retention 
defined more than 5 kg 
weight gain at 12 
months postpartum 
Secondary:  various 




No search limits 
Small sample size, use of self-
reported pre-pregnancy BMI in 
included studies, poor 
description of the evaluated 
interventions and adherence to 
them, and variation in the 
interventions’ components. 
Conclusions 
Effect on the main outcome  
derived from evidence limited 
by relatively small sample size 
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Limitations and conclusions 
32 Song  
201632 
To examine the effect of 
lifestyle intervention on 




Mixed approach Primary outcome: 
GDM 
29 Limitations 
Only studies in English or 
Chinese 
Included studies were mainly 
conducted in developed 
countries; lack of power to 
investigate the effects of 
individual components of the 
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Limitations and conclusions 
33 Perales  
201633 
To understand what 
evidence exists with regard 
to maternal and offspring 
benefits of aerobic and 





Physical activity Not pre-specified 61 Limitations 
Only studies in English 
Small sample size, high loss to 
follow-up, differences among 
studies in frequency, intensity, 
duration or timing of exercise, 
low adherence to the training 
schedule, and weak overall 
quality of included studies. 
 
Conclusions 
Effect on the maternal 
cardiorespiratory fitness and 
prevention of urinary 
incontinence  
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Limitations and conclusions 
34 Gresham  
201634 
To determine the effect of 
dietary intervention before 





Diet1 Not pre-specified 14 Limitations 
Only studies in English 
Human studies 
Small number of included 
studies, variation in outcome 
reporting, statistical 
heterogeneity in outcomes such 
as blood pressure, GDM and 
length of gestation that could 
not be explained by subgroup 
analyses. 
Conclusions 
Effect on the evaluated 
outcomes  but small 
 





To examine the 
relationship between 
exercise dose and 
reductions in weight gain 




Physical activity Gestational weight gain 21 Limitations 
No search limits  
Probability of missing out trials 
Heterogeneity of the exercise 
doses prescribed and 
insufficient reporting of the 
received dose. 
Conclusions 
Effect on the evaluated 
outcomes (?) 
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Limitations and conclusions 
36 Zhang  
201636 
To examine the effects of 
low-GI diets on maternal 




Diet Gestational weight gain, 
fasting blood glucose, 




gestational age at 
delivery, birth weight, 
Ponderal index, LGA, 
SGA, macrosomia, head 
circumference, body 






Heterogeneity and small number 
of studies 
Conclusions 
Effect on the evaluated 
outcomes (?)  
37 Magro-Malosso  
201737 
To evaluate the effect of 
exercise on the risk of 
preterm birth in 







Physical activity Primary: preterm birth 
(<37 wks) 
Secondary: Gestational 
age at delivery,  
cesarean delivery, 
GDM, birth weight, 




No search limits  
Additional intervention (dietary) 
provided in some of the 
included studies, variation in 
type, duration amd intensity of 
main intervention, variation in 
the main outcome definition 
(spontaneous and indicated 
preterm birth) 
Conclusions 
Effect on the main outcome  
Effect on GDM  
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Limitations and conclusions 
38 da Silva  
201738 
To compare the 
associations between 
leisure-time physical 
activity in pregnancy and 
maternal and child health 
outcomes between RCTs 













Only studies in English, 
Portuguese or Spanish 
 
Conclusions 
Effect on the gestational weight 
gain, GDM, preterm birth and 
LGA 





To review literature on the 
effectiveness of nutritional 
factors before or during 





Diet1 Primary outcome: 
GDM 
8 Limitations 
Only studies in English, French 
or Spanish 
Probable publication bias 
 
Conclusions 
Effect on the main outcome (?)  
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Limitations and conclusions 
40 Fealy  
201740 
To test if routine weighing 
as a stand-alone 
intervention can reduce 
gestational weight gain 
Pregnant 
women 
Mixed approach Gestational weight 
gain, excessive 
gestational weight gain 
according to IOM 
guidelines pregnancy, 
 
infant and birth 
outcomes 
2 Limitations 
Only studies in English  
Human studies 
Small number of studies with 
lack of blinding of participants 
and personnel.  
 
Conclusions  
Effect on the main outcome  
 
41 Tieu  
201741 
(Cochrane) 
To assess the effects of 





Diet Primary: LGA, 
macrosomia, perinatal 
mortality, GDM, mode 
of birth (normal 
vaginal birth, operative 
vaginal birth, caesarean 
section) 
Secondary: various 
maternal and infant 
outcomes 
11 Limitations 
Heterogeneity, and moderate to 
low quality of included studies. 
 
Conclusions  
Effect on the GDM  derived 
from very low-quality evidence 
Effect on the PIH  
Effect on the other outcomes  
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Limitations and conclusions 
42 Yeo  
201742 
To review studies targeting 
gestational weight gain in 
obese and overweight 







Mixed approach Primary outcome: 
gestational weight gain 
32 Limitations 
Published 2005 – 2016 
High heterogeneity in the 
effects, probable bias due to 
lack of blinding in the included 
studies. 
   
Conclusions 
Effect on the main outcome  
was more efficacious when 
delivered by primary care 
providers during routine 
prenatal care 
 
RCT, Randomised Controlled Trial; IOM, Institute of Medicine; GDM, gestational diabetes; NICU, neonatal intensive care unit; SGA, small for gestationa age infant; LGA, large for gestational 1111 
age infant; 1112 
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Appendix 2.1 Search strategy for identification of randomised trials on diet and physical 1198 







6 Pregnant Women/ 
7 pregnant wom#n.tw. 




12 Weight Gain/ph [Physiology] 
13 weight gain*.tw. 
14 Weight Loss/ph [Physiology] 
15 weight loss*.tw. 
16 weight change*.tw. 
17 Obesity/dh, me, ph, pc, px, th [Diet Therapy, Metabolism, Physiology, Prevention & 
Control, Psychology, Therapy] 
18 obes*.tw. 
19 Adiposity/ph [Physiology] 
20 adipos*.tw. 
21 Overweight/dh, me, ph, pc, px, th [Diet Therapy, Metabolism, Physiology, Prevention & 
Control, Psychology, Therapy] 
22 overweight*.tw. 
23 Body Mass Index/ 
24 bmi.tw. 
25 or/12-24 
26 exp Randomized Controlled Trial/ 
27 "randomized controlled trial".pt. 
28 "controlled clinical trial".pt. 
29 (random$ or placebo$).tw,sh. 
30 ((singl$ or double$ or triple$ or treble$) and (blind$ or mask$)).tw,sh. 
31 single-blind method/ 
32 double-blind method/ 
33 or/26-32 
34 11 and 25 and 33 
35 exp Animals/ 
36 (rat$ or mouse or mice or hamster$ or animal$ or dog$ or cat$ or bovine or sheep or 
lamb$).af. 
37 35 or 36 
38 Humans/ 
39 human$.tw,ot,kf. 
40 37 or 38 
41 37 not (37 and 40) 
42 34 not 41 
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Median IQR Median IQR 










Large for Gestational 
Age 
7 1.25 
Preterm birth 7 2 Admission to NICU 8 1 
Caesarean section: 
elective 




> 1 perinatal 
complication 
8 1 
Thromboembolism 8 1.25 Birth trauma 8 0.5 
















7 1.25 Hypoglycemia 7 1 




Induction of Labour 8 1.25 Skinfold thickness 6 1 
Miscarriage 6 1.5 Fetal fat mass 6 1.25 






Physical activity 6 0.25 Ponderal index 6 2 
Dietary behaviour  7 0.25 
Birthweight related 




6 1.25 Hyperbilirubinemia 6 2 
Prolonged Labour  6 1 Neural Tube Defect 6 2 
  1202 






Median IQR Median IQR 




Perineal Trauma 6.5 1 Apgar score 6 1 
Antepartum 
Haemorrhage 
6 1 Abnormal cord pH 7 2 
Postnatal depression 6 2.25 Head circumference 5 0.25 





Body fat (%) 6 2.25 Head/abdomen ratio 5 1 
Breast feeding 5 2.25 





7 2 CTG abnormalities 5.5 1.25 
Coronary artery disease 6 3.25 Cord Abnormalities 5 2.25 








Anaemia 5 3 
 
  
Infections 6 2 
   
Postnatal Infection 6 2.25 
   
Anxiety 5 0.5 
   
Back pain 6 2 




   
Threatened Abortion  3.5 2 
   
 1203 
  1204 
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Appendix 3.2 Forest plots with maternal and offspring composite outcomes 1205 
 1206 
Maternal composite outcome in the individual studies 1207 
 1208 
 1209 
Offspring composite outcome in the individual studies 1210 
 1211 
  1212 
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Appendix 4.1 List of sought data items for i-WIP IPD meta-analysis 1213 
iWIP IPD meta-analysis project: “Effects of weight management interventions on maternal 
and fetal outcomes in pregnancy” 
Variable name 
Variables marked with (*) are the mandatory ones 
Collected/Reported 
Please specify: Yes/No 
Baseline characteristics Please state way of information obtained: self-reported / measured 
by health worker / medical chart 
Age*  
Height*  
Weight at baseline*  
BMI at baseline*  
Pre-pregnancy weight *  
Pre-pregnancy BMI*  
Race*  
Ethnicity*  
Gestational age at baseline*  
Known medical condition (please specify)  
Mental health and medication (depression, anxiety, QoL, etc.)  
History of pregnancy abnormalities (e.g. GDM)   




Educational status*  
Socioeconomic status (income, work)*  
Substance misuse – alcohol  
Substance misuse – drugs  
Baseline diet*  
Baseline physical activity*  
Lifestyle*  
Intervention  
Type:  Diet, Physical Activity, Behavioural  
Intervention components  
Intervention provider  
Setting  
Gestational age of commencement  
Frequency  
Format (individual, groups)  




GA at delivery *  
Last Weight*  
Last BMI*  
GA at which last wt or BMI was calculated*  
Gestational weight gain (GWG)* and how it was calculated  
Weight at 3, 6 and 12 months after delivery (post-partum)  
Institute of Medicine (IOM) guidelines adherence  
Mental health   
Obstetric (if definition is not specified in the protocol please provide used definition of the 
outcome) 
Pre-eclampsia (PE)* with GA of onset  
Gestational diabetes mellitus (GDM)* with GA of onset  
GDM Biochemistry, GTT values  
Pregnancy induced hypertension (PIH)* with GA of onset  
Induction of labour (IOL)* with GA of onset and Indication  
Mode of delivery*  
Preterm birth*  
Shoulder dystocia*  
Postpartum haemorrhage (Atonic, Traumatic; 3rd degree tear 4th 
degree tear; Antepartum haemorrhage) 
 
HELLP (Hemolysis Elevated Liver enzymes and Low Platelets)  
Admission to HDU/ITU*  
Meconium stained liquor  
Dietary behaviour  
Physical activity  
Breast feeding  
Severe infection needing admission  
Venous thromboembolism*  
Pulmonary embolism  




  1215 
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 1216 
Fetal (if definition is not specified in the protocol please provide used definition of the outcome) 
Please state way of information obtained: self-reported / measured by health worker / medical 
chart 
Birth weight*  
1’ Apgar Score  
5’ Apgar Score  
Admission to NICU*  
Respiratory distress syndrome (RDS)  
Intra-uterine death*  
Birth trauma*  
Hypoglycaemia   
Hyperbilirubinaemia   
Large for gestational age   
Small for gestational age*  
Birth length   
Head circumference   
Abdominal circumference  
Crown-heel length (CRL)  
Hypoxic ischaemic encephalopathy  
Cord pH (Arterial; Venous)  
Infant death  
Long term neurological sequel*  
Other 
Any long-term neonatal or childhood outcome  
Losses to follow-up - mother  
Losses to follow-up - baby  
Compliance*  
 1217 
  1218 
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Appendix 4.2 Grouping of variables ethnic origin, education and physical activity before 1219 
pregnancy  1220 










































































































   
161 
Education level 1224 
Low Medium High 
< 12 yrs (preparatory school 
or occupational school) 
<4 years of study 
First degree 
Grammar school <=10 years 
LBO 
Less than high school 
Low 






Primary and secondary school 
Primary education 
Primary or less 
Primary school 
VMBO 
Year 10 or below 
Year 11 or equivalent 
Elementary school 
Grade school(<6yrs) 
junior high school(7-9yrs) 
Less than Primary school 
middle 
middle school (8 years) 
primary school 





12 yrs ( high school) 
4-8 years of study 
A level (or equivalent) 
GCE (or equivalent) 
General secondary school 




High school / Grammar school 
High school diploma 
High school, 12yrs 




Secondary school 12 years 
Upper secondary school 
Vocational upper secondary 
education 
Year 12 or equivalent 
complete secondary 
high school 
high school (13 years) 
high school(10-12yrs) 
medium length education 
school max 10yrs, additional 
education 
technical, additional education 
until 18 year, possible a 
speciality of 1/2 year 
vocational training 
Vocational training school 
<4years addl edu 
> 12 yrs (university or 
equivalent to it) 
>8 years of study 
>=4years addl edu 
College/University<4yrs 







Post graduate education 
Post-graduate 
Tertiary 
















complete 3rd level 
graduate or professional 
education 
graduated 
high school, additional 
education 
masters level or higher 
post-graduation level 
same college(<4yrs) 
some 3rd level 
university 
 1225 
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Physical activity prior pregnancy  1227 
No exercise / sedentary At least some activity 
<600 MET-min/week 
<600 met/hr/week 
Accelerometer <2.5 hrs/wk 
Does not attend gym 
Does not exercise regularly at inclusion 
Less than 10000 steps/dy 
Low 
Paffenbarger PA questionnaire <1000cals 
Sedentary 
Sedentary Work 









Accelerometer 2.5+ hrs/wk 
Does attend gym 







Paffenbarger PA questionnaire 1000+cals 
Physically active 
Work in movement 
Work standing 
Work standing and in movement 
active 
active (PPAQ) 
active (exercise two to three times a week) 
active work 










  1229 
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Appendix 4.3 Characteristics of eligible randomised trials on diet and physical activity  1230 
based interventions in pregnancy 1231 
Study ID Country 
Sample 
size* 
Intervention BMI group 
Studies contributing IPD 
Althuizen 2012 Netherlands 269 Mixed approach 
All BMI groups 
Baciuk 2008 Brazil 70 Physical activity 
All BMI groups 
Barakat 2008  Spain 140 Physical activity 
All BMI groups 
Barakat 2011  Spain 67 Physical activity 
All BMI groups 
Barakat 2012 Spain 279 Physical activity 
All BMI groups 
Bogaerts 2012 Belgium 197 
Mixed approach  
(2 arms) 
BMI ≥ 30 
Dodd 2014 Australia 2,199 Mixed approach 
BMI ≥ 25 
El Beltagy 2013 Egypt 93 Mixed approach 
BMI ≥ 30 
Guelinckx 2010 Belgium 195 
Mixed approach (2 
arms) 
BMI ≥ 30 
Haakstad 2011 Norway 101 Physical activity 
All BMI groups 
Harrison 2013 Australia 238 Mixed approach 
BMI ≥ 25 
Hui 2011 Canada 183 Mixed approach 
All BMI groups 
Jeffries 2009 Australia 282 Mixed approach 
All BMI groups 
Khaledan 2010 Iran 39 Physical activity 
All BMI groups 
Khoury 2005 Norway 289 Diet 
All BMI groups 
Luoto 2011§ Finland 395 Mixed approach 
All BMI groups 
Nascimento 2011 Brazil 82 Physical activity 
BMI ≥ 25 
Ong 2009 Australia 13 Physical activity 
BMI ≥ 30 
Oostdam 2012 Netherlands 105 Physical activity 
BMI ≥ 25 
Perales 2014 Spain 165 Physical activity 
All BMI groups 
Perales 2016 Spain 163 Physical activity 
All BMI groups 
Petrella 2013 Italy 61 Mixed approach 
BMI ≥ 25 
Phelan 2011 USA 393 Mixed approach 
All BMI groups 
Poston 2015 UK 1,554 Mixed approach 
BMI ≥ 30 
Prevedel 2003 Brazil 39 Physical activity 
All BMI groups 
*Refers to sample size in IPD meta-analyses 
§Trials with randomisation by cluster 
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Study ID Country 
Sample 
size* 
Intervention BMI group 
Rauh 2013§ Germany 244 Mixed approach 
All BMI groups 
Renault 2013 Denmark 425 
Physical activity & 
Mixed approach  
(2 arms) 
BMI ≥ 30 
Ruiz 2013 Spain 927 Physical activity 
All BMI groups 
Sagedal 2016 Norway 600 Mixed approach 
All BMI groups 
Stafne 2012 Norway 854 Physical activity 
All BMI groups 
Vinter 2011 Denmark 304 Mixed approach 
BMI ≥ 30 
Vitolo 2011 Brazil 301 Diet 
All BMI groups 
Walsh 2012 Ireland 759 Diet 
All BMI groups 
Wolff 2008 Denmark 59 Diet 
BMI ≥ 30 
Yeo 2000 USA 16 Physical activity 
All BMI groups 
Yeo unpub USA 18 
Physical activity (2 
arms) 
All BMI groups 
Studies that did not contribute IPD 
Arthur 2016 Australia 400 Mixed approach All BMI groups 
Asbee 2009 USA 100 Mixed approach All BMI groups 
Aşcı 2016 Turkey 102 Mixed approach All BMI groups 
Badrawi 1993 Egypt 100 Mixed approach BMI ≥ 30 
Barakat 2012 Spain 83 Physical Activity All BMI groups 
Barakat 2013 Spain 428 Physical Activity All BMI groups 
Barakat 2014 Spain 200 Physical Activity All BMI groups 
Barakta 2015 Spain 765 Physical Activity All BMI groups 
Bisson 2015 Canada 45 Physical Activity BMI ≥ 30 
Blackwell 2002 USA 46 Diet All BMI groups 
Briley 2002 USA 20 Diet All BMI groups 
Brownfoot 2016 Australia 741 Mixed approach All BMI groups 
Bruno 2016 Australia   BMI ≥ 25 
Clapp 2000 USA 46 Physical Activity All BMI groups 
Cordero 2014 Spain 247 Physical Activity All BMI groups 
Daley 2015 UK 68 Mixed approach All BMI groups 
*Refers to sample size in IPD meta-analyses 
§Trials with randomisation by cluster 
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Study ID Country 
Sample 
size* 
Intervention BMI group 
Daly 2017 Ireland 88 Physical activity BMI ≥ 30 
Das 2015 USA 36 Diet All BMI groups 
de Oliveria Melo 
2012 
Brazil 171 Physical Activity All BMI groups 
Studies that did not contribute IPD (cont.) 
Dekker 2015 USA 35 Physical Activity BMI ≥ 30 
Deveer 2013 Turkey 100 Diet All BMI groups 
Di Carlo 2014 Italy 120 Diet All BMI groups 
Garnæs 2016 Norway 91 Physical activity BMI ≥ 25 
Garshasbi 2005 Iran 212 Physical Activity All BMI groups 
Gesell 2015 USA 87 Mixed approach All BMI groups 
Gomez Tabarez 1994 Colombia 60 Diet BMI ≥ 30 
Hawkins 2015 USA 68 Mixed approach BMI ≥ 25 
Herring 2016 USA 56 Mixed approach BMI ≥ 25 
Hopkins 2010 New Zealand 84 Physical Activity All BMI groups 
Huang 2011 Taiwan 125 Mixed approach All BMI groups 
Hui 2014 Canada 113 Mixed approach All BMI groups 
Jackson 2010 USA 287 Mixed approach All BMI groups 
Jing 2015 China 221 Mixed approach All BMI groups 
Kihlstrand 1999 Sweden 258 Physical Activity All BMI groups 
Ko 2016 USA 1,124 Physical Activity All BMI groups 
Koivusalo 2015 Finland 293 Mixed approach BMI ≥ 30 
Kong 2014 USA 37 Physical Activity BMI ≥ 25 
Korpi-Hyovalti 2012 Finland 54 Diet All BMI groups 
Lee 1996 UK 353 Physical Activity All BMI groups 
Marquez 2000 USA 15 Mixed approach All BMI groups 
McCarthy 2016 
Australia 371 Mixed approach BMI ≥ 25 




63 Physical Activity All BMI groups 
*Refers to sample size in IPD meta-analyses 
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Study ID Country 
Sample 
size* 
Intervention BMI group 
Studies that did not contribute IPD (cont.) 
Parat 2015 France 268 Diet BMI 25 – 29.9 
Peaceman 2017 USA 281 Mixed approach BMI ≥ 25 
Perales 2016a Spain 241 Physical activity All BMI groups 
Petrov Fieril 2015 Sweden 92 Physical activity All BMI groups 
Polley 2002 USA 110 Mixed approach BMI ≤ 30 
Price 2012 USA 62 Physical Activity All BMI groups 
Qiuling Li 2014 China 118 Mixed approach All BMI groups 
Quinlivan 2011 Australia 124 Diet BMI ≥ 25 
Rakhshani 2012 India 68 Physical activity All BMI groups 
Ramirez Velez 2011 Colombia 35 Physical Activity All BMI groups 
Ramirez Velez 2013 Colombia 20 Physical Activity All BMI groups 
Ronnberg 2014 Sweden 374 Physical Activity All BMI groups 
Santos 2005 Brazil 72 Physical Activity BMI 25 – 29.9 
Sedaghati 2007 Iran 90 Physical Activity All BMI groups 
Seneviratne 2015 New Zealand 74 Physical Activity BMI ≥ 25 
Simmons 2016 Europe 436 Mixed approach BMI ≥ 30 
Smith 2016 USA 45 Mixed approach All BMI groups 
Sun 2016 China 74 Mixed approach All BMI groups 
Thornton 2009 USA 232 Diet BMI ≥ 30 
Tomic 2013 
Croatia 334 Physical Activity All BMI groups 
Toosi 2016 
Iran 120 Physical Activity All BMI groups 
Vesco 2014 USA 114 Mixed approach BMI ≥ 30 
Wang 2016 
China 300 Physical Activity BMI ≥ 25 
Willcox 2017 Australia 100 Mixed approach BMI ≥ 25 
*Refers to sample size in IPD meta-analyses 
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Mean (SD) or N (%)# 
Age (years) 35 12006 30.1 (5.2) 30.0 (5.1) 
Age category 35 12006   
- 20+ years   5634 (97.4%) 6080 (97.7%) 
- Less than 20 years of age   151 (2.6%) 141 (2.3%) 
Height (cm) 31 11689 165.0 (7.0) 165.4 (6.7) 
Race/Ethnicity: 27 10020   
- Caucasian incl. Russia&Austr   4217 (87.2%) 4562 (88%) 
- Asian   156 (3.2%) 157 (3.0%) 
- Black   292 (6.0%) 292 (5.6%) 
- Central/South American   64 (1.3%) 67 (1.3%) 
- Middle East incl. Iran&Turkey   37 (0.8%) 37 (0.7%) 
- Other   68 (1.4%) 71 (1.4%) 
Education Mum l/m/h 29 8914   
- Low   724 (16.9%) 722 (15.6%) 
- Medium   1292 (30.2%) 1372 (29.6%) 
- High   2268 (52.9%) 2536 (54.8%) 
Current smoker 29 10958 865 (16.4%) 875 (15.4%) 
Ex-smoker (pre pregnancy) 13 4099 456 (23.8%) 523 (24.0%) 
Adherent (intervention group only) 18 3321 n/a 2022 (60.9%) 
Parity 33 11805   
- 0   2692 (47.3%) 3027 (49.5%) 
- 1   2083 (36.6%) 2136 (34.9%) 
- 2   634 (11.1%) 647 (10.6%) 
- 3   165 (2.9%) 179 (2.9%) 
- 4+   113 (2.0%) 129 (2.1%) 
No exercise / Sedentary 27 7583 1731 (47.6%) 1761 (44.6%) 
Baseline BMI category 34 12031   
- Normal (BMI 18.5-24.9)   1842 (31.8%) 1974 (31.7%) 
- Overweight (BMI 25-29.9)   1523 (26.3%) 1578 (25.3%) 
- Obese (BMI 30+)   2434 (42.0%) 2680 (43.0%) 
Previous macrosomia 8 2906 400 (29.1%) 390 (25.5%) 
Previous GDM 11 4297 49 (2.4%) 60 (2.9%) 
GDM 20 8256 14 (0.4%) 23 (0.6%) 
Diabetes Mellitus 25 9589 9 (0.2%) 6 (0.1%) 
PIH 20 5695 37 (1.3%) 47 (1.6%) 
Hypertension 23 5494 54 (2.1%) 73 (2.5%) 
Diabetes Mellitus or Hypertension 20 5124 57 (2.4%) 75 (2.8%) 
* Refers to total number of observations across all studies and treatment arms 1235 
















outcome data  
Selective reporting 
Arthur 2016 U U U U U U 
Asci 2016 L L U U L L 
Althuizen 2012 L L U L L U 
Asbee 2009 L L U U U H 
Baciuk 2008 L L H L L L 
Badrawi 1993 U U U U U U 
Barakat 2008 U U U L L L 
Barakat 2011 L U U U L L 
Barakat 2012 U U U U L L 
Barakat 2012a L U U U H L 
Barakat 2013 U U U L L L 
Barakat 2014 L U U U L L 
Barakat 2015 L L U L L L 
Bisson 2015 L L H L L L 
Blackwell 2002 H U U U H L 
Bogaerts 2012 L U H H L L 
Bruno 2016 L U H L H L 
Briley 2002 U U U U H L 
Brownfoot 2016 L L H U L L 
Clapp 2000 L U U U L L 
Cordero 2014 U U H U H L 
Daly 2017 U U H U H U 
Daley 2015 L L H H L L 
Das 2015 U U U U U U 
Dekker 2015 L L U U L L 
de Oliveria Melo 2012 L L H L L L 
Deveer 2013 H H U U L L 
Di Carlo 2014 U L H L U L 
Risk of bias: L – low  U – unclear  H – high    













outcome data  
Selective reporting 
Dodd 2014 L L U L L L 
El Beltagy 2013 L L U L L U 
Garshasbi 2005 U U U U L L 
Garnaes 2016 L L H L L L 
Gesell 2015 L L U U H L 
Gomez Tabarez 1994 U U U U L U 
Guelinckx 2010 L U U H H H 
Haakstad 2011 L L U L L H 
Harrison 2013 L L U L L L 
Hawkins 2015 U U U L L L 
Herring 2016 L L U U L L 
Hopkins 2010 U U U U H L 
Huang 2011 L U U L H L 
Hui 2011 L U H U L L 
Hui 2014 L U H L L H 
Jackson 2010 L L H U L L 
Jeffries 2009 L L U L L L 
Jing 2015 L U U L L L 
Kihlstrand 1999 U U H U L U 
Khaledan 2010 L U H H L L 
Khoury 2005 L L U L L L 
Ko 2014 L U U L L L 
Koivusalo 2016 L L U L U U 
Kong 2014 L L H U L L 
Korpi-Hyovalti 2012 L L H H L H 
Lee 1996 L U U U U H 
Luoto 2011 L L H H L L 
Marquez 2000 U U U U H H 
McCarthy 2016 L L H L L L 
Mujsindi 2014 U U U U U U 
Risk of bias: L – low  U – unclear  H – high    













outcome data  
Selective reporting 
Murtezani 2014 L U U U L L 
Nascimento 2011 L L H H L L 
Ong 2009 L U H H L L 
Oostdam 2012 L L H L H L 
Peaceman 2017 U U U L L U 
Parat 2015 U U U U L U 
Perales 2014 L L H L L L 
Perales 2016 L U U L H L 
Perales 2016a L U H L H L 
Petrella 2013 L H H H L H 
Phelan 2011 L L U L L L 
PetrovFieril 2015 L L H L H L 
Polley 2002 U U U U L L 
Poston 2015 L L H H L L 
Prevedel 2003 L L H H U L 
Price 2012  L L H U H U 
Li 2014 U U U U L L 
Quinlivan 2011 L L U L L L 
Rakhshani 2012 L L H L H L 
Ramirez Valez 2011 L L H L H L 
Ramirez Valez 2013 U U U U U U 
Rauh 2013 L L H H L U 
Renault 2013 L L H H L H 
Ronnberg 2014 L L H L L L 
Ruiz 2013 L U U U L U 
Sagedal 2016 L L U L L H 
Santos 2005 L U U U U L 
Sedaghati 2007 U U U U H L 
Seneviratne 2015 L L U U L L 
Simmons 2016 L L U L L L 
Risk of bias: L – low  U – unclear  H – high    













outcome data  
Selective reporting 
Smith 2016 U U U U L L 
Sun 2016 H H U U L L 
Stafne 2012 L L H H L L 
Tomic 2013 H H U U L L 
Toosi 2016 L U H U L L 
Wang 2017 U U H U L L 
Thornton 2009 L U U U L L 
Vesco 2014 L U U U L L 
Vinter 2011 L L H H L H 
Vitolo 2011 L H H L L H 
Walsh 2013 L L H U L H 
Wolff 2008 L L U H H L 
Willcox 2017 L L H U L L 
Yeo unpub  U U U U U U 
Yeo 2000 L L H L L L 
Risk of bias: L – low  U – unclear  H – high    
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Appendix 4.6 Funnel plots for meta-analyses of trials on diet and physical activity based 1242 
interventions 1243 
 1244 
Gestational weight gain 1245 
 1246 
 1247 
(A) Study-level of only IPD trials; (B) Individual Participant Data; (C) IPD and study-level;  1248 
(D) Study –level of all published trials 1249 
 1250 
Gestational diabetes  1251 
 1252 
 1253 
(A) Study-level of only IPD trials; (B) Individual Participant Data; (C) IPD and study-level;  1254 
(D) Study –level of all published trials 1255 
 1256 
  1257 
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 1258 
Preterm birth 1259 
 1260 
 1261 
(A) Study-level of only IPD trials; (B) Individual Participant Data; (C) IPD and study-level;  1262 
(D) Study –level of all published trials 1263 
 1264 
 1265 
Caesarean section 1266 
 1267 
 1268 
(A) Study-level of only IPD trials; (B) Individual Participant Data; (C) IPD and study-level;  1269 
(D) Study –level of all published trials 1270 
 1271 
  1272 
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Small for Gestational Age (SGA) 1273 
 1274 
 1275 
(A) Study-level of only IPD trials; (B) Individual Participant Data; (C) IPD and study-level;  1276 
(D) Study –level of all published trials 1277 
 1278 
 1279 
Large for Gestational Age (LGA) 1280 
 1281 
 1282 
(A) Study-level of only IPD trials; (B) Individual Participant Data; (C) IPD and study-level;  1283 
(D) Study –level of all published trials 1284 
 1285 
  1286 
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(A) Study-level of only IPD trials; (B) Individual Participant Data; (C) IPD and study-level;  1291 
(D) Study –level of all published trials 1292 
  1293 
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Appendix 4.7 Effect estimates derived from Individual Participant Data   1294 
Gestational weight gain 1295 
Study ID ES seES Sample size 
Althuizen 2012 0.450257 0.99408 191 
Baciuk 2008 -1.66513 1.319366 69 
Barakat 2008 -0.47299 0.592639 140 
Barakat 2012a -1.579053 0.487956 279 
Bogaerts 2012 -3.220636 1.046076 197 
Dodd 2014 -0.102647 0.276536 1586 
Guelinckx 2010 0.184219 1.085839 168 
Haakstad 2011 -0.72458 0.842061 82 
Harrison 2013 -0.568627 0.418545 213 
Hui 2011 -1.158225 0.891469 183 
Jeffries 2009 -0.788455 0.528606 232 
Khaledan 2010 -0.674955 0.680337 39 
Khoury 2005 -0.620036 0.502042 198 
Luoto 2011 -0.702901 0.550609 382 
Nascimento 2011 -0.46649 0.942019 80 
Ong 2009 -0.567741 1.299728 12 
Oostdam 2012 0.134949 0.950506 80 
Perales 2014 -1.197192 0.675496 164 
Petrella 2013 -3.749265 1.502137 61 
Phelan 2011 -0.515103 0.466411 389 
Poston 2015 -0.172835 0.528419 415 
Prevedel 2003 0.076834 0.853281 39 
Rauh 2013 -1.675133 0.607498 226 
Renault 2013 -1.041364 0.508377 376 
Ruiz 2013 -1.074056 0.264285 927 
Sagedal 2016 -0.768288 0.416029 575 
Stafne 2012 -0.258392 0.186998 725 
Vinter 2011 -1.132644 0.617247 292 
Vitolo 2011 -0.508094 0.444175 292 
Walsh 2012 -0.765013 0.358049 622 
Wolff 2008 -2.198558 1.13611 56 
Yeo 2000 -1.393053 2.068035 14 
ES, effect estimate (here: Mean Difference), seES, standard error of effect estimate,  1296 
  1297 
   
161 
Gestational diabetes 1298 
Study ID ES seES Sample size 
Barakat 2008 -0.36849469 0.3819699 140 
Barakat 2011 -0.19782574 0.5623516 67 
Barakat 2012a -0.68548432 0.515098 279 
Bogaerts 2012 0.08134555 0.4813407 197 
Dodd 2014 0.25264678 0.1349276 2199 
El Beltagy 2013 -17.577264 2864.9277 93 
Guelinckx 2010 0.89794013 1.1079748 170 
Harrison 2013 -0.11370972 0.3286657 150 
Hui 2011 -0.85629897 0.879438 178 
Jeffries 2009 0.1108539 0.4148326 257 
Khoury 2005 0.06317839 1.0070003 289 
Luoto 2011 0.46609731 0.2690104 391 
Nascimento 2011 -0.63990287 0.6271261 72 
Ong 2009 -18.461306 7279.2081 13 
Oostdam 2012 -0.55734566 0.5596459 102 
Perales 2014 -0.22314345 0.6530473 163 
Petrella 2013 -1.5998685 0.571972 61 
Poston 2015 -0.03682727 0.1267981 1305 
Rauh 2013 -0.88088878 0.5073073 234 
Renault 2013 -0.7602864 0.4621562 359 
Ruiz 2013 -0.6536812 0.318625 927 
Sagedal 2016 0.25837647 0.2809408 578 
Stafne 2012 0.28373445 0.3320668 698 
Vinter 2011 0.15262963 0.5000527 304 
Vitolo 2011 0.65232516 0.8152198 50 
Walsh 2012 -0.04000533 0.5542469 92 
Wolff 2008 -0.98941308 1.1858658 59 
ES, effect estimate (here: log odds ratio), seES, standard error of effect estimate 1299 
 1300 
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Preterm birth 1302 
Study ID ES seES Sample size 
Althuizen 2012 -0.629296 0.72201 197 
Baciuk 2008 -0.280302 0.946614 69 
Barakat 2008 1.371479 1.131208 140 
Barakat 2011 1.130361 1.181881 67 
Barakat 2012a 0.319782 0.51884 279 
Bogaerts 2012 0.364643 0.684917 197 
Dodd 2014 -0.254295 0.169831 2139 
El Beltagy 2013 -1.506923 0.82059 93 
Guelinckx 2010 0.532708 0.818466 177 
Haakstad 2011 0.581443 0.560164 101 
Harrison 2013 0.518587 0.496589 215 
Hui 2011 -0.840305 0.879046 183 
Jeffries 2009 -0.258955 0.447638 257 
Khoury 2005 -1.799033 0.773226 289 
Luoto 2011 0.996546 0.52278 394 
Nascimento 2011 1.482686 0.704326 78 
Oostdam 2012 -1.077106 1.173179 97 
Perales 2014 -0.49091 0.780328 165 
Perales 2016 0.405464 0.926634 163 
Petrella 2013 -19.44475 2259.364 61 
Phelan 2011 0.005698 0.341554 389 
Poston 2015 -0.05378 0.21302 1520 
Prevedel 2003 0.581922 1.269431 39 
Rauh 2013 -0.693148 0.648282 232 
Renault 2013 0.07238 0.505073 411 
Ruiz 2013 0.140046 0.336628 927 
Sagedal 2016 -0.007247 0.353403 586 
Stafne 2012 0.048833 0.327951 852 
Vinter 2011 0.168137 0.530756 304 
Vitolo 2011 -1.71778 0.640655 293 
Walsh 2012 -0.670092 0.711171 703 
Wolff 2008 0.17589 1.439 59 
ES, effect estimate (here: log odds ratio), seES, standard error of effect estimate 1303 
 1304 
  1305 
   
161 
Caesarean section 1306 
Study ID ES seES Sample size 
Althuizen 2012 -0.281182 0.364428 199 
Baciuk 2008 -0.530628 0.495164 70 
Barakat 2008 -0.067823 0.464495 140 
Barakat 2011 -0.517018 0.568658 67 
Barakat 2012a -0.535422 0.30806 279 
Bogaerts 2012 -0.239059 0.338778 197 
Dodd 2014 -0.089633 0.090508 2137 
El Beltagy 2013 -0.030772 0.452117 93 
Guelinckx 2010 0.178192 0.388622 177 
Haakstad 2011 -0.960743 0.66252 59 
Harrison 2013 0.863298 0.296343 215 
Hui 2011 -0.491408 0.926239 168 
Jeffries 2009 0.066182 0.269686 257 
Khaledan 2010 -0.711166 0.704462 39 
Khoury 2005 -0.538822 0.398729 289 
Luoto 2011 0.227199 0.303525 394 
Nascimento 2011 -0.315474 0.492255 78 
Oostdam 2012 -0.309661 0.579334 105 
Perales 2014 -0.610763 0.393796 165 
Petrella 2013 0.187599 0.542858 61 
Phelan 2011 -0.125789 0.238685 342 
Poston 2015 -0.035199 0.107015 1520 
Prevedel 2003 0.708651 0.653393 39 
Rauh 2013 -0.481158 0.287668 232 
Renault 2013 -0.242285 0.21886 414 
Ruiz 2013 -0.059256 0.170007 881 
Sagedal 2016 0.050169 0.248779 587 
Stafne 2012 -0.126525 0.217977 851 
Vinter 2011 0.069769 0.261587 304 
Vitolo 2011 -0.107631 0.250861 292 
Walsh 2012 -0.263815 0.192839 700 
Wolff 2008 -0.133531 0.812843 59 
ES, effect estimate (here: log odds ratio), seES, standard error of effect estimate 1307 
 1308 
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Large for gestational age  1310 
Study ID ES seES Sample size 
Althuizen 2012 0.064351 0.332771 229 
Baciuk 2008 0.544112 0.642315 70 
Barakat 2008 -1.390385 0.820693 140 
Barakat 2011 0.693147 1.25 67 
Barakat 2012a -1.237948 0.81097 279 
Bogaerts 2012 0.036716 0.562388 197 
Dodd 2014 -0.186563 0.127125 2199 
El Beltagy 2013 -2.404239 0.558057 93 
Guelinckx 2010 -0.471857 0.370974 195 
Haakstad 2011 0.293806 0.463687 101 
Harrison 2013 0.887707 0.373173 238 
Hui 2011 -0.237294 0.446524 183 
Jeffries 2009 -0.166303 0.312092 282 
Khaledan 2010 0.641854 0.976029 39 
Khoury 2005 -0.312756 0.360691 289 
Luoto 2011 -0.359532 0.268775 395 
Nascimento 2011 -0.435318 0.580941 82 
Oostdam 2012 1.910543 0.668601 105 
Perales 2014 -1.341843 0.83218 165 
Perales 2016 -0.012423 1.422971 163 
Petrella 2013 0.139262 0.811059 61 
Phelan 2011 -0.094738 0.259592 393 
Poston 2015 0.187199 0.193071 1554 
Prevedel 2003 -17.80793 3367.344 39 
Rauh 2013 0.395453 0.495525 244 
Renault 2013 -0.035516 0.285067 425 
Ruiz 2013 -0.608843 0.368008 927 
Sagedal 2016 -0.249216 0.267835 600 
Stafne 2012 0.106696 0.279196 854 
Vinter 2011 0.028987 0.396677 304 
Vitolo 2011 -0.398085 0.391981 301 
Walsh 2012 -0.007288 0.15375 759 
Wolff 2008 -0.282863 0.706121 59 
Yeo 2000 20.27408 4137.378 16 
ES, effect estimate (here: log odds ratio), seES, standard error of effect estimate 1311 
 1312 
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Small for gestational age  1315 
Study ID ES seES Sample size 
Althuizen 2012 -0.251659 0.425426 197 
Baciuk 2008 0.837247 0.680559 69 
Barakat 2008 0.7817 0.449593 140 
Barakat 2011 0.287682 0.806226 67 
Barakat 2012a -0.214255 0.304595 279 
Bogaerts 2012 0.04025 0.416234 197 
Dodd 2014 0.011783 0.145345 2137 
El Beltagy 2013 0.307827 0.939271 87 
Guelinckx 2010 -0.439672 0.609046 177 
Haakstad 2011 0.508119 0.684167 88 
Harrison 2013 0.405465 0.375859 215 
Hui 2011 0.188836 0.468184 183 
Jeffries 2009 -0.274199 0.384784 256 
Khaledan 2010 -21.63677 7868.748 39 
Khoury 2005 -0.089034 0.398805 287 
Luoto 2011 0.286462 0.461252 394 
Nascimento 2011 -1.292768 0.631236 78 
Oostdam 2012 0.105361 0.50277 96 
Perales 2014 0.771351 0.417465 163 
Perales 2016 0.398496 0.374174 163 
Petrella 2013 -0.897942 0.763211 58 
Phelan 2011 -0.172658 0.461765 377 
Poston 2015 0.266571 0.138488 1520 
Prevedel 2003 -0.17185 1.055998 39 
Rauh 2013 -0.728239 0.520752 231 
Renault 2013 -0.012526 0.317471 411 
Ruiz 2013 -0.001215 0.179354 927 
Sagedal 2016 0.401208 0.345554 586 
Stafne 2012 -0.192311 0.250363 852 
Vinter 2011 -0.103022 0.374503 303 
Vitolo 2011 -0.099271 0.331179 290 
Walsh 2012 -0.098542 0.523154 701 
Wolff 2008 0.17589 1.439 59 
ES, effect estimate (here: log odds ratio), seES, standard error of effect estimate 1316 
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Admission to Neonatal Intensive Care Unit 1319 
Study ID ES seES Sample size 
Bogaerts 2012 0.7815578 0.65979291 195 
Dodd 2014 -0.041112 0.25569686 2199 
Guelinckx 2010 13.797323 1834.2978 182 
Harrison 2013 0.3676373 0.32001206 215 
Jeffries 2009 -0.0521861 0.4138228 256 
Khoury 2005 -1.4736638 0.65185031 289 
Luoto 2011 0.1633553 0.29298172 391 
Oostdam 2012 -0.7024785 0.52340718 62 
Petrella 2013 -0.1758908 1.0347559 61 
Phelan 2011 -0.0632624 0.38672555 378 
Poston 2015 0.1279526 0.19045119 1554 
Rauh 2013 11.624728 486.09195 231 
Renault 2013 0.5050779 0.581917 399 
Sagedal 2016 -0.011788 0.24594802 585 
Stafne 2012 -0.3301969 0.35919882 839 
Vinter 2011 -0.0235308 0.32924349 304 
ES, effect estimate (here: log odds ratio), seES, standard error of effect estimate 1320 
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Appendix 4.8 Effect estimates and their precision for binary outcomes derived from the study-1323 
level meta-analysis with numbers of randomised as a reference sample size 1324 
 1325 
Outcome 
Number of studies 
(Number of participants) 
Odds ratio (95% CI) 
Gestational diabetes 50 (18 457) 0.75 (0.64, 0.89) 
Caesarean section 58 (17 406) 0.90 (0.84, 0.97)* 
Preterm birth 34 (12 444) 0.80 (0.67, 0.95) 
Large for gestational age  21 (7 451) 0.82 (0.62, 1.10) 
Small for gestational age  16 (4 459) 1.10 (0.87, 1.40) 
Admission to NICU 10 (7 063) 0.99 (0.85, 1.15) 
 *DerSimonian and Laird method; REML did not converge;  1326 
 1327 
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Appendix 4.9 Forest plots with the individual effect estimates derived from study-level data 1329 
Gestational weight gain  1330 
  1331 
  1332 
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Gestational diabetes 1333 
 1334 
  1335 
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Preterm birth 1336 
 1337 
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Caesarean section 1339 
 1340 
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Large for gestational age  1342 
 1343 
Small for gestational age  1344 
 1345 
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Appendix 4.10 Detailed characteristics of studies that provided Individual Participant Data 1350 
Study Year 
Language 





 First pregnancy 
 Ability to read, write and 
speak Dutch; 
 Gestational age less than 14 
weeks 
 
Number of participants  
Intervention 123 
Control 123 
Two personal counsellors with a background in physical 
activity or remedial education provided 5 counselling 
sessions at 18, 22, 30, 36 weeks gestation and at 8 weeks 
postpartum. Principles of a psychological intervention 
method called ‘problem-solving treatment for primary 
care’ were used. Sessions lasted for 15 minutes except 
the first that lasted 30 minutes. A general information 
brochure was provided after the first session. The 
sessions were aimed at making the participants aware of 
issues related to weight gain in pregnancy including IOM 
guidelines. Weight gain charts specific to BMI categories 
with markings to show recommended weight gain (IOM 
guidelines) were provided. Dietary advice provide as per 
Dutch nutrition centre guidelines with emphasis on 
healthy eating, adjusting energy intake to activity levels 
and decreasing intake of high fat food. Physical activity 
was assessed by questionnaires and general information 
provided. Specific individualized activities were 
discussed in those not meeting physical activity 
guidelines. The American Centre for Disease Control 
and Prevention guidelines formed the basis for physical 
activity counselling. The last counseling session 
(telephone) focused on delivery, breast feeding, care of 
the new born along with physical activity and diet. 
The counselors were trained for the study by recording 
conversations with 10 pregnant women followed by 
feedback on performance by other members of the 





Standard Care Primary 
 Change in body weight and body 
mass index (measured at 15, 25 
and 35 weeks of pregnancy and at 
7, 25 and 51 weeks postpartum) 




 Physical activity by Short 
Questionnaire to Assess Health 
enhancing physical activity 
(SQUASH) and accelerometer 
data 
 Questionnaire for nutrition and 
related behaviours (Dutch eating 
behavior questionnaire) 
 Leptin, ghrelin, fasting glucose, 
insulin, cortisol insulin growth 
factor 1, insulin growth factor 
binding proteins 1 and 3 from a 
subgroup of participants and cord 
blood. 









 Singleton and 
uncomplicated pregnancy  
 Not at high risk for preterm 
delivery (no history of 
recurrent spontaneous 
preterm birth, i.e., number 
of previous preterm 
deliveries ≤1) 
 Age 25–35 years 
 Sedentary before gestation 
(not exercising > 20 min on 
> 3 days/week) 
 
Exclusion criteria: 
 Not being under medical 
follow-up throughout the 
entire pregnancy period  
 Women not planning to give 
birth in the same obstetrics 
hospital associated with the 
study 
 Women with any serious 
medical condition 
preventing them from 
exercising safely 
 
Number of participants  
Intervention 80 
Control 80 
The programme consisted of 35-40 minute sessions 
thrice weekly from 12-13 weeks gestation to end of 
pregnancy (38-39 weeks) with an estimated average of 
80 sessions per participant). They were supervised by a 
trained fitness specialist with each group consisting of 
10-12 women. The venue was spacious and well-lit with 
favourable conditions (altitude 600 m, temperature 19 – 
21 degree C and humidity 50 – 60%). The sessions were 
accompanied by music. The exercise activity was of light 
to moderate intensity with a target heart rate of ≤ 80% of 
maximum predicted heart rate for age (220-age). All 
participants were provided heart rate monitors. Each 
session included warm-up (8 minutes), core session (20 
minutes) and a cool-down period (8 minutes). Warm-up 
and cool-down components involved light stretching 
exercises for limbs, neck and trunk.  Additionally, the 
cool-down period included relaxation exercises.  
The core portion involved toning and very mild 
resistance exercises. Toning included shoulder shrugs 
and rotations, arm elevations and leg lateral elevations, 
pelvic rocks and tilts.  The resistance exercises included 
one set of (10– 
12 repetitions of each of i) abdominal curls and ii) the 
below exercises using barbells (3 kg/exercise) or low-to-
medium resistance bands: biceps curls, arm side lifts and 
extensions, shoulder elevations, bench press, seated 
lateral row, leg circles and  lateral leg elevations, knee 
(hamstring) curls and extensions, ankle flexions and 
extensions. 
Exercises such as jumping, ballistics, extreme stretching 
and joint overextension were avoided 
The women were 
asked to maintain 
their level of activity 
 Gestational weight gain (Weight 
before delivery minus weight 
before pregnancy) 
 Preterm deliveries 
 Birth weight 
 Macrosomia 
 Birth length 
 Head circumference 
 Ponderal index, 
 Apgar score 1 min, 
 Apgar score 5 min, 
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 Absolute obstetrical 
contraindication to exercise 
[(as per American College 
of Obstetricians and 
Gynecologists (2002)]  
 Plans to deliver baby 
elsewhere 
 Not receiving antenatal care 
throughout the pregnancy 
 Participating in another 
physical activity program 
 Regular exercise before 
pregnancy (four or more 
times per week). 
 
Number of participants  
Intervention 160 
Control 160 
The programme consisted of 40 - 45 minute sessions 
thrice weekly from 6-9 weeks gestation to end of 
pregnancy (38-39 weeks) with an estimated average of 
85 sessions per participant). The participants were 
supervised by a trained fitness specialist with each group 
consisting of 10-12 women. The venue was spacious and 
well-lit with favourable conditions (altitude 600 m, 
temperature 
19 – 21 degree C and humidity 50 – 60%). The sessions 
were accompanied by music. 
The exercise activity was of light to moderate intensity 
with a target heart rate of ≤ 70% of maximum predicted 
heart rate for age (220-age). All participants were 
provided heart rate monitors. Each session included 
warm-up (7-8 minutes), core session (25 minutes) and a 
cool-down period (7-8 minutes). Warm-up and cool-
down components involved light stretching exercises for 
limbs, neck and trunk.  
The core portion included exercises for arms and 
abdomen and aerobic dance to improve posture, 
strengthen muscles of labour and pelvic floor and 
prevent lower back pain.  
Exercises such as jumping, ballistics, extreme stretching 
and joint overextension were avoided. Supine exercises 
were limited to a maximum of 2 minutes and exercises 
involving Valsalva maneuver were avoided.   Care was 
taken to ensure adequate nutrition prior to exercise 
sessions 
 
Usual care  Type of delivery (Normal, 
instrumental, Caesarean) 
 Gestational age at delivery 
 Preterm delivery (<37 weeks) 
 Maternal weight gain 
 Blood pressure 
 1-hour glucose tolerance test 
 Gestational diabetes 
 Birth weight/length 
 pH of the umbilical cord blood 
 Apgar score 
 









 Singleton, live gestation 
between 10 to 20  weeks 
gestation 
 Obese or overweight at their 
first antenatal visit. 
 
Exclusion criteria:  
 
 Multiple pregnancy 
 Pre-existing type 1 or 2 
diabetes  
 
Number of participants  
Intervention 1108 
Control 1104 
Intervention: A combination of dietary, exercise and 
behavioral strategies, delivered by a research dietician 
and trained research assistants. Balanced diet containing 
carbohydrates, fat and protein was encouraged. They 
were asked to reduce refined carbohydrates and saturated 
fats, and increase intake of fiber, and consume two 
serves of fruit and five serves of vegetables each day. 
Women were encouraged to adopt a more active 
lifestyle, mainly by increasing the amount of walking. 
Interventions were tailored by stage theories of health 
decision making that suggests individuals’ progress 
through a series of cognitive phases when undertaking 
behavioral change. Initially, as part of a planning session 
with a research dietician, women were given written 
dietary and activity information, tailored diet and 
physical activity plan, a diary and recipe book. Women 
were encouraged to set their own goals for lifestyle 
changes and monitor their progress with support from the 
research team.  
They were also asked to identify the barriers to achieving 
their goals. They were supported at regular intervals 
throughout their pregnancy, by the research dietician (at 
28 weeks’  gestation) and trained research assistants 
(telephone calls at 22, 24, and 32 weeks’  gestation and a 
face-face interview at 36 weeks’  gestation). 
Usual hospital 
guidelines, with no 
routine provision of 




 Large for gestational age infant 




 Preterm birth (< 37 weeks 
gestation); 
 Mortality (stillbirth or infant 
death) 
 Death of a live born infant prior 
to hospital discharge, and 
excluding lethal congenital 
anomalies 
 Congenital anomalies; 
 Infant birth weight ≥  4000 
grams; 
 Hypoglycaemia requiring 
intravenous treatment 
 Admission to NICU or SCBU 
 Hyperbilirubinaemia requiring 
phototherapy; 
 Nerve palsy 
 Fracture 
 Birth trauma 
 Shoulder dystocia. 
 Maternal hypertension and pre-
eclampsia 
 Maternal gestational Diabetes 
 Antenatal hospital stay 
 Antepartum haemorrhage 
requiring hospitalisation; 
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 Preterm prelabour ruptured 
membranes; 
 Chorioamnionitis requiring 
antibiotic use during labour; 
 Need and reason for induction of 
labour 
 Any antibiotic use during labour 
 Caesarean section; 
 Postpartum haemorrhage (defined 
as blood loss ≥ 600 mL);  
 Perineal trauma 
 Wound infection; 
 Endometritis 
 Use of postnatal antibiotics 
 Length of postnatal hospital stay; 
 Thromboembolic disease 
 Maternal death 
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 Obese (BMI >29.0, IOM 
criteria) 
 White women with 
gestational age less than 15 
weeks consecutively 




 Pre-existing diabetes or 
developing GDM 
 Multiple pregnancy 
 Gestational age > 15 weeks 
 Premature labour (< 37 
weeks) 
 Special nutritional needs 
such as metabolic disorder, 
allergic conditions kidney 
problems and Crohn disease  
 Suboptimal knowledge of 
Dutch language 
 
Number of participants  
Intervention (Active) 65 
Intervention (Passive) 65 
Control  65 
Lifestyle intervention based on a brochure or on active 
education; 
Passive group: Provided with a brochure containing 
information on diet, physical activity and tips to limit 
gestational weight gain at the first antenatal consultation.  
Active group: Received same brochure and also actively 
counselled by a trained nutritionist (IG) in 3 group 
sessions at 15, 20, and 32 weeks gestation. The sessions 
had up to 5 women and lasted one hour each. 
Counselling on balanced diet was based on the official 
National Dietary Recommendations (Energy intake: 9 - 
11% proteins, 30 -35% fat, and 50 - 55% carbohydrates). 
Aim was to limit intake of energy-dense foods, replacing 
with healthier alternatives such as fruits, increasing 
whole-wheat grains and low-fat dairy products, and 
reducing saturated fatty acids. General topics such as 
energy balance, body composition, food labels, and 
physical activity were discussed. Tips for behavioral 
modification to reduce emotional eating and binge 
eating, were provided. Total energy intake was not 
restricted in any group but aimed to do so indirectly by 
limiting the intake of energy-dense foods. Nutritional 
data were obtained from 7-d dietary records. A Physical 
Activity score was calculated for each trimester of the 
pregnancy by using the Baecke questionnaire. 
No intervention  Pregnancy-induced hypertension, 
preeclampsia, chronic 
hypertension 
 GWG in accordance with IOM 
 GWG >11.2 kg, (weight gain 
from prepregnancy to 38 weeks) 
 Gestational age at delivery 
 Induction of labour 
 Caesarean section  
 Birth weight/length  
 Macrosomia (Birth 
weight>4000g) 
 Total physical activity score  
 









 Gestational age 12-15 
weeks  
 Overweight (body mass 
index; BMI ≥ 25 or ≥ 23 
kg/m2 if high-risk ethnicity 
[Polynesian, Asian, and 
African populations] or 
obese (BMI ≥ 30 kg/m2), 
 Increased risk of GDM as 
per a validated risk 
prediction tool.   
 Willing to complete an oral 
glucose tolerance test at 28 
weeks gestation instead of 
the standard glucose 




 Multiple pregnancies  
 Type 1 or 2 diabetes 
 BMI ≥ 45 kg/m2 
 Preexisting 
 chronic medical conditions  
 Non-English-speaking 
 
Number of participants  
Intervention 121 
Control  107 
Individual four sessions behavior change lifestyle 
intervention in antenatal clinic setting at 14-16, 20, 24, 
and 28 weeks gestation. The intervention was based on 
the Social Cognitive 
Theory, adapted from the study group’s earlier lifestyle 
intervention program (HeLP-her).  
The sessions were delivered by a  
health coach (exercise physiologist)  
Healthy eating and physical activity was encouraged 
along with specific dietary advice in pregnancy. 
Behavioral change strategies were aimed at identifying 
short-term goals and promoting self-efficacy and self-
monitoring. 
Goals included lifestyle changes such as reducing high 
fat or convenience foods, increasing fruit/vegetable 
intake, and increasing frequency of physical activity. 
Participants themselves set goals. 
Pedometers and weight gain charts based on IOM 
recommendations were provided to monitor the progress. 
Written Australian dietary and physical activity 
guidelines and other resources to encourage optimal 
health, GWG, and lifestyle were provided 
A single brief 
education session 
based on Australian 
Dietary and Physical 
Activity Guidelines 
was provided along 
with written versions 
of guidelines.  




 Gestational weight gain (weight 
was measured at baseline; 12, 16 
and 28 weeks gestation 
 
Secondary 
 Diagnosis of GDM as per 
Australasian Diabetes in 
Pregnancy Society (ADIPS) 
criteria. IADPSG criteria were 
also evaluated       
 Physical activity using pedometer 
and International physical activity 
questionnaire (IPAQ)    
 Risk perception for GDM 
development and excess 
gestational weight gain (four-
point Likert scale adapted from 
the theory of health Stage of 
Change was used) 
 
   
161 
  1354 
Study Year 
Language 




Pregnant women with 
gestational age ≤ 14 weeks 
gestation 
Exclusion criteria: 
 Age <18 or >45 years  
 Non-English speaking 
 Multiple pregnancy 
 Type 1 or 2 diabetes 
mellitus 
 
Number of participants  
Intervention 148 
Control  138 
Women allocated to the intervention group were given 
personalized weight measurement card including 
information on optimal gestational weight gain (based on 
their BMI at the time of recruitment and the US Institute 
of Medicine guidelines) and were asked to record their 
weight at 16, 20, 24, 28, 30, 32, and 34 weeks’ gestation.  
Particpant was allowed to choose to measure weight at 




 Gestational weight gain- weekly 
and total from 11 weeks to 
delivery (and compliance with 
IOM recommendation) 
 Birth weight  
 SGA and LGA (weight< 10 
centile and >90 centile) 
 Preterm delivery 
 Instrumental delivery 
 Caesarean delivery 
 Pre-eclampsia 
 Pregnancy-induced hypertension 
 Gestational Diabetes Mellitus 
 Apgar score <7 at 5 min 
 Hypoglycaemia 
 Shoulder dystocia 
 Gestational age at delivery 









 BMI of 19 to 32 kg/m2 
 Non-smokers or ex-smokers 
(quit ≥ 5 years ago) 
 Not immigrants to Norway 
from non-Western countries   
 Single healthy fetus at 17-20 
weeks gestation on 
ultrasound 
 No previous pregnancy 
complications 
 Not vegetarian or following 
a Mediterranean-type diet 
 
Exclusion criteria: 
 High-risk pregnancies 
caused by: diabetes, 
endocrine disease, 
hypertension, drug abuse, 
thromboembolic disease or 
significant cardiac, 
gastrointestinal, pulmonary, 
or hematologic disease 
 History of neonatal death, 
stillbirth, preterm delivery, 
or recurrent abortion (more 
than 3 previous spontaneous 
abortions) 
  
Number of participants  
Intervention 141 
Control 149 
Diet/dietary advice – cholesterol-lowering diet from 
gestational week 17 to 20 to birth. 
Dietitian visits were arranged at inclusion, and at 24, 30, 
and 36 weeks gestation. 
Aims of dietary intervention were to: 
 Limit dietary cholesterol to 150 mg/day 
 Reduce the intake of saturated fat to 8% of dietary 
energy 
 Target total fat 32% of total energy intake (including 
8%-9% of energy from polyunsaturated fat and 16%-
17% from monounsaturated fat), protein 16% to 17% 
of energy, and carbohydrates 50% to 51% of energy. 
 Tailor energy intake for target at a weight gain of 8 to 
14 kg from prepregnancy levels. 
 Encourage the intake of fatty fish, vegetable oils, 
mainly olive oil and rapeseed oil, nuts, nut butters, 
margarine based on olive- or rapeseed oil, 
 At least 6 a day of fresh fruits and vegetables was 
advised (at least 6 a day) 
 Prefer low-fat dairy products 
 
Subjects were advised to have meat for a main meal 
twice a week and use legumes, fatty fish, poultry etc on 
other days. 
Cooking lessons were arranged for special foods. Coffee 
was limited to 2 cups/day. 
Control group was 
advised to consume 
their usual diet, not to 
introduce more oils, 
low-fat meat and 
dairy products than 
usual; Target weight 
gain was 8-14 kg and 
energy intake 
breakdown of fats, 
carbohydrate and 
proteins was same as 
intervention group. 
 Gestational age at delivery  
 Preterm delivery 
 Maternal weight gain between 
inclusion and week 30 
 Preterm stillbirth 
 Intrauterine growth restriction 
 Hypertensive complications 
(pregnancy induced hypertension/ 
preeclampsia 
 Fetal distress 
 Birth weight 
 Maternal and neonatal lipid 
profile  
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 Pregnancy  
 Pre-pregnancy overweight 
(BMI 26.0–29.9 kg/m2) or 
obesity (BMI ≥ 30.0 kg/m2) 
 Age ≥ 18 years 
 Gestational age 14 to 24 




 Multiple pregnancy 
 Exercising regularly 
 Contraindications for 
exercise, such as cervical 
incompetence, severe 
hypertension, diabetes with 
vascular complications and 
risk of abortion. 
 
Number of participants 
Intervention 39 
Control 41 
Exercise protocol; Women performed exercise weekly 
under the guidance of a trained physical therapist. The 
exercises were light to moderate intensity exercises, with 
heart rates note exceeding 140 beats per minute.  
(ACOG recommendations). Standardised research 
protocol consisting of 22-exercise sequence was 
followed. Group or individual exercises lasted 40 
minutes with 10 minutes of general stretching, 22 
minutes of exercises to strengthen the limb muscles, and 
10 minutes of guided relaxation.  
Home exercise counseling. Women were counseled on 
home exercise to be done 5 times/week, with exercises 
from the protocol or walking. They were required to note 
the details of daily exercise in a monthly exercise book. 
Routine antenatal 
advice and standard 
nutritional 
counselling. They 




 Gestational weight gain 
 Excessive maternal weight gain 
 
Secondary 
 Increased blood pressure 
 Perinatal outcomes – caeserian 
section, newborn weight, 
gestational age at delivery, 
preterm birth, Apgar scores at 1 
and 5 minutes, LGA,  SGA 
 Quality of life (WHOQOL –
BREF questionnaire) 
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Participants Interventions Control Outcomes 
Ong 2009 
English 
Inclusion criteria:  
 Singleton pregnancy 
 Normal 18 week anatomy 
scan 
 No evidence of 
cardiovascular disease 
 No preexisting diabetes 
 
Number of participants 
Intervention 6 
Control  6 
Physical activity: home-based exercise programme 
beginning at week 18 of gestation Three sessions per 
week of stationary cycling – home-based supervised 
exercise; Exercise training was performed at home on an 
upright stationary cycle ergometer provided to each 
participant for the study period. Each session consisted 
of a 10 min warm-up followed by one or two 15 min 
bouts of cycling (with rest periods if necessary). Exercise 
intensity was controlled by heart rate initially aimed at 
50–60% HRmax and later increased to 60–70% HRmax. 
The duration was later increased to 40–45 min. Sessions 
ended with a 10 min cool-down period of slow pedalling. 
 
No intervention  Weight gain from 18 to 28 weeks 
 Post-intervention glucose and 
insulin levels on oral glucose 
tolerance test 
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 Pregnant women living in 
Madrid, Spain who 
underwent ultrasound 





 Absolute obstetrical 
contraindication to exercise 
(as per American College of 
Obstetricians and 
Gynecologists (2002) 
 Plans to deliver baby 
elsewhere 
 Not receiving antenatal care 
throughout the pregnancy 
 Participating in another 
physical activity program 
 Regular exercise before 
pregnancy (four or more 
times per week). 
 
Number of participants  
Intervention 101 
Control  83 
 
The program consisted of three 55-60 minutes sessions 
thrice weekly from 9-12 weeks gestation to end of 
pregnancy (39-40 weeks gestation). Each session 
consisted of warm-up (5-8 minutes), aerobic dance and 
resistance exercises for muscle groups of legs, buttocks 
and abdomen to stabilize the lower back (25 minutes), 
balancing exercises (10 minutes), pelvic floor muscle 
training (10 minutes) and a cool-down (5-8 minutes). 
Exercises in supine position were limited to 2 minutes 
and extreme stretching, jumping, ballistic movements, 
overextension of joints and exercises involving valsalva 
maneuver were specifically avoided.  
The exercise intensity was light to moderate and was 
guided by the target heart rate (55-60% of maximum 
heart rate) for each participant displayed on a poster. All 
participants wore heart rate monitors during exercise 
sessions. Karvonen’s formula based on trimester, 
physical condition and age was used to calculate 
maximum heart rate. Borg scale ratings were also used to 
adjust the intensity of exercise. Sessions had groups of 
10-12 women and were supervised by a qualified fitness 
specialist and assisted by an obstetrician. The venue was 
a spacious well-lit room in a hospital (altitude 600 m, 
temperature 19–21 degrees C, and humidity 50 –60% ) 
and sessions were accompanied by music. Care was 
taken to ensure adequate nutrition prior to exercise 
sessions. 
Usual care  Center for Epidemiologic Studies 
Depression Scale (CES-D) 
questionnaire for depression at 9-
12 weeks gestation and end of 
pregnancy 
 Gestational weight gain 
 Percentage of women with 
excessive weight gain (as per 
IOM guidelines) 
 Percentage of women with 
adequate weight gain (as per IOM 
guidelines) 
 Gestation age at delivery 
 Mode of delivery (Normal, 
instrumental, Caesarian section) 
 Birth weight 
 Birth length 
 Head circumference 
 APGAR score at 1 minute 
 APGAR score at 5 minutes 









 Women with singleton 
pregnancies,  
 pre-pregnancy BMI ≥ 25 
kg/m2 and age > 18 years 
were  recruited during 
twelfth week of gestation 




 Twin pregnancy 
 Chronic conditions such as 
diabetes mellitus, 
hypertension and untreated 
thyroid diseases 
 Other medical conditions 
known to affect body weight 
 Previous  gestational 
diabetes mellitus 
 Smoking during pregnancy 
 Previous bariatric surgery 
 Women who just started 
regular physical activity, or 
used  herbal products or 
dietary supplements known 
to affect body weight, 
 
Number of participants  
Intervention 33 
Control  30 
Diet: The intervention group diet was initiated at 
randomisation by a gynecologist and a dietitian who 
provided further 1-hour counseling on recommended 
weight gain in pregnancy for each BMI category. The 
calorie allowance was 1500 kcal/day with an extra 200 
kcal/day for obese women and 300 kcal/day for 
overweight women to account for physical activity 
program. The target diet composition was 55% 
carbohydrate (80% complex, low-Glycemic Index), 20% 
protein (50% animal and 50% vegetable) and 25% fat 
(12% mono-unsaturated, 7% poly-unsaturated and 6% 
saturated fat) given as three main meals and three snacks. 
The last snack was 2 hours after dinner to prevent 
overnight hypoglycaemia. 
The minimum recommended intake of carbohydrates 
was 225 g/day. Urine was examined for ketonuria thrice 
during pregnancy. 
 
Exercise: The exercise intervention was in line with 
recommendations for the general population. Women 
were advised 30 min of moderate intensity activity for a 
minimum of 3 days a week. Adherence was checked by a 
pedometer. Women were advised that the exercise 
intensity should allow them to maintain a conversation 
(‘talk test’) 
The Control group 
received a simple 
nutritional booklet 
based on Italian 
guidelines for a 
healthy 
diet during pregnancy 
Primary  
 
 Rate of women with weight gain 
exceeding the ranges 
recommended by IOM for each 




 Diagnoses of gestational diabetes 
mellitus  
 Gestational hypertension 
 Rate of preterm delivery.  
 











Women with singleton 
pregnancy between 15 to 18+6 
weeks gestation and BMI ≥ 30 




 No informed consent 
 Outside 15 to 18+6 weeks 
gestation 
 Multiple pregnancy 
 Medical disorders including 
essential hypertension 
requiring treatment, pre-
existing renal disease, 
systemic lupus 
erythematosus, sickle cell 
disease, antiphospholipid 
syndrome, thalassemia, 
coeliac disease, thyroid 
disease 
 Current psychosis 
 On metformin. 
 
Number of participants  
Intervention 783 
Control  772 
One-to-one interview at baseline with a health trainer 
specifically trained for the study, followed by 8 weekly 
sessions of 1 to 1.5 hours each. Women are encouraged 
to attend all and strongly recommended to attend a 
minimum of 5 sessions with other sessions covered by 
phone or email. Health trainers cover specific goal 
setting, self-monitoring, and feedback on performance, 
problem solving and use of social support. Women were 
provided with handbook, DVD of recommended exercise 
regime, pedometer, logbook for recording weekly goals 
and steps achieved through pedometer. 
Exercise advice: to increase pedometer steps and daily 
activity incrementally; moderate activity in the form of 
walking  encouraged in line with UKRCOG 
recommendations, with more options depending on 
baseline activity 
Diet: To promote healthier eating with no restriction of 
calories, substitute low-GI for medium/high-GI food, 
restrict sugar-sweetened beverages but not fruit and 
reduce saturated fatty acid intake.  
Routine antenatal 
care, explaining the 
risks of obesity, 
advising on  healthy 
diet and safe levels of 
physical activity 
Primary: 
 Diagnosis of gestational diabetes 
according to IADPSG criteria 
 Large for gestational age baby 




 Mode of delivery 
 Induction of labour 
 Blood loss at delivery 
 Inpatient nights 
 Gestational weight gain 
 Fasting glucose, insulin, Insulin 
resistance at 28 weeks gestation 
 Insulin or metformin treatment in 
pregnancy 
 Quality of life 
 Anthropometry including mid-
arm, hip, thigh circumference and 
skin-fold thickness 
 Diet and physical activity 
 Depression 
 Smoking 
 Birthweight of baby 
 Gestational age at delivery 
 Neonatal death 
 Neonatal complications 
 Baby’s anthropometry including 
head/abdominal circumference 
and skin-fold thickness 
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 Age > 18 years 
 Singleton pregnancy  
 Gestational age < 18 weeks  
 BMI: ≥  18.5 kg/m2 
 Language skills:      




 Contraindication to physical 
activity, such as cervical 
incompetence, placenta 
praevia, or persistent 
bleeding.  
 Prepregnancy diabetes  
 Uncontrolled chronic 
diseases affecting weight 
such as thyroid dysfunction 
or psychiatric diseases 
 
Number of participants  
Intervention 4 practices (167) 
Control  4 practices (83) 
The intervention group received two individual 
counseling modules at 20th and 30th weeks of gestation, 
the first session lasting 60 minutes and the second 30 
minutes. General lifestyle advice including nutrition, 
physical activity and appropriate gestational weight gain 
was provided. Healthy nutrition and energy balance as 
per German Nutrition Society were explained. The 
dietary goals were to reduce the intake of high-fat and 
energy dense foods and increase the intake of low-fat 
foods and fruits, whole grain foods and vegetables. 
Women were encouraged to consume more fish and 
advised regarding appropriate fat/cooking oil/spreads.  
Physical activity equivalent to 30 minutes of moderate 
intensity exercises on most days was recommended. 
Non-weight bearing endurance exercises such as 
walking, swimming, aquatic exercises and cycling were 
suggested. Women were also provided with information 
on local antenatal exercise programs and encouraged to 
join them. The exercise recommendations were based on 
the guidelines of American College of Obstetricians and 
Gynecologists (ACOG) and Society of Obstetricians and 
Gynecologists (SOGC) of Canada.  
Women were provided with personalized weight charts 
as per BMI category including IOM recommendations 
for that category. They were asked to monitor their 
weights on a weekly basis. 
The individual counseling sessions also provided 
personalized feedback on diet and physical activity based 
on the 7-day records of diet and physical activity 
questionnaires 
Routine antenatal 
care including an 
information leaflet 
consisting of ten 
general statements on 
a healthy lifestyle 
during pregnancy not 
including advice on 




 Proportion of pregnant women 
exceeding IOM recommendations 




 Postpartum weight retention 
(Self-reported weight at 4 months 
postpartum minus prepregnancy 
weight) 
 Birth weight 
 Birth length 
 Gestational diabetes/ Impaired 
glucose tolerance 
 Mode of delivery (spontaneous, 
caesarian, vacuum) 
 Induction of labour 
 Preterm delivery 
 Infant sex 
 Large for gestational age 
 Small for gestational age 









 Sedentary (not exercising > 
20 min on > 3 days a week 
 Singleton 
 Uncomplicated pregnancy 
 Not at high risk of preterm 
delivery ( ≤ previous 
preterm delivery) 





 Contraindication to exercise 
 
Number of participants  
Intervention 481 
Control  481 
The programme consisted of supervised 50-55 minute 
physical activity sessions thrice weekly from week 9 to 
weeks 38-39 with an estimated average of 85 sessions 
per participant. Each group consisting of 10-12 women. 
The exercise activity was of light to moderate intensity 
with a target heart rate of ≤ 60% of maximum predicted 
heart rate for age (208-[0.7 x age in years]). All 
participants were provided heart rate monitors. Intensity 
was also guided by Borg’s conventional (6-20 point) 
scale with the rate of perceived exertion ranging from 10 
to 12 (‘fairly light’ to ‘somewhat hard’). 
Each session included warm-up (10 minutes), core 
session (25-30 minutes) and a cool-down period (10 
minutes). Warm-up and cool-down components involved 
walking and light stretching exercises for limbs, neck 
and trunk.  Additionally, the cool-down period included 
relaxation and pelvic floor exercises.  
The core portion involved moderate intensity aerobic 
exercises once weekly and resistance exercises twice a 
week. Aerobic dance took place for periods of 3 to 4 
minutes with 1-minute breaks and included stretching 
and relaxation. Resistance exercises for pectoral muscles, 
back, shoulder, upper and lower limb muscles aimed to 
improve posture, strengthen muscles of labour and pelvic 
floor and prevent lower back pain. They involved 
exercises using barbells (3 kg/exercise) or low-to-
medium resistance elastic and included biceps curls, arm 
side lifts and extensions, shoulder elevations, bench 
press, seated lateral row, leg circles and lateral leg 
elevations, knee (hamstring) curls and extensions, ankle 
flexions and extensions. 
Exercises such as jumping, ballistics, extreme stretching 
and joint overextension were avoided. Supine exercises 
were limited to a maximum of 2 minutes.  
Usual care with 
regular scheduled 






and physical activity 
counseling and they 




 Gestational weight gain (Weight 
at last clinic visit before delivery 





 Gestational diabetes 
 Hypertension 
 Gestational age at delivery 
 Type of delivery (Natural, 
instrumental or cesarean) 
 Time of dilation, expulsion and 
childbirth 
 Birth weight 
 Low birth weight 
 Macrosomia 
   
161 
  1359 
Study Year 
Language 





 White women ≥ 18 years  




 High-risk pregnancies 
 Diseases that could interfere 
with participation 
 Women who lived too far 
(more than 30-minute drive) 
from the hospitals  
 
Number of participants 
Intervention 375 
Control 327 
Standardized exercise program including aerobic 
activity, strength training, and balance exercises 
supervised by a physiotherapist. Training sessions  
in groups of 8–15 women offered once weekly for 12 
weeks (between 20 to 36 weeks of gestation ). Each 
session lasted 60 minutes. 
 
A written 45-minute home exercise program  
(30 minutes of endurance training and 15 minutes of 
strength/balance exercises) was recommended twice 
weekly and women were asked to record the exercise 
activities in personal training diaries. Physical activity 
was also assessed by questionnaires 











 Prevalence of GDM at 32-36 
weeks gestation 
 Insulin resistance estimated by 





 Maternal weight at follow-up 
 Weight gain at follow-up 
 Body mass index at follow-up 
 Preeclampsia 
 Gestational hypertension 
 Caesarean delivery 
 Operative vaginal delivery 
 Gestational age at delivery 
 Birth weight 
 Birth weight at least 4000 g 
 Apgar score 
 Admission to NICU  
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  1360 
Study Year 
Language 




 Pregnant women between 
10 to 29 weeks gestation 
 
Exclusion criteria: 
 Positive HIV test 




 Any conditions 
preventing women from 
undertaking exercise in 
pregnancy 
 Age above 35 years 
 
Number of participants  
Intervention 159 
Control  162 
Dietary counseling according to nutritional status. For 
pregnant women with low birth weight, was adopted as a 
priority to increase the energy density of the diet with the 
addition of a tablespoon of oil in the main meals, eat two 
snacks per day of high energy (with sample portions) 
100 g kid once a week and fruit daily. For normal weight 
pregnant women, it was directed fractionate the power 
six times a day, daily servings of vegetables, legumes, 
fruit and water; restrict the consumption of foods high in 
fat and oil preparations. For pregnant women with excess 
weight, between meals (three to four hours) were 
prioritized; not repeat the food portions of meals and 
snacks; restrict daily consumption of soft drinks and 
sweets, processed foods high in fat and also oil 
preparations. They were determined daily servings of 
vegetables, vegetables and fruit. All guidance provided 
values and portion sizes. 
 
The control group did 
not receive the 
dietary guidelines, 
but were informed 
about the nutritional 
status that had, and 
were asked to 
perform the prenatal 
care. 
 Gestational weight gain 
 Diabetes 
 Preeclampsia 







   
161 
  1361 
Study Year 
Language 
Participants Interventions Control Outcomes 









 Secundigravid women with 
previous macrosomic infant 
(birthweight > 4 kg) were 




 Women with medical 
disorders including history 
of gestational diabetes, 
 those on any drugs, and 
those unable to give full 
informed consent were 
excluded.  
 Age less than 18 years 
 Gestational age greater than 
18 weeks 
 Multiple pregnancy 
 
 
One two-hour dietary education session with the research 
dietitian in groups of two to six women. The diet was in 
line with current recommendations for pregnant women. 
General advice on healthy eating in pregnancy and 
following the food pyramid was provided. Women were 
taught about the rationale for having low glycaemic 
index food and encouraged to replace high glycaemic 
index carbohydrates for low glycaemic index 
alternatives. Written resources were provided after the 
education session. Women were not advised to reduce 
their total caloric intake. The research dietitian met again 
at 28 and 34 weeks’ gestation to reinforce the advice and 
clarify any doubts. All women completed three food 
diaries of three days each—before dietary intervention, 
in the second and third trimesters of pregnancy.  
A questionnaire was provided at 34 weeks visit to assess 
adherence to the diet. It was based on a five point Likert-
type scale (1=“I followed the recommended diet all of 
the time”; 5=“I followed the recommended diet none of 
the time”). 
Routine antenatal 







 Mean birth weight centiles and 
ponderal indices at 14, 28 and 34 





 Maternal weight gain at 14, 28 
and 34 weeks gestation, at birth 
and 3 months post-partum 
 Adherence to IOM 
recommendations for gestational 
weight gain 
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  1362 
Study Year 
Language 










 BMI ≥30 kg/m 2 
 Early pregnancy (15 ± 3 
weeks of gestation) 
 Non-diabetic at inclusion 
 
Exclusion criteria: 
 Smoking  
 Age below 18 or above 45 
years 
 Multiple pregnancy 
 Medical complications 
known to affect fetal growth 
adversely 
 Contraindication for 
limiting weight gain 
 
10-h dietary consultations (healthy diet, restriction of 
energy intake): The intervention group received 10 
consultations of 1 hour each with a trained dietitian 
during the pregnancy. Women were asked to eat a 
healthy diet according to the official Danish dietary 
recommendations [fat intake: max 30 energy percent 
(E%), protein intake: 15–20 E%, carbohydrate intake: 
50–55 E%]. Energy intake was restricted on the basis of 
individually estimated energy requirements and 
estimated energy requirements of fetal growth (energy 
requirement=basal metabolic rate x 1.4 (physical activity 
level factor of 1.2 + 0.2 added to cover energetic cost of 
fetal growth). 
No intervention  Gestational diabetes mellitus    
 Gestational age at delivery                  
 Pregnancy induced hypertension 
 Preeclampsia  
 Prolonged pregnancy 
 Cesarean delivery,                                    
 Total gestational weight gain 
(Weight at delivery minus self-
reported pre-pregnancy weight) 
 Weight gain from 15 weeks to 36 
week 
 Birth weight 
 Placental weight 
 Infant length 
 Head circumference 
 Abdominal circumference 
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  1363 
Study Year 
Language 







Control  8 
Inclusion criteria: 
 ≥ 18 years old 
 High risk of gestational 
hypertensive disorders 
(Mild hypertension, history 
of gestational hypertensive 
disorders or family history 
of hypertensive disorders) 
 
Exclusion criteria: 
 Diabetes mellitus 
 Renal disease  
 Multiple pregnancies 
 Extremely vigorous 
exercisers (more than 3 
times per week at a level 
above RPE 14 for longer 
than 30 min per session) 
Exercise of moderate intensity. 
Exercise sessions of 30 minutes each were held in a 
laboratory three times a week  
A motorized treadmill and bicycle ergometer were 
alternated. Exercise consisted of a five-minute warm-up 
using the Branching protocol, followed by a 30-minute 
steady state, and ended with a 10 minute cool down. 
Steady state was defined as RPE 13, which was 




No intervention  Resting blood pressure before 
and after 10 weeks of exercise 
 Mean Percentage body fat of 
mother  
 Percentage of time/energy spent 
on light/moderate /heavy exercise 
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1364 Study Year 
Language 






Gestational age less than 12 
weeks gestation plus one or 
more of the following: 
 History of preeclampsia 
 Type 2 diabetes 
 Chronic hypertension 
 BMI ≥ 30 kg/m2 either pre-
pregnancy or at first visit in 
the first trimester for 
primiparous women 
 Diastolic blood pressure ≥ 
90 mmHg before 12 weeks 
gestation  
 
Exclusion criteria:  
 Multiple pregnancy 
 Vaginal bleeding 
 Diagnosed placenta previa 
 Any condition prohibiting 
regular exercise (walking 
exercise and stretching) 
between 12 to 22 weeks 
gestation 
 Already exercising more 
thrice weekly during the 
first 11 weeks of pregnancy 
 
The women are divided into 3 
groups: Walking, stretching, 
and standard care 
 
Data unpublished 
There are two intervention groups, walking exercise and 
stretching and the intervention runs for 10 weeks and 
involves 30 minute activity three times a week. The 
participants are free to choose the days of exercise 
provided they have a rest day between two exercise days. 
Research staff will train both groups for the first 2 
weeks. Subsequently one session per week will be 
supervised and the remaining two unsupervised. 
Childcare facilities are arranged either onsite or by 
arranging exercise venues with child care arrangements. 
The  
 
Walking group: Walking exercise consists of 30 minutes 
moderate intensity walking in an environment (home, 
gym, workplace, neighborhood) agreed with the research 
staff. The exercise intensity is guided by a heart rate 
monitor and the Rate of Perceived Exertion (RPE). 
Women are advised to maintain the heart rate to 55-69% 
of age determined maximum heart rate (HRMAX) and are 
guided by the digital screen on their wrists that senses 
information from the chest belts they wear. The 
suggested Rate of Perceived Exertion is 12 or 13. If there 
is a discrepancy between heart rate and RPE, they are 
advised to keep both within/below the recommended 
limits.  
 
Stretching group: This consists of 30 minutes of 
stretching exercise thrice weekly without increasing the 
heart rate by more than 10% of the resting heart rate. The 
exercise involves slow muscle movements without 
aerobic or muscle resistance components, and 
participants are guided by a videotape showing 
recommended movements 
Research nurse visits 
for 30 minutes every 
other week to take 
measurements and is 
allowed to answer 
any queries related to 
healthy pregnancy 
and lifestyle 
 Recruitment Rate - 15 subjects in 
3 months 
 Feasibility of walking and 
stretching exercise: 85% of 
frequency and dropout rate within 
5 weeks < 10% due to social and 
behavioral reasons (excluding 
obstetrical reasons)  
 Feasibility of collecting 
scheduled blood samples, and 
establishing a protocol for 
measuring superoxide dismutase 




Appendix 4.11 Comparison of the effect estimates derived from study-level and Individual 1365 
Participant Data in the group of trials contributing to the i-WIP IPD meta-analysis 1366 
 1367 
 1368 
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Caesarean section 1374 
 1375 
 1376 
  1377 
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Appendix 5.1 Interactions between the effects of the interventions and women’s BMI – meta-1378 




Interaction term for  
one unit of change in average 
BMI 
I² (%) 
  Coef. (95% CI)  
Gestational weight gain  25 0.01 (-0.08, 0.11) 60.5% 
  OR (95% CI)  
Gestational diabetes  17 0.98 (0.93, 1.05) 44.2 
Preterm birth 16 0.98 (0.91, 1.04) 4.0 
Caesarean section 22 1.01 (0.99, 1.03) 0.0 





















Althuizen 2012 primary English main The Netherlands Yes specialist Mixed 3.407 
Asbee 2009 primary English main US Yes specialist Mixed 4.357 
Baciuk 2008 RepH08 primary English main Brazil Yes specialist Exercise 1.084 
Baciuk 2008 RepH09 subsequent English main Brazil Yes specialist Exercise 1.167 
Barakat 2008 BrJSpM primary English main Spain No specialist Exercise 2.126 
Barakat 2008 IntJOb subsequent English main Spain No specialist Exercise 4.343 
Barakat 2011 primary English main Spain Yes specialist Exercise 3.468 
Barakat 2012 primary English main Spain No specialist Exercise 3.668 
Barakat 2012a primary English main Spain Yes specialist Exercise 1.495 
Barakat 2013 primary English main Spain No specialist Exercise 3.668 
Blackwell 2002 primary English main US No specialist Diet 0.457 
Bogaerts 2012 primary English main Belgium No specialist Mixed 4.691 
Briley 2002 primary English main US No specialist Diet 2.868 
Callaway 2010 
ANZJObsGyn 
subsequent English pilot Australia Yes specialist Exercise 1.620 
Callaway 2010 
BMCPregC 
subsequent English pilot Australia Yes specialist Exercise 2.834 
Callaway 2010 DiabCare primary English pilot Australia No specialist Exercise 7.141 
Clapp 2000 primary English main US Yes specialist Exercise 2.600 


















de Oliveria Melo 2012 primary English main Brazil Yes specialist Exercise 4.730 
Deveer 2013 primary English main Turkey No specialist Diet 1.093 
Di Carlo 2014 primary English main Italy Yes specialist Diet 1.279 
Dodd 2014 BMCMed subsequent English main Australia No general Mixed 7.280 
Dodd 2014 BMJ primary English main Australia No general Mixed 16.3 
Garshasbi 2005 primary English main Iran Yes specialist Exercise 0.952 
Gomez Tabares 1994 primary 
Non-
English 
main Colombia Yes specialist Diet N/A 
Guelinckx 2010 primary English main Belgium No specialist Mixed 6.606 
Haakstad 2011 
BMCPregC 
subsequent English main Norway Yes specialist Exercise 2.834 
Haakstad 2011 
EurJCRepH 
primary English main Norway Yes specialist Exercise 1.456 
Harrison 2013 
IntJBehNPA 
subsequent English main Australia No specialist Mixed 3.680 
Harrison 2013 Obes primary English main Australia No specialist Mixed 4.389 
Hawkins 2015 primary English pilot US No specialist Mixed 3.064 
Hopkins 2010 primary English main New Zealand No specialist Exercise 6.495 
Huang 2011 primary English main Taiwan No specialist Mix 1.777 
Hui 2006 primary English pilot Canada No specialist Mix 0.411 
Hui 2011 primary English main Canada Yes specialist Mix 3.407 
Hui 2014 primary English main Canada Yes specialist Mix 2.150 


















Jackson 2010 primary English main US No specialist Mix 2.237 
Jeffries 2009 primary English main Australia No specialist Mix 2.894 
Jing 2015 primary English main China Yes specialist Mixed 1.563 
Khaledan 2010 primary 
Non-
English 
main Iran No specialist Exercise N/A 
Khoury 2005 primary English main Norway Yes specialist Diet 3.100 
Kong 2014 primary English pilot US No specialist Exercise 4.459 
Korpi-Hyovalti 2012 primary English main Finland No specialist Diet 3.013 
Lee 1996 primary English main UK No specialist Exercise N/A 
Luoto 2011 EurJClinNut subsequent English main Finland No specialist Mixed 2.462 
Luoto 2011 PlosMed primary English main Finland No general Mix 14.659 
Marquez 2000 primary English main US No specialist Exercise 2.363 
Nascimento 2011 primary English main Brazil Yes specialist Exercise 3.407 
Ong 2009 primary English main Australia No specialist Exercise 2.426 
Oostdam 2012 primary English main The Netherlands Yes specialist Exercise 3.407 
Perales 2014 primary English main Spain No specialist Exercise 1.482 
Perales 2014a primary English main Spain No specialist Exercise 1.415 
Petrella 2013 primary English main Italy Yes specialist Mixed 1.495 
Phelan 2011 primary English main US No specialist Mixed 6.669 


















Polley 2002 primary English main US No specialist Mixed 2.706 
Poston 2013 primary English pilot UK Yes specialist Mixed 2.834 
Prevedel 2003 primary 
Non-
English 
main Brazil Yes specialist Exercise N/A 
Price 2012 primary English pilot US No specialist Exercise 4.431 
Qiuling Li 2014 primary 
Non-
English 
main China No general Exercise N/A 
Quinlivan 2011 primary English main Australia Yes specialist Diet 1.237 
Ramirez Velez 2011 
JObsGyn 
primary English main Colombia Yes specialist Exercise 0.942 
Ramirez Velez 2011 
RevSPub 
subsequent English main Colombia No specialist Exercise 1.328 
Rauh 2013 primary English main Germany Yes specialist Mixed 2.150 
Renault 2013 primary English main Denmark Yes specialist Mixed 3.468 
Ronnberg 2014 primary English main Sweden Yes specialist Exercise 3.862 
Ruiz 2013 primary English main Spain No general Exercise 5.698 
Santos 2005 primary English main Brazil Yes specialist Exercise 3.700 
Sedaghati 2007 primary English main Iran No general Exercise N/A 
Stafne 2012 BJOG subsequent English main Norway Yes specialist Exercise 3.407 
Stafne 2012 ObsGyn primary English main Norway Yes specialist Exercise 4.730 
Thornton 2009 primary English main US No general Diet 1.275 
Vesco 2014 primary English main US No specialist Mixed 4.389 


















Vinter 2011 AOGS subsequent English main Denmark Yes specialist Mixed 2.005 
Vinter 2011 DiabCare primary English main Denmark No specialist Mixed 8.087 
Vinter 2011 DiabMed subsequent English main Denmark No specialist Mixed 3.064 
Vitolo 2011 primary 
Non-
English 
main Brazil Yes specialist Diet 0.608 
Walsh 2012 primary English main Ireland No general Diet 17.215 
Wolff 2008 primary English main Denmark No specialist Diet 3.640 
Yeo 2000 primary English main US Yes specialist Exercise 0.878 
N/A – not available 1383 





Appendix 6.2 List of measured outcomes reported in articles from trials with diet and physical 1387 
activity interventions in pregnancy not covered by the Delphi ranking 1388 
  1389 
Measured outcomes Number of studies 
Adequate for gestational age 3 
Adherence to intervention 7 
Admission to SCBU 1 
Anal incontinence 1 
Antepartum hospital admissions 2 
Biomarkers: insulin resistance 12 
Birth injury (Neonate) 1 
Bleeding 1 
Blood pressure (Mother) 14 
Blood pressure Postpartum (Mother) 1 
Body image (Mother) 2 
Bone density (Neonate) 1 
Breathlessness 1 
Calf pain 1 
Cardiovascular capacity (Mother) 1 
Chest pain 1 
Child weight development 1 
Chronic hypertension 1 
Composite: maternal morbidity 1 
Composite: Vascular complications 1 
Delivery: Mode of delivery 2 
Delivery: post term 3 
Delivery: term 1 
Delivery: vaginal 14 
Discharged home on oxygen 1 
Dizziness 1 
Endometritis (Mother) 1 
Energy expenditure (Mother) 2 
Energy intake 4 
Excessive weight gain IOM 23 
Fatigue 3 
Fecal incontinence 1 
Fetal blood circulation 1 
Fetal distress 1 
Fetal Harte Rate (FHR) 1 
Fitness level 6 
Flexibility of spine 1 
Food intake 13 
Food knowledge 1 
Gender (Neonate) 6 
Gestational age at delivery 47 
Headache 1 
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  1390 
Measured outcomes Number of studies 
Health promoting behavior 1 
Health Questionnaire (Mother) 1 
Hospitalization Postpartum 1 
Intrauterine growth restriction 2 
Ketonuria (Mother) 1 
Knowledge of weight gain guidelines 1 
Labor: Blood loss (Mother) 1 
Labor: Chorioamnionitis (Mother) 1 
Labor: Lacerations (Mother) 2 
Labor: pain score 1 
Level of physical activity Postpartum 1 
Lipids level (Neonate) 1 
Lipids levels (Mother) 4 
Low Birthweight 10 
Macrosomia 26 
Maternal Harte Rate 2 
Meconium 1 
Metabolic parameters (Neonate) 1 
Mother's death 3 
Musculoskeletal problems 1 
Nausea 3 
Necrotizing enterocolitis (Neonate) 1 
Need for GDM treatment 1 
Neonatal asphyxia 1 
Pain overall 2 
Painful contractions 1 
Patent ductus arteriosus 1 
Pelvic girdle 1 
Physical Discomfort 1 
Placenta size 4 
Polyhydramnios (Neonate) 1 
Postpartum hospital stay 1 
Postpartum recovery 1 
Proven systemic infection (Neonate) 1 
Respiratory disease (Neonate) 1 
Respiratory Distress Syndrome (RDS) 1 
Respiratory exchange (Mother) 2 
Respiratory morbidity (Neonate) 1 
Respiratory support 1 
Retinopathy (Neonate) 1 
Risk perception (Mother) 1 
Seizures (Neonate) 1 
Self-efficacy 1 
Skin temperature (Mother) 1 
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Appendix 6.3 Quality of outcome reporting in primary publications issued before and after 1391 
update of CONSORT statement in 2001 and 2010 1392 
N Median (IQR) N Median (IQR) Wilcoxon rank-sum 
Published ≤2001 Published>2001 p-value 
5 0.25 (0.0, 0.5) 61 0.6 (0.25, 0.83) 0.19 
Published ≤2010 Published>2010  
26 0.42 (0.25, 0.60) 40 0.67 (0.45, 0.83) <0.01 
 1393 
  1394 
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Appendix 7.1 List of considered confounders for the relationship between gestational weight 1395 
gain outside the Institute of Medicine ranges and adverse pregnancy outcomes 1396 
a) Outcome: any type of caesarean section 1397 
Considered confounders Remarks 
 Booking BMI (kg/m2) Stratification factor 
 Diabetes prior to pregnancy or in 
pregnancy 
Mandatory confounder 
 Age Potential confounder (1) 
 Gestational age at delivery Potential confounder (2) 
 Parity Potential confounder (3) 
 Smoking Potential confounder (4) 
 Education level Potential confounder (5) 
 Ethnic origin Potential confounder (6) 
 Exercise prior to pregnancy Potential confounder (7) 
 Pre-existing vascular disease such as 
hypertension 
Potential confounder (8) Available as ‘Baseline 
hypertension’ 
 Induction of labour Potential confounder (9) 
 Multiple pregnancy Only singletons in the dataset 
 Pregnancy interval of more than 
10 years 
Information not available in the dataset 
 Family history of pre-eclampsia Information not available in the dataset 
 Previous history of pre-eclampsia Information not available in the dataset 
 Pre-existing renal disease Information not available in the dataset 
 Previous macrosomia Information not available in the dataset 
 1398 
b) Outcome: baby born large for gestational age 1399 
Considered confounders Remarks 
 Booking BMI (kg/m2) Stratification factor 
 Diabetes prior to pregnancy or in 
pregnancy 
Mandatory confounder, available as any diabetes 
related event 
 Age Potential confounder (1) 
 Parity Potential confounder (2) 
 Smoking Potential confounder (3) 
 Education level Potential confounder (4) 
 Ethnic origin Potential confounder (5) 
 Exercise prior to pregnancy Potential confounder (6) 
  1400 
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Considered confounders Remarks 
 Pre-existing vascular disease such as 
hypertension 
Potential confounder (7), baseline hypertension  
 Multiple pregnancy Dataset with singleton pregnancy only 
 Previous macrosomia Low availability in the dataset 
 Pregnancy interval of more than 
10 years 
Information not available in the dataset 
 Family history of pre-eclampsia Information not available in the dataset 
 Previous history of pre-eclampsia Information not available in the dataset 
 Pre-existing renal disease Information not available in the dataset 
 1401 
c) Outcome: baby born small for gestational age 1402 
Considered confounders Remarks 
 Booking BMI (kg/m2) Stratification factor 
 Smoking Mandatory confounder 
 Age Potential confounder (1) 
 Parity Potential confounder (2) 
 Education level Potential confounder (3) 
 Ethnic origin Potential confounder (4) 
 Exercise prior to pregnancy Potential confounder (5) 
 Pre-existing vascular disease such as 
hypertension 
Potential confounder (6) 
 1403 
d) Outcome: delivery before 37 weeks’ gestation 1404 
Considered confounders Remarks  
 Booking BMI (kg/m2) Stratification factor 
 Smoking Mandatory confounder 
 Age Potential confounder (1) 
 Diabetes prior to pregnancy or in 
pregnancy 
Potential confounder (2) 
 Parity Potential confounder (3) 
 High blood pressure 
Potential confounder (4) Available as any 
hypertensive disease in pregnancy 
 Education level 
Potential confounder (5) Used as a proxy of 
socioeconomic status 
 Ethnic origin Potential confounder (6) 
 Exercise prior to pregnancy Potential confounder (6) 
 Multiple pregnancy Only singletons in the dataset 
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Appendix 7.2 Specification of regression models  1405 
** Outcome: Caesarean section  1406 
* Analysis within the IOM recommendation by BMI cat 1407 
* crude models 1408 
* All women 1409 
xtmelogit outcm_csbin gwg if adh_iom==1 || study_name:, or nolog 1410 
tab outcm_csbin if e(sample) 1411 
* Normal BMI 1412 
xtmelogit outcm_csbin gwg if adh_iom==1 & b_bmi_cat==0 || study_name:, or nolog 1413 
tab outcm_csbin if e(sample) 1414 
* Overweight  1415 
xtmelogit outcm_csbin gwg if adh_iom==1 & b_bmi_cat==1 || study_name:, or nolog 1416 
tab outcm_csbin if e(sample) 1417 
* Obese  1418 
xtmelogit outcm_csbin gwg if adh_iom==1 & b_bmi_cat==2 || study_name:, or nolog 1419 
tab outcm_csbin if e(sample) 1420 
 1421 
* adjusted models 1422 
* All women 1423 
xtmelogit outcm_csbin gwg i.b_bmi_cat anydiabetes age ga_delivery parity smoker_curr if 1424 
adh_iom==1 || study_name:, or nolog 1425 
tab outcm_csbin if e(sample) 1426 
* Normal BMI 1427 
xtmelogit outcm_csbin gwg anydiabetes age ga_delivery parity smoker_curr if adh_iom==1 1428 
& b_bmi_cat==0 || study_name:, or nolog 1429 
tab outcm_csbin if e(sample) 1430 
* Overweight 1431 
xtmelogit outcm_csbin gwg anydiabetes age ga_delivery parity smoker_curr if adh_iom==1 1432 
& b_bmi_cat==1 || study_name:, or nolog 1433 
tab outcm_csbin if e(sample) 1434 
* Obese 1435 
xtmelogit outcm_csbin gwg anydiabetes age ga_delivery parity smoker_curr if adh_iom==1 1436 
& b_bmi_cat==2 || study_name:, or nolog 1437 
tab outcm_csbin if e(sample) 1438 
 1439 
** Departure from the IOM recommendations 1440 
** Below the IOM recommendations 1441 
* crude models 1442 
 1443 
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* All women 1444 
xtmelogit outcm_csbin c.DR##i.direction if adh_iom!=1 || study_name:, or nolog 1445 
tab outcm_csbin direction if e(sample) 1446 
* Normal BMI 1447 
xtmelogit outcm_csbin c.DR##i.direction if adh_iom!=1 & b_bmi_cat==0 || study_name:, or 1448 
nolog 1449 
tab outcm_csbin direction if e(sample) 1450 
* Overweight  1451 
xtmelogit outcm_csbin c.DR##i.direction if adh_iom!=1 & b_bmi_cat==1 || study_name:, or 1452 
nolog 1453 
tab outcm_csbin direction if e(sample) 1454 
* Obese  1455 
xtmelogit outcm_csbin c.DR##i.direction if adh_iom!=1 & b_bmi_cat==2 || study_name:, or 1456 
nolog 1457 
tab outcm_csbin direction if e(sample) 1458 
 1459 
** Above the IOM recommendations 1460 
* All women 1461 
xtmelogit outcm_csbin c.DR##b(1).direction if adh_iom!=1 || study_name:, or nolog 1462 
* Normal BMI 1463 
xtmelogit outcm_csbin c.DR##b(1).direction if adh_iom!=1 & b_bmi_cat==0 || study_name:, 1464 
or nolog 1465 
* Overweight  1466 
xtmelogit outcm_csbin c.DR##b(1).direction if adh_iom!=1 & b_bmi_cat==1 || study_name:, 1467 
or nolog 1468 
* Obese  1469 
xtmelogit outcm_csbin c.DR##b(1).direction if adh_iom!=1 & b_bmi_cat==2 || study_name:, 1470 
or nolog 1471 
 1472 
* adjusted models 1473 
** Below the IOM recommendations 1474 
* All women 1475 
xtmelogit outcm_csbin c.DR##i.direction i.b_bmi_cat anydiabetes age ga_delivery parity 1476 
smoker_curr if adh_iom!=1 || study_name:, or nolog 1477 
tab outcm_csbin direction if e(sample) 1478 
* Normal BMI 1479 
xtmelogit outcm_csbin c.DR##i.direction anydiabetes age ga_delivery parity smoker_curr if 1480 
adh_iom!=1 & b_bmi_cat==0 || study_name:, or nolog 1481 
tab outcm_csbin direction if e(sample) 1482 
* Overweight  1483 
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xtmelogit outcm_csbin c.DR##i.direction anydiabetes age ga_delivery parity smoker_curr if 1484 
adh_iom!=1 & b_bmi_cat==1 || study_name:, or nolog 1485 
tab outcm_csbin direction if e(sample) 1486 
* Obese 1487 
xtmelogit outcm_csbin c.DR##i.direction anydiabetes age ga_delivery parity smoker_curr if 1488 
adh_iom!=1 & b_bmi_cat==2 || study_name:, or nolog 1489 
tab outcm_csbin direction if e(sample) 1490 
 1491 
** Above the IOM recommendations 1492 
* All women 1493 
xtmelogit outcm_csbin c.DR##b(1).direction i.b_bmi_cat anydiabetes age ga_delivery parity 1494 
smoker_curr if adh_iom!=1 || study_name:, or nolog 1495 
* Normal BMI 1496 
xtmelogit outcm_csbin c.DR##b(1).direction anydiabetes age ga_delivery parity smoker_curr 1497 
if adh_iom!=1 & b_bmi_cat==0 || study_name:, or nolog 1498 
* Overweight  1499 
xtmelogit outcm_csbin c.DR##b(1).direction anydiabetes age ga_delivery parity smoker_curr 1500 
if adh_iom!=1 & b_bmi_cat==1 || study_name:, or nolog 1501 
* Obese 1502 
xtmelogit outcm_csbin c.DR##b(1).direction anydiabetes age ga_delivery parity smoker_curr 1503 
if adh_iom!=1 & b_bmi_cat==2 || study_name:, or nolog 1504 
 1505 
** Outcome: Large for gestational age  1506 
* Within the IOM recommendations 1507 
* crude models 1508 
* All women 1509 
xtmelogit outcb_lga gwg if adh_iom==1 || study_name:, or nolog 1510 
tab outcb_lga if e(sample) 1511 
* Normal BMI 1512 
xtmelogit outcb_lga gwg if adh_iom==1 & b_bmi_cat==0 || study_name:, or nolog 1513 
tab outcb_lga if e(sample) 1514 
* Overweight  1515 
xtmelogit outcb_lga gwg if adh_iom==1 & b_bmi_cat==1 || study_name:, or nolog 1516 
tab outcb_lga if e(sample) 1517 
* Obese 1518 
xtmelogit outcb_lga gwg if adh_iom==1 & b_bmi_cat==2 || study_name:, or nolog 1519 
tab outcb_lga if e(sample) 1520 
 1521 
* adjusted models 1522 
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* All women 1523 
xtmelogit outcb_lga gwg i.b_bmi_cat anydiabetes age if adh_iom==1 || study_name:, or nolog 1524 
tab outcb_lga if e(sample) 1525 
* Normal BMI 1526 
xtmelogit outcb_lga gwg anydiabetes age if adh_iom==1 & b_bmi_cat==0 || study_name:, or 1527 
nolog 1528 
tab outcb_lga if e(sample) 1529 
* Overweight  1530 
xtmelogit outcb_lga gwg anydiabetes age if adh_iom==1 & b_bmi_cat==1 || study_name:, or 1531 
nolog 1532 
tab outcb_lga if e(sample) 1533 
* Obese 1534 
xtmelogit outcb_lga gwg anydiabetes age if adh_iom==1 & b_bmi_cat==2 || study_name:, or 1535 
nolog 1536 
tab outcb_lga if e(sample) 1537 
 1538 
* Departure from IOM recommendations 1539 
* Below IOM recommendations 1540 
* crude models 1541 
* All women 1542 
xtmelogit outcb_lga c.DR##i.direction if adh_iom!=1 || study_name:, or nolog 1543 
tab outcb_lga direction if e(sample) 1544 
* Normal BMI 1545 
xtmelogit outcb_lga c.DR##i.direction if adh_iom!=1 & b_bmi_cat==0 || study_name:, or 1546 
nolog 1547 
tab outcb_lga direction if e(sample) 1548 
* Overweight 1549 
xtmelogit outcb_lga c.DR##i.direction if adh_iom!=1 & b_bmi_cat==1 || study_name:, or 1550 
nolog 1551 
tab outcb_lga direction if e(sample) 1552 
* Obese 1553 
xtmelogit outcb_lga c.DR##i.direction if adh_iom!=1 & b_bmi_cat==2 || study_name:, or 1554 
nolog 1555 
tab outcb_lga direction if e(sample) 1556 
 1557 
* Above the IOM recommendations 1558 
* All women 1559 
xtmelogit outcb_lga c.DR##b(1).direction if adh_iom!=1 || study_name:, or nolog 1560 
* Normal BMI 1561 
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xtmelogit outcb_lga c.DR##b(1).direction if adh_iom!=1 & b_bmi_cat==0 || study_name:, or 1562 
nolog 1563 
* Overweight 1564 
xtmelogit outcb_lga c.DR##b(1).direction if adh_iom!=1 & b_bmi_cat==1 || study_name:, or 1565 
nolog 1566 
* Obese 1567 
xtmelogit outcb_lga c.DR##b(1).direction if adh_iom!=1 & b_bmi_cat==2 || study_name:, or 1568 
nolog 1569 
 1570 
* adjusted models 1571 
* Below the IOM recommendations 1572 
* All women 1573 
xtmelogit outcb_lga c.DR##i.direction i.b_bmi_cat anydiabetes age if adh_iom!=1 || 1574 
study_name:, or nolog 1575 
tab outcb_lga direction if e(sample) 1576 
* Normal BMI 1577 
xtmelogit outcb_lga c.DR##i.direction anydiabetes age if adh_iom!=1 & b_bmi_cat==0 || 1578 
study_name:, or nolog 1579 
tab outcb_lga direction if e(sample) 1580 
* Overweight 1581 
xtmelogit outcb_lga c.DR##i.direction anydiabetes age if adh_iom!=1 & b_bmi_cat==1 || 1582 
study_name:, or nolog 1583 
tab outcb_lga direction if e(sample) 1584 
* Obese 1585 
xtmelogit outcb_lga c.DR##i.direction anydiabetes age if adh_iom!=1 & b_bmi_cat==2 || 1586 
study_name:, or nolog 1587 
tab outcb_lga direction if e(sample) 1588 
 1589 
* Above IOM recommendations 1590 
* All women 1591 
xtmelogit outcb_lga c.DR##b(1).direction i.b_bmi_cat anydiabetes age if adh_iom!=1 || 1592 
study_name:, or nolog 1593 
* Normal BMI 1594 
xtmelogit outcb_lga c.DR##b(1).direction anydiabetes age if adh_iom!=1 & b_bmi_cat==0 || 1595 
study_name:, or nolog 1596 
* Overweight 1597 
xtmelogit outcb_lga c.DR##b(1).direction anydiabetes age if adh_iom!=1 & b_bmi_cat==1 || 1598 
study_name:, or nolog 1599 
* Obese 1600 
xtmelogit outcb_lga c.DR##b(1).direction anydiabetes age if adh_iom!=1 & b_bmi_cat==2 || 1601 
study_name:, or nolog 1602 
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** Outcome: Small for gestational age 1603 
 1604 
* Within the IOM recommendations 1605 
* crude models 1606 
* All women 1607 
xtmelogit outcb_sga gwg if adh_iom==1 || study_name:, or nolog 1608 
tab outcb_sga if e(sample) 1609 
* Normal BMI 1610 
xtmelogit outcb_sga gwg if adh_iom==1 & b_bmi_cat==0 || study_name:, or nolog 1611 
tab outcb_sga if e(sample) 1612 
* Overweight 1613 
xtmelogit outcb_sga gwg if adh_iom==1 & b_bmi_cat==1 || study_name:, or nolog 1614 
tab outcb_sga if e(sample) 1615 
* Obese 1616 
xtmelogit outcb_sga gwg if adh_iom==1 & b_bmi_cat==2 || study_name:, or nolog 1617 
tab outcb_sga if e(sample) 1618 
 1619 
* adjusted models 1620 
* All women 1621 
xtmelogit outcb_sga gwg i.b_bmi_cat smoker_curr age parity if adh_iom==1 || study_name:, 1622 
or nolog 1623 
tab outcb_sga if e(sample) 1624 
* Normal BMI 1625 
xtmelogit outcb_sga gwg smoker_curr age parity if adh_iom==1 & b_bmi_cat==0 || 1626 
study_name:, or nolog 1627 
tab outcb_sga if e(sample) 1628 
* Overweight 1629 
xtmelogit outcb_sga gwg smoker_curr age parity if adh_iom==1 & b_bmi_cat==1 || 1630 
study_name:, or nolog 1631 
tab outcb_sga if e(sample) 1632 
* Obese 1633 
xtmelogit outcb_sga gwg smoker_curr age parity if adh_iom==1 & b_bmi_cat==2 || 1634 
study_name:, or nolog 1635 
tab outcb_sga if e(sample) 1636 
 1637 
* Departure from IOM recommendations 1638 
* crude models 1639 
 1640 
* Below the IOM recommendations 1641 
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* All women 1642 
xtmelogit outcb_sga c.DR##i.direction if adh_iom!=1 || study_name:, or nolog 1643 
tab outcb_sga direction if e(sample) 1644 
* Normal  1645 
xtmelogit outcb_sga c.DR##i.direction if adh_iom!=1 & b_bmi_cat==0 || study_name:, or 1646 
nolog 1647 
tab outcb_sga direction if e(sample) 1648 
* Overweight  1649 
xtmelogit outcb_sga c.DR##i.direction if adh_iom!=1 & b_bmi_cat==1 || study_name:, or 1650 
nolog 1651 
tab outcb_sga direction if e(sample) 1652 
* Obese 1653 
xtmelogit outcb_sga c.DR##i.direction if adh_iom!=1 & b_bmi_cat==2 || study_name:, or 1654 
nolog 1655 
tab outcb_sga direction if e(sample) 1656 
 1657 
* Above the IOM recommendations 1658 
* All women 1659 
xtmelogit outcb_sga c.DR##b(1).direction if adh_iom!=1 || study_name:, or nolog 1660 
* Normal  1661 
xtmelogit outcb_sga c.DR##b(1).direction if adh_iom!=1 & b_bmi_cat==0 || study_name:, or 1662 
nolog 1663 
* Overweight  1664 
xtmelogit outcb_sga c.DR##b(1).direction if adh_iom!=1 & b_bmi_cat==1 || study_name:, or 1665 
nolog 1666 
* Obese 1667 
xtmelogit outcb_sga c.DR##b(1).direction if adh_iom!=1 & b_bmi_cat==2 || study_name:, or 1668 
nolog 1669 
 1670 
* adjusted models 1671 
* Below the IOM recommendations 1672 
* All women 1673 
xtmelogit outcb_sga c.DR##i.direction i.b_bmi_cat smoker_curr age parity if adh_iom!=1 || 1674 
study_name:, or nolog 1675 
tab outcb_sga direction if e(sample) 1676 
* Normal 1677 
xtmelogit outcb_sga c.DR##i.direction smoker_curr age parity if adh_iom!=1 & 1678 
b_bmi_cat==0 || study_name:, or nolog 1679 
tab outcb_sga direction if e(sample) 1680 
* Overweight 1681 
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xtmelogit outcb_sga c.DR##i.direction smoker_curr age parity if adh_iom!=1 & 1682 
b_bmi_cat==1 || study_name:, or nolog 1683 
tab outcb_sga direction if e(sample) 1684 
* Obese 1685 
xtmelogit outcb_sga c.DR##i.direction smoker_curr age parity if adh_iom!=1 & 1686 
b_bmi_cat==2 || study_name:, or nolog 1687 
tab outcb_sga direction if e(sample) 1688 
 1689 
* Above the IOM recommendations 1690 
* All women 1691 
xtmelogit outcb_sga c.DR##b(1).direction i.b_bmi_cat smoker_curr age parity if adh_iom!=1 1692 
|| study_name:, or nolog 1693 
* Normal 1694 
xtmelogit outcb_sga c.DR##b(1).direction smoker_curr age parity if adh_iom!=1 & 1695 
b_bmi_cat==0 || study_name:, or nolog 1696 
* Overweight 1697 
xtmelogit outcb_sga c.DR##b(1).direction smoker_curr age parity if adh_iom!=1 & 1698 
b_bmi_cat==1 || study_name:, or nolog 1699 
* Obese 1700 
xtmelogit outcb_sga c.DR##b(1).direction smoker_curr age parity if adh_iom!=1 & 1701 
b_bmi_cat==2 || study_name:, or nolog 1702 
 1703 
** Outcome: Preterm birth 1704 
* Within the IOM recommendations 1705 
* crude models 1706 
* All women 1707 
xtmelogit outcm_preterm gwg if adh_iom==1 || study_name:, or nolog 1708 
tab outcm_preterm if e(sample) 1709 
* Normal 1710 
xtmelogit outcm_preterm gwg if adh_iom==1 & b_bmi_cat==0 || study_name:, or nolog 1711 
tab outcm_preterm if e(sample) 1712 
* Overweight 1713 
xtmelogit outcm_preterm gwg if adh_iom==1 & b_bmi_cat==1 || study_name:, or nolog 1714 
tab outcm_preterm if e(sample) 1715 
* Obese 1716 
xtmelogit outcm_preterm gwg if adh_iom==1 & b_bmi_cat==2 || study_name:, or nolog 1717 
tab outcm_preterm if e(sample) 1718 
 1719 
* adjusted models 1720 
* All women 1721 
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xtmelogit outcm_preterm gwg i.b_bmi_cat smoker_curr if adh_iom==1 || study_name:, or 1722 
nolog 1723 
tab outcm_preterm if e(sample) 1724 
* Normal 1725 
xtmelogit outcm_preterm gwg smoker_curr if adh_iom==1 & b_bmi_cat==0 || study_name:, 1726 
or nolog 1727 
tab outcm_preterm if e(sample) 1728 
* Overweight 1729 
xtmelogit outcm_preterm gwg smoker_curr if adh_iom==1 & b_bmi_cat==1 || study_name:, 1730 
or nolog 1731 
tab outcm_preterm if e(sample) 1732 
* Obese 1733 
xtmelogit outcm_preterm gwg smoker_curr if adh_iom==1 & b_bmi_cat==2 || study_name:, 1734 
or nolog 1735 
tab outcm_preterm if e(sample) 1736 
 1737 
* Departure from the IOM recommendations 1738 
 1739 
* Below the IOM recommendations 1740 
* Overall 1741 
xtmelogit outcm_preterm c.DR##i.direction if adh_iom!=1 || study_name:, or nolog 1742 
tab outcm_preterm direction if e(sample) 1743 
* By BMI category  1744 
* Normal BMI 1745 
xtmelogit outcm_preterm c.DR##i.direction if adh_iom!=1 & b_bmi_cat==0 || study_name:, 1746 
or nolog 1747 
tab outcm_preterm direction if e(sample) 1748 
* Overweight  1749 
xtmelogit outcm_preterm c.DR##i.direction if adh_iom!=1 & b_bmi_cat==1 || study_name:, 1750 
or nolog 1751 
tab outcm_preterm direction if e(sample) 1752 
* Obese 1753 
xtmelogit outcm_preterm c.DR##i.direction if adh_iom!=1 & b_bmi_cat==2 || study_name:, 1754 
or nolog 1755 
tab outcm_preterm direction if e(sample) 1756 
 1757 
*Above the IOM recommendations 1758 
* Overall 1759 
xtmelogit outcm_preterm c.DR##b(1).direction if adh_iom!=1 || study_name:, or nolog 1760 
* Normal BMI 1761 
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xtmelogit outcm_preterm c.DR##b(1).direction if adh_iom!=1 & b_bmi_cat==0 || 1762 
study_name:, or nolog 1763 
* Overweight  1764 
xtmelogit outcm_preterm c.DR##b(1).direction if adh_iom!=1 & b_bmi_cat==1 || 1765 
study_name:, or nolog 1766 
* Obese 1767 
xtmelogit outcm_preterm c.DR##b(1).direction if adh_iom!=1 & b_bmi_cat==2 || 1768 
study_name:, or nolog 1769 
 1770 
* adjusted models 1771 
* Below the IOM recommendations 1772 
* Overall 1773 
xtmelogit outcm_preterm c.DR##i.direction i.b_bmi_cat smoker_curr if adh_iom!=1 || 1774 
study_name:, or nolog 1775 
tab outcm_preterm direction if e(sample) 1776 
* Normal BMI 1777 
xtmelogit outcm_preterm c.DR##i.direction smoker_curr if adh_iom!=1 & b_bmi_cat==0 || 1778 
study_name:, or nolog 1779 
tab outcm_preterm direction if e(sample) 1780 
* Overweight 1781 
xtmelogit outcm_preterm c.DR##i.direction smoker_curr if adh_iom!=1 & b_bmi_cat==1 || 1782 
study_name:, or nolog 1783 
tab outcm_preterm direction if e(sample) 1784 
* Obese 1785 
xtmelogit outcm_preterm c.DR##i.direction smoker_curr if adh_iom!=1 & b_bmi_cat==2 || 1786 
study_name:, or nolog 1787 
tab outcm_preterm direction if e(sample) 1788 
 1789 
*Above the IOM recommendations 1790 
* Overall 1791 
xtmelogit outcm_preterm c.DR##b(1).direction i.b_bmi_cat smoker_curr if adh_iom!=1 || 1792 
study_name:, or nolog 1793 
* Normal BMI 1794 
xtmelogit outcm_preterm c.DR##b(1).direction smoker_curr if adh_iom!=1 & b_bmi_cat==0 1795 
|| study_name:, or nolog 1796 
* Overweight 1797 
xtmelogit outcm_preterm c.DR##b(1).direction smoker_curr if adh_iom!=1 & b_bmi_cat==1 1798 
|| study_name:, or nolog 1799 
* Obese 1800 
xtmelogit outcm_preterm c.DR##b(1).direction smoker_curr if adh_iom!=1 & b_bmi_cat==2 1801 
|| study_name:, or nolog 1802 
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All women    
Preterm birth 81/1286, 6.30 57/1483, 3.84 49/1643, 2.98 
Any Caesarean section 277/1271, 21.79 340/1456, 23.35 503/1618, 31.09 
Large for gestational age  92/1291, 7.13 135/1492, 9.05  267/1646, 16.22  
Small for gestational age 186/1280, 14.53  157/1482, 10.59 117/1641, 7.13  
Normal BMI    
Preterm birth 34/647, 5.26 22/662, 3.32 14/309, 4.53 
Any Caesarean section 83/636, 13.05 112/649, 17.26 68/300, 22.67 
Large for gestational age  48/649, 7.40 62/663, 9.35 49/310, 15.81 
Small for gestational age 76/642, 11.84 64/662, 9.67 26/308, 8.44 
Overweight    
Preterm birth 15/241, 6.22 19/360, 5.28 13/640, 2.03 
Any Caesarean section 54/239, 22.59 76/351, 21.65 174/631, 27.58 
Large for gestational age  14/242, 5.79 37/362, 10.22 104/641, 16.22 
Small for gestational age 33/241, 13.69 39/360, 10.83 31/640, 4.84 
Obese    
Preterm birth 32/398, 8.04 16/461, 3.47 22/694, 3.17 
Any Caesarean section 140/396, 21.79 152/456, 33.33 261/687, 37.99 
Large for gestational age  30/400, 7.50 36/467, 7.71 114/695, 16.40 
Small for gestational age 77/397, 19.40 54/460, 11.74 60/693, 8.66 
n, number of events; N, number of participants; BMI, Body Mass Index; IOM, Institute of Medicine 1804 
 1805 
  1806 
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Appendix 7.4 Summary of women’s BMI values in the individual studies (control arms)  1807 
----------------+------------------------------------------------------------ 1808 
       Study ID |         N      mean       p50       p25       p75       IQR 1809 
----------------+------------------------------------------------------------ 1810 
 Althuizen 2012 |        98  24.63467  23.82395  22.07191  25.84027  3.768362 1811 
    Baciuk 2008 |        37  23.44865      22.6      20.8      24.7  3.900002 1812 
   Barakat 2008 |        68  23.52538  23.18855   21.2562  25.32342  4.067217 1813 
  Barakat 2012a |       143  24.04824   23.4375  21.63115  25.39063  3.759476 1814 
  Bogaerts 2012 |        63  34.42619     33.62     30.76     37.47  6.710001 1815 
      Dodd 2014 |       779  32.33017        31      27.6      35.4  7.800001 1816 
 Guelinckx 2010 |        55  33.84554  32.41922  30.17882  36.93213  6.753304 1817 
  Haakstad 2011 |        40  25.40345  24.81339   22.6717  27.01273  4.341032 1818 
  Harrison 2013 |       103   30.9632  28.61703  25.83978   35.2784  9.438614 1819 
       Hui 2011 |        86  25.84535      25.1        22        28         6 1820 
  Jeffries 2009 |       110  25.34926  24.63958  22.04779  27.18163  5.133839 1821 
  Khaledan 2010 |        21  28.86803  29.02494  26.37024  31.24499  4.874756 1822 
    Khoury 2005 |       103  24.15098  23.98752  22.57563  25.63201  3.056385 1823 
     Luoto 2011 |       166  26.58152  26.22571  23.52941  29.05475  5.525341 1824 
Nascimento 2011 |        41  38.01005  37.63132  32.47498  41.83867  9.363686 1825 
       Ong 2009 |         5  34.09023  32.31834  31.66208  36.07157  4.409492 1826 
   Oostdam 2012 |        39  34.58955  34.15533   31.4133  36.04343  4.630131 1827 
   Perales 2014 |        74  24.36338    23.265     21.35     25.71  4.359999 1828 
  Petrella 2013 |        28  33.09059      31.6     27.75  37.93438  10.18438 1829 
    Phelan 2011 |       195  27.72668  26.42051  23.49711   31.1191   7.62199 1830 
   Poston unpub |       221  37.06561      36.1      33.1      39.4  6.300003 1831 
  Prevedel 2003 |        18  25.47645  23.89095   21.6409  25.84648   4.20558 1832 
      Rauh 2013 |        77  24.77493     23.31     21.18     26.75      5.57 1833 
   Renault 2013 |       132  34.32167  33.18733  31.65409  36.26231  4.608221 1834 
      Ruiz 2013 |       457  23.86211     23.03     21.26      25.4  4.139999 1835 
  Sagedal unpub |       286  24.55519  23.61073  21.79931  26.06168  4.262371 1836 
    Stafne 2012 |       340  24.86972  24.39019  22.53685  26.37694  3.840092 1837 
    Vinter 2011 |       148  34.32917  33.47135  31.80073  36.94463  5.143908 1838 
    Vitolo 2011 |       149  25.71625  24.91588  22.40588  27.88762  5.481741 1839 
     Walsh 2012 |       317   26.9183      25.7      23.7      29.2       5.5 1840 
     Wolff 2008 |        30  34.75333        34      32.1      36.6       4.5 1841 
       Yeo 2000 |         0         .         .         .         .         . 1842 
      Yeo unpub |         0         .         .         .         .         . 1843 
----------------+------------------------------------------------------------ 1844 
          Total |      4429  28.32074  26.79244  23.38714      32.2  8.812857 1845 
----------------------------------------------------------------------------- 1846 
 1847 
 1848 
